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Summary 
Budding yeast Slx4 binds to the structure-specific DNA repair nucleases Slx1 and 
Rad1XPF-Rad10ERCC1, and it was reported that Slx4 is essential for DNA flap 
cleavage by Rad1XPF-Rad10ERCC1 during certain types of DNA repair in yeast. At the 
outset of this thesis, bioinformatic analyses identified the uncharacterised protein 
BTBD12 in higher eukaryotes as a putative orthologue of yeast Slx4. In the first 
results chapter of this thesis, I describe the identification of BTBD12-interacting 
proteins, including XPF-ERCC1 and SLX1. These findings led me to refer to 
BTBD12 as human SLX4. I found that SLX4 binds to another structure-specific 
nuclease MUS81-EME1, and other proteins involved in telomere maintenance and 
cell cycle progression. The remainder of this chapter describes detailed biochemical 
analysis of the nuclease activities associated with the SLX4 complex isolated from 
human cells.  
 
Work from this lab and others revealed that depletion of SLX4 from human cells 
using siRNAs causes defects in the repair of DNA interstrand crosslinks (ICLs). 
Inherited mutations in humans that reduce the efficiency of ICL repair cause Fanconi 
anaemia (FA). The cellular sensitivity of SLX4 depleted cells to ICLs prompted me 
to investigate SLX4 as a candidate FA gene. Dr. Johan de Winter (VU University 
Medical Center, Amsterdam) and Dr. Detlev Schindler (University of Wurzburg) 
had identified several patients with unclassified FA that was not caused by mutations 
in the FA genes known at the time. In the second results I describe characterisation 
of SLX4, and the SLX4 holo-complex, in cells from some of these FA patients who 
had bi-allelic SLX4 mutations. In three of the patients SLX4 was expressed at 
normal levels but was missing part of the first, and all of the second, UBZ-type 
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putative ubiquitin-binding domain. This prompted me to investigate the function of 
the SLX4 UBZ domains. I found that the first, but not the second, UBZ domain of 
SLX4 binds to ubiquitin in vitro and targets SLX4 to sites of DNA damage in vivo. 
Furthermore, the first but not the second SLX4 UBZ domain appears to be required 
for ICL repair, demonstrating the important of correctly localising SLX4 for DNA 
repair.  
 
In the final chapter, I present preliminary data which suggests that SLX4 is regulated 
in an unusual manner in during S-phase of the cell cycle, and that SLX4 interacts 
with the PLK1 kinase in a phosphorylation-dependent manner.  
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Chapter I 
 
1 Introduction 
1.1 The DNA damage response 
Damage to DNA represents a continuous threat to the integrity of the nuclear genome 
and can be caused by a wide range of sources including DNA metabolic processes, 
cellular metabolites or exogenous DNA-damaging agents. These can cause different 
types of damage. Usually DNA damage is repaired quickly but, if not repaired, it can 
cause cell death or mutations that can lead to the development of diseases such as 
cancer. This threatens the survival of the organism or the integrity of the genetic 
information passed on to offspring (Fig. 1.1). To counteract the potentially devastating 
consequences of DNA damage, the DNA damage response (DDR) has evolved in 
eukaryotic cells. This is a complex signalling network that can sense DNA damage and 
initiate cell cycle arrest, DNA repair or apoptosis. Defects in the DNA damage response 
can cause genetic diseases such as Fanconi anaemia (FA) or xeroderma pigmentosum 
(XP). This shows the importance of an intact DDR. 
 
1.2 Different types of DNA damage 
Cellular DNA is constantly threatened by both endogenous and exogenous factors. 
Examples of different types of DNA lesions and the repair pathways that can rectify 
them, are shown in Figure 1.1.  
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Figure 1.1: Common sources of DNA lesions and the pathways that can repair them. Top: 
Common DNA damaging agents and the types of DNA lesions they induce; Bottom: The main 
DNA repair pathways are shown. Abbreviations: cis-Pt, cisplatin; MMC, mitomycin C; (6-4)PP, 
6-4 photoproduct; NHEJ, non-homologous end joining; HR, homologous recombination 
(modified from (Hoeijmakers, 2001a)) 
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Endogenous sources of DNA damage include the misincorporation of dNTPs during 
replication. Other examples are oxidation of DNA bases, deamination, depurination and 
DNA alkylation. All of these cause alterations in DNA that can be potentially 
deleterious (Lindahl & Barnes, 2000) and it has been estimated that every cell could 
experience up to 105 spontaneous lesions every day (Hoeijmakers, 2009). 
Exogenous sources of DNA damage are diverse. Among the environmental factors, UV 
light causes pyrimidine dimers. Ionising radiation (e.g. from cosmic radiation) causes 
single-strand breaks (SSBs) and double-strand breaks (DSBs), which if not repaired 
correctly can cause genomic rearrangements. Cigarette smoke for example, contains 
many compounds that can cause DNA damage, mainly DNA adducts, and 40 years of 
smoking can result in up to 1000 DNA lesions per cell (Phillips et al, 1988). 
 
Many drugs used in chemotherapy cancer treatment work by inducing DNA damage. 
Drugs such as cisplatin or mitomycin-C (MMC) induce covalent linkages of bases on 
the same (intrastrand crosslinks) or opposite (interstrand crosslinks) DNA strands. 
Inhibitors of topoisomerases I or II, such as camptothecin and etoposide, cause DSBs 
and SSBs by trapping topoisomerase–DNA covalent complexes. Table 1.1 illustrates the 
different types of DNA damage and the estimated number of DNA lesions per cell per 
day (modified from (Ciccia & Elledge, 2010). 
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Endogenous DNA damage DNA lesion generated Number lesions /cell/day 
Depurination AP site 10000 (Lindahl & Barnes, 2000) 
Cytosine deamination Base transition 100-500 (Lindahl and Barnes, 2000) 
Oxidation 8oxoG 400-1500 (Klungland et al, 1999) 
Replication DSB ~50 (Vilenchik and Knudson, 2003) 
  
Exogenous DNA damage Dose exposure (mSv) DNA lesion 
generated 
Number lesions/cell 
Sunlight (peak hr) - Pyrimidine dimers 100.000/day 
(Hoeijmakers, 2009) 
Cigarette smoke - Aromatic DNA 
adducts 
45-1029 (1-2 packs a day, 
~40 years) (Philips at al., 
1988) 
Body CT* 7 DSBs 0.28 
 
 
 
 
1.3 DNA base damage 
DNA as the carrier of all genetic information is subject to instability and decay 
(Lindahl, 1993). Damage to DNA bases is very common; the majority of lesions are 
spontaneous and caused by oxidation, alkylation or deamination of bases. For example, 
reactive oxygen species (ROS) arise during cellular metabolism and can react with 
guanine (G), resulting in the generation of 8-oxo-guanine (Kasai et al, 1984), that can 
lead to mutation during DNA replication. Spontaneous deamination of DNA bases can 
also occur for example cytosine can undergo hydrolytic deamination giving rise to 
uracil (Shapiro, 1972). Deamination of 5-methylcytosines, resulting in the formation of 
thymine with the potential to cause G:T mispairing, happens  approximately 2–3 times 
faster than at cytosine residues (Lindahl, 1979; Shen et al, 1994). Deamination of 
Table 1.1:  Examples of lesions induced by both endogenous and exogenous factors. The 
type of DNA damage and the estimated number of DNA lesions are shown. *Based on the 
effective dose received by the whole body. The number of DSBs has been calculated 
assuming that mammalian cells irradiated with 1 Sv (corresponding to 1 Gy for X and ã-rays) 
experience approximately 40 DSBs (Modified from (Ciccia & Elledge, 2010). 
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guanine and adenine residues to hypoxanthine or xanthine respectively also occurs, but 
much more slowly, at a rate of just 2–3% of cytosine deamination (Karran & Lindahl, 
1980; Lindahl, 1979). Alkylating agents are usually electrophilic reagents that attack the 
nucleophilic centres of DNA leading to base alkylation. S-adenosylmethionine is a 
metabolic intermediate that can readily donate alkyl groups to the nucleophilic centres 
in DNA bases, leading to lesions such as N7˗methylguanine and N3–methyladenine. 
N3-methyladenine is a strong replication block that impedes replication fork 
progression (Beranek, 1990; Sancar & Reardon, 2004). 
 
So called abasic sites (apurinic or apyrimidinic (AP) sites) can arise by spontaneous 
base loss. This is due to slow hydrolysis of the N-glycosyl bonds that link bases to the 
DNA sugar–phosphate backbone; these bonds are perhaps the most vulnerable in DNA. 
Approximately 103 bases are lost every day in every cell by spontaneous hydrolysis 
(Lindahl & Andersson, 1972).  
 
Base damage is also caused by ultraviolet light (UV) forming “photoproducts”. 
Cyclobutane pyrimidine dimers (CPDs) are the most frequent photoproducts that are 
formed  by a UV-induced four-membered ring structure between adjacent pyrimidines 
within a DNA strand (Lober & Kittler, 1977). CPDs distort the DNA structure because 
the two adjacent pyrimidines are pulled closer to each other than usual thus blocking 
DNA replication and transcription (Chan et al, 1985). 
 
1.3.1 Repair of DNA base damage 
The simplest way of repairing damaged bases is a mechanism in which base alkylation 
is reversed. Alkyl groups on guanines, for example, can be removed by O6MeG DNA 
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methyltransferases (MGMT). In yeast and bacteria, UV-induced pyrimidine dimers can 
be directly reversed by photolyases (Sancar, 2004). However, most lesions are repaired 
by more complex mechanisms such as base excision repair (BER) and nucleotide 
excision repair (NER). 
 
1.3.2 Base excision repair 
BER mainly removes small, non-helix-distorting base lesions from the genome, such 
as alkylated bases (for example N3-methyladenine), oxidised bases (8-oxo-guanine), 
deaminated bases (xanthine and hypoxanthine) and uracil (formed by deamination of 
cytosine). During BER the damaged base is removed and replaced. The core BER 
pathway consists of four proteins: a DNA glycosylase, an AP endonuclease or AP 
DNA lyase, a DNA polymerase and a DNA ligase. Depending on the initial steps of 
base removal, the repaired gap might be a single nucleotide (single patch) or 2–10 
nucleotides (long patch) (Frosina et al, 1996). The initial step of BER is the 
recognition of the damaged base by DNA glycosylases, which are enzymes that can 
recognise and bind a range of structurally different types of damaged bases. 
Glycosylases catalyse the cleavage of an N-glycosidic bond, removing the damaged 
base and leaving an abasic site in the DNA (Barnes et al, 1993). In addition to 
catalyse the cleavage of the N-glycosidic bond, some glycosylases are bifunctional 
and have AP lyase activity (O’Connor and Laval, 1989). The DNA backbone is 
cleaved either by an AP endonuclease or an AP lyase. The AP endonuclease creates 
a single stranded DNA nick 5’ to the AP site whereas the AP lyase creates a nick 3’ 
to the AP site. The short patch pathway is used when the phosphodiester bond is 
cleaved 3′ to the AP site. Then an AP endonuclease, for example APE1 (apurinic 
endonuclease 1), cleaves the bond 5′ to the AP site and creates a single nucleotide 
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gap. Then polymerase β (POLβ) is recruited to fill the gap with the correct 
nucleotide and the LIG3 (DNA ligase 3) / XRCC1 complex completes the process 
(Matsumoto & Kim, 1995; Sancar et al, 2004). 
 
The long patch pathway is used when the AP site is generated by spontaneous 
hydrolysis or oxidative base loss. APE1 cleaves the 5′ phosphodiester bond 5′ to the AP 
site and POL δ/ε (DNA polymerase δ/ε) carries out repair synthesis and nick translation, 
displacing several nucleotides (Frosina et al, 1996; Klungland & Lindahl, 1997). The 
endonuclease FEN1 can cleave the resulting flap structure and DNA ligase 1 complete 
the repair by sealing the break (Frosina et al, 1996; Klungland & Lindahl, 1997). 
 
1.3.3 Nucleotide excision repair (NER) 
NER is the main pathway for the removal of bulky, helix-distorting lesions, such as 
UV-induced lesions. It is a complicated excision repair system involving over 30 
different proteins and defects in NER cause extreme photosensitivity and predisposition 
to skin cancer, as observed in patients with xeroderma pigmentosum (XP). XP is caused 
by defects in any of the seven currently known XP complementation groups (XPA – 
XPG and the variant form XPV). Other diseases associated with defects in NER are 
Cockayne syndrome (CS) that is caused by mutations in CSA or CSB, and 
trichothiodistrophy (TTD), caused by mutations in XPD, XPB or p8/TTDA or TTCN1. 
XPD, XPB and p8/TTDA are subunits of the NER factor TFIIH. CS and TTD are 
characterised by physical and mental retardation, cutaneous photosensitivity and a short 
life span (Cleaver et al, 2009). Interestingly patients with CS or TTD do not develop 
skin cancer, in contrast to patients suffering from XP.  
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There are two main modes of NER: repair of lesions over the entire genome is known as 
global genome NER (GG-NER) while repair of lesions which block transcription is 
called transcription coupled NER (TC-NER). The main difference between these two 
pathways is the damage recognition step (Nouspikel, 2009) (Fig. 1.2). 
 
In GG-NER the XPC-hHR23B complex detects the DNA lesion, for example UV-
damage, and is involved in recruitment of the other NER repair factors (Sugasawa et al, 
1998) (Fig. 1.2). In the case of lesions that are poorly recognised by XPC-hHR23B, the 
DDB1 (DNA damage binding protein 1) and DDB2/XPE (DNA damage binding protein 
2 or XPE) facilitate lesion recognition (Nouspikel, 2009). In TC-NER, DNA damage 
recognition is independent of XPC-hHR23B. Instead the elongating polymerase II 
(POLII) that becomes blocked by the lesion on the transcribed DNA strand acts as 
damage sensor and initiates repair (Donahue et al, 1994; Hanawalt & Mellon, 1993). 
The blocked polymerase is then removed, by the proteins CSA and CSB (Nouspikel, 
2009), allowing the recruitment of downstream repair factors to the lesion. The later 
events in TC-NER and GG-NER are very similar: following damage recognition the 
pre-incision complex is formed, consisting of TFIIH, the helicases XPB and XPD and 
the proteins XPA and RPA (Bankmann et al, 1992). The pre-incision complex unwinds 
the double helix at the site of the lesion. XPA is believed to “verify” the DNA lesion 
and to be involved in the positioning of the structure-specific endonucleases (SSEs) 
XPF-ERCC1 and XPG at the sites of the lesion (de Laat et al, 1999). RPA (replication 
protein A) is important for the stabilisation of the unwound lesion (Evans et al, 1997). 
The bubble-like intermediate of unwound DNA is cleaved by XPG and XPF-ERCC1. 
XPG cleaves at the 3′ side and XPF-ERCC1 at the 5′ sites of the DNA lesion. This 
allows the excision of a fragment of about 24-32 nucleotides that contains the lesion. 
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The resulting gap is filled by DNA polymerase δ or ε, followed by ligation of the nick 
by a DNA ligase I (Prakash & Prakash, 2000; Shivji et al, 1995). 
 
 
 
 
 
Figure 1.2: Nucleotide excision repair. In GG-NER the XPC-hHR23B complex screens for 
helix distorting lesions. In TC-NER stalling of RNA polymerase II is critical. CSB and CSA 
displace POLII to make the lesion accessible for repair factors. The XPB and XPD helicases 
of the multi-subunit transcription factor TFIIH unwind the DNA around the lesion (II). XPA 
probes for the presence of the lesion and RPA stabilises the open DNA structure (III). The 
endonucleases XPF-ERCC1 and XPG cleave 5′ and 3′ of the DNA lesion. This generates a 
gap of 24-32 bases (IV). Replication factors then fill the gap. (Taken from Hoeijmakers, 
2001). 
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1.4 DNA Single strand breaks (SSBs) 
SSBs are common DNA lesions in cells (Bradley & Kohn, 1979). The major cause of 
SSBs is endogenous reactive oxygen species (ROS) and they can also be caused by 
ionising radiation (IR) and abortive DNA-topoisomerase I activity, or they can arise 
during BER of abasic sites (Demple & DeMott, 2002; Dianov & Parsons, 2007).  
 
1.4.1 Repair of DNA single strand breaks  
SSBs are detected by poly-(ADP-ribose) polymerase (PARP) -1 with contributions from 
of other members of the PARP superfamily (Ame et al, 2004). Activation of PARP 
leads to formation of poly (ADP-ribose) (PAr)- chains within seconds of the lesion 
being recognised. This is considered to be one of the earliest events in DDR. The 
attachment of PAr chains on histones is called PArylation. This leads to chromatin 
reorganisation, which allows repair factors to be recruited to the DNA damage site 
(Poirier et al, 1982). After PAr-chain formation, PARP1 quickly dissociates from DNA 
and PAr is rapidly degraded by poly(ADP-ribose) glycohydrolase (PARG) (Davidovic 
et al, 2001). 
 
After PARP1 dissociation repair of the SSB depends on the nature of the 3′ and 5′ ends 
of the SSB. DNA polymerase β (POL β) can recognise a SSB of a one nucleotide gap 
with 3′-hydroxyl and 5′-phosphate or 3′-hydroxyl and 5′-deoxyribose phosphate ends. 
Then the 5′-deoxyribose phosphate is removed by the lyase activity of POL β after gap 
filling, and the XRCC1-DNA ligase IIIα complex is recruited to seal the gap. 
If the SSB contains modified ends, a different pathway is used. Modified ends such as 
5′-hydroxyl, 3′-phosphate or adenylated 5′-phosphates are recognised by processing 
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enzymes such as AP endonuclease 1 (APE1), polynucleotide kinase (PNK), aprataxin 
and tyrosyl-DNA phosphodiesterase 1 (TDP1) (Caldecott, 2004). PNK is required for 
the of repair of 3′-phosphate-containing SSBs while APE1 initiates repair of 3′-
phosphoglycolate-containing SSBs (Parsons et al, 2005). Modified ends are converted 
to ligatable ends and POL β and the XRCC1-DNA ligase IIIα complex are recruited to 
complete repair. Unrepaired SSBs can be converted into DSBs in S phase, which can 
then be repaired by the homologous recombination (HR) pathway.  
Diseases due to defects in SSB repair are spinocerebellar ataxia with axonal neuropathy, 
that is due to defects in TDP1 and ataxia with oculomotor apraxia 1 which is caused by 
defective aprataxin (McKinnon, 2009). 
 
1.5 DNA double strand breaks (DSBs) 
DNA double strand breaks (DSBs) are cytotoxic DNA lesions and their repair is critical 
for cell survival. Unrepaired, even a single DSB can be sufficient to cause apoptosis 
(Rich et al, 2000). The repair of DSBs is usually fast and efficient and a certain 
threshold level of damage must be reached to result in checkpoint activation and cell 
cycle arrest (Buscemi et al, 2004; Rouse & Jackson, 2002). DSBs are induced in a 
controlled manner during meiosis to facilitate strand exchange between homologous 
chromosomes. DSBs are also specifically induced during the rearrangements of the 
immunoglobulin loci in B cells and the T-cell receptor loci in T cells (Hoeijmakers, 
2001b; Khanna & Jackson, 2001; Soulas-Sprauel et al, 2007). DSBs also occur in an 
unscheduled manner for example due to damage caused by ROS produced in the course 
of normal metabolism. Furthermore, an estimated fifty DSBs occur in a single human 
cell during DNA replication when RFs encounter nicks in the DNA backbone 
(Vilenchik & Knudson, 2003). 
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1.5.1 Repair of DNA double strand breaks 
The repair of DSBs is usually fast and efficient and there are two separate pathways: 
homologous recombination (HR) and non-homologous end-joining (NHEJ). A third, 
somewhat intermediate, mechanism exists, i.e. the so-called single-strand annealing 
(SSA) pathway. NHEJ is the dominant mechanism that acts during the whole cell cycle 
but it is error-prone (Lieber, 2010). During S and G2 phase of the cell cycle HR is the 
predominant mechanism (Wyman et al, 2004). Importantly, HR is dependent on an 
intact DNA template for the repair of the broken DNA strand. SSA is a homology-
directed repair pathway that promotes recombination between repeated sequences 
(Krogh & Symington, 2004). 
 
1.5.2 Non-homologous end-joining (NHEJ) 
NHEJ is a DSB repair mechanism used during all stages of the cell cycle. As the name 
implies, NHEJ involves direct ligation of the broken DNA ends and it represents the 
simplest mechanism to repair DSBs and to restore chromosome integrity (Lieber, 2010). 
NHEJ seems to be the major pathway for the repair of DSBs induced by IR and 
consequently NHEJ defective cells are radiosensitive (Rothkamm et al, 2003). NHEJ 
also plays a crucial role in V(D)J recombination in developing B-cells, and as a result, 
defects in NHEJ cause severe combined immunodeficiency (Schwarz et al, 2003). 
NHEJ is often described as an ‘error-prone’ repair mechanism because, in cases where 
ends cannot be directly re-joined, DSB end-processing can lead to deletions at the 
break-sites (Lieber, 2010). 
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The NHEJ process is thought to be initiated at a DSB by binding of the KU70 and 
KU80 heterodimer to the free DNA end (Lieber, 2010). This heterodimer binds as a ring 
surrounding the broken DNA end and structurally supporting it to facilitate re-joining 
(Walker et al, 2001). The DNA-end/KU complex recruits the DNA-PK catalytic subunit 
(DNA-PKcs) to the DSB resulting in increased DNA-PK kinase activity, which 
stimulates NHEJ and facilitates processing of DNA ends (Cui et al, 2005). The DNA-
bound DNA-PK complex recruits a complex containing DNA ligase IV, XRCC4 and 
XLF/Cernunnos (Ahnesorg et al, 2006; Revy et al, 2006). These three proteins are core 
NHEJ proteins and loss of any of them confers marked radiosensitivity and defective 
DSB re-joining (Jeggo & Lobrich, 2006). The chemical composition of the broken DNA 
ends can differ, and IR induced DSBs for example cannot be directly ligated and have to 
be processed to produce 5′ phosphate and 3′ hydroxyl groups required for ligation by all 
known DNA ligases (Jeggo & Lobrich, 2006). 
 
Proteins have been identified which are involved in the NHEJ processing of DNA ends 
with different structures. One of these proteins is the Artemis endonuclease which 
cleaves DNA structures with single-strand/double-strand transitions, such as 3′ -or 5′ 
overhangs, hairpins, flaps and gaps (Ma et al, 2002; Ma et al, 2005) and requires 
interaction with DNA-PKcs for activity. Artemis-defective cells re-join the majority of 
IR-induced DSBs normally but fail to re-join approximately 10% of X-ray induced 
DSBs (Riballo et al, 2004). Other proteins involved in NHEJ are the DNA polymerases 
POL µ and POL λ, and terminal deoxynucleotidyl transferase (TdT) (Ma et al, 2004). 
Each of these polymerases has properties that are potentially useful depending on the 
structure of the DNA ends.  
  
- 14 - 
 
1.5.3 Homologous recombination (HR) 
HR is a major pathway for the maintenance of genomic integrity. It is important for 
accurate chromosome segregation during the first meiotic division and it is crucial for 
the repair of complex DNA damage such as DSBs, interstrand crosslinks (ICLs) and 
DNA gaps. Defects in HR lead to genetic diseases with the common features of 
genomic instability and cancer predisposition (Hoeijmakers, 2001b). HR is restricted to 
the S and G2 phases of the cell cycle by cyclin dependent kinase (CDK)-mediated 
phosphorylation of HR proteins. 
 
There are several models for DSB repair by HR: the synthesis-dependent strand 
annealing (SDSA) model (Haber, 1992; Nassif et al, 1994), the DSBR (double-strand 
break repair) or Szostak model (Szostak et al, 1983), and the break-induced replication 
(BIR) model (Kreuzer et al, 1995) (Fig 1.3). HR can be divided into three steps: 
presynapsis, synapsis and postsynapsis. Presynapsis and synapsis are common in all 
three DSB repair models. In presynapsis the 5′ ends of the DSB are resected to form a 
region of single stranded 3′ overhangs (Huertas, 2010). DSB resection is promoted by 
the MRE11/RAD50/NBS1 (MRN) complex (Adams et al, 2006; Jazayeri et al, 2006; 
Myers & Cortez, 2006). The MRN complex interacts with CtIP, which has been shown 
to be also required for DSB resection (Sartori et al, 2007). CtIP has been demonstrated 
to be critical in restricting HR to the S and G2 phase of the cell cycle by regulating the 
DNA resection step of repair (Yun & Hiom, 2009). The resulting 3′ ssDNA overhangs 
are coated by the ssDNA-binding protein RPA (replication protein A) (Iftode et al, 
1999).  
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During synapsis, the Rad51 protein performs homology search and DNA-strand 
invasion. In this step one of the two previously generated 3′ ssDNA overhangs invades 
the homologous duplex and anneals to the homologous sequence forming a 
displacement loop (D-loop) structure. During strand invasion RAD51 displaces RPA 
and forms a nucleoprotein filament on ssDNA regions. RAD51 filament formation 
requires the presence of the tumour suppressor BRCA2/FANCD1 (Tarsounas et al, 
2003) and it catalyses the search for homologous sequences, strand pairing and strand 
exchange (Baumann et al, 1996; Baumann & West, 1998). BRCA2/FANCD1 contains 
ssDNA binding motifs (OB-folds), a dsDNA binding motif (tower domain) and a 
number of RAD51 binding sites. This suggests that BRCA2/FANCD1 targets RAD51 
filament nucleation to the dsDNA junction at the resected end (Yang et al, 2005). The 
helicase RTEL1 is thought to be capable of disassembling these D-loop structures to 
suppress inappropriate recombination events (Barber et al, 2008). After D-loop 
formation, DNA synthesis extends the annealed 3′end using the information from the 
intact template. In postsynapsis the three HR sub-pathways are distinguished: 
1.5.3.1 The synthesis depending strand annealing (SDSA) model 
The SDSA pathway (Haber, 1992) results in non-crossover products (Fig. 1.3 left side). 
The invading strand of the DSB, which was extended by repair synthesis, is displaced 
from the donor sequence after completion of repair synthesis. The extended strand 
anneals to the 3′ end of the original DSB, and is now used as template for repair 
synthesis of the other 3′ end. After strand annealing the reaction is completed by 
ligation of the nicks. This process differs from the Szostak model in that the second end 
is never captured by the intact chromatid or chromosome homologue (Paques & Haber, 
1999). 
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1.5.3.2 The double strand break repair model (DSBR) model – Szostak model 
The DSBR model (Szostak et al, 1983) involves a two-end strand invasion mechanism 
in which the displaced strand of the donor DNA (after the strand invasion of the 3′ end) 
anneals to the free 3′ end of the damaged chromosome (Fig. 1.3 middle). The second 
end of the break is engaged by either second end capture through DNA annealing, or 
through a second invasion event. Annealing of the second end is catalysed by the 
RAD52 protein, which promotes single-strand annealing reactions independently of 
RAD51 (Mortensen et al, 1996; Sugiyama et al, 2006). RAD52 has also been shown to 
stimulate RAD51-mediated strand invasion though a direct interaction with RAD51 and 
RPA (West, 2003). Repair DNA synthesis then extends the second 3′ end using the 
displaced strand of the donor DNA as template. The resulting nicks are then ligated. 
This second end capture mechanism leads to formation of two four-stranded DNA 
(Holliday) junctions or double HJs (dHJs) (Paques & Haber, 1999). Dissolution of these 
Holliday junctions can occur by the combined actions of the BLM DNA helicase 
(Bloom’s syndrome protein), TOPOIIIα, RMI1 and RMI2 (Singh et al, 2008; Wu & 
Hickson, 2003; Xu et al, 2008). This is achieved through branch migration of the two 
junctions towards each other (Plank et al, 2006). The hemi-catenates that topologically 
link the two duplexes are then removed by TOPOIIIα, resulting in the formation of 
exclusively non-crossover products. Interestingly, cells from Bloom’s patients deficient 
for the BLM helicase show an increase in sister-chromatid exchange which probably 
reflects an alternative processing of HJs by structure-specific endonucleases (Chaganti 
et al, 1974). HJ resolution by SSEs can result in either crossover or non-crossover 
products (Szostak et al, 1983) (Fig 1.3). Classical Holliday junction resolvases cleave 
Holliday junctions symmetrically in vitro to create products that can be re-ligated 
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without further processing (Fogg & Lilley, 2000). This is discussed in more detail in 
Chapter 1.10.3. 
 
1.5.3.3 The BIR model 
BIR is thought to be used to initiate DNA replication when only one end of a DSB 
shares homology with a template. BIR is used to re-establish replication at stalled and 
collapsed replication forks and to act at eroding telomeres in cells that lack telomerase 
in pathways known as 'alternative lengthening of telomeres' (Henson et al, 2002; 
Lydeard et al, 2007; McEachern & Haber, 2006). It is thought that BIR may be used in 
the case of RF collapse where only one DNA strand is available for recombination or 
for the repair of DSBs at telomeres. The BIR model (Kreuzer et al, 1995) of HR (Fig 1.3 
right) also involves resection of the DSB to yield single stranded 3′ overhangs. One 3′ 
end invades a homologous sequence and is extended by DNA synthesis. The second end 
of the DSB is lost and is not engaged in the DSB repair reaction. In the BIR model, the 
synthesis of the lost sequence of the broken chromosome is continued until the end of 
the donor chromosome is reached, which can continue over many bases (Paques & 
Haber, 1999). This results in a non-crossover product with loss of heterozygosity and 
therefore is probably not used frequently.  
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1.5.4 Single strand annealing 
  
Figure 1.3: Three models for DSB repair by HR. After DSB induction both DNA ends are 
resected to yield single-stranded 3′ overhangs. Three models exist for the processing of these 
3′ ends to repair DSB: synthesis-dependent strand annealing (SDSA) results in non-
crossovers. The Szostak model involves a two-end strand invasion mechanism. This leads to 
the formation and resolution of Holliday junctions resulting in crossover or non-crossover 
products. The third model is break-induced replication (BIR), which engages a one-ended 
recombination event and replication for repair. 
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1.5.4 Single strand annealing (SSA) 
An alternative mechanism to NHEJ and HR, for the repair of DSBs that occur between 
direct repeats, is single strand annealing (SSA). The ends of the DSB are digested by an 
exonuclease until homologous regions on the two sides of the break are exposed. The 
complementary strands then anneal at the repeat sequence. This is likely catalysed by 
RAD52A (Helleday, 2003). The non-homologous 3′ single strand tails that are cleaved 
by the XPF-ERCC1 endonuclease (Al-Minawi et al, 2008; Zhang et al, 2007a), and the 
resulting nicks are sealed by ligation by an as yet unidentified enzyme. Thus, SSA 
results in deletion of one copy of the repeat plus the sequence located between the 
repeats (Paques & Haber, 1999). Work in mammalian cells suggests that SSA is a 
frequent repair event between repetitive sequences (Liang et al, 1998). Since a large 
proportion of mammalian genomes consist of repetitive sequences, e.g. Alu sequences, 
SSA may frequently be used in the repair of DSBs within these areas. 
 
1.6 The DNA damage- induced cell cycle checkpoint response 
DNA damage is a frequent event and cells can respond in different ways. Most lesions 
are repaired rapidly. Occasionally they persist however. This may be because they are 
complex in nature or numerous, or because they are difficult to access, for example in 
heterochromatin. These persistent lesions are potentially dangerous, and to prevent them 
from causing genome instability cells launch the DNA damage response (DDR) which 
can lead to apoptosis, if the damage is too severe. Alternatively the cell can activate the 
DNA damage checkpoint, which stops or slows the cell cycle progression giving the cell 
more time for repair. 
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The cell cycle is divided loosely into four main phases. During G1 phase (GAP-1) the 
cell grows and prepares for DNA synthesis, which occurs in the S-phase (synthesis 
phase). During S-phase the cell replicates its genome before entering G2-phase (GAP-2) 
in which the cell again grows and prepares for mitosis. In M-phase (mitosis) the cell 
divides and segregates its duplicated chromosomes. There are three main DNA damage 
cell cycle checkpoints that can be activated following DNA damage. The G1–S and 
intra-S checkpoints control the entry into, and transition through, S-phase. The G2–M 
checkpoint regulates entry into mitosis following DNA damage (Niida & Nakanishi, 
2006). 
 
1.6.1 The G1-S checkpoint 
The main DNA damage response pathway in mammalian cells going through the G1/S 
transition of the cell cycle is the ATM/CHK2-p53/MDM2-p21-CDK2 pathway (Kastan 
& Bartek, 2004) that can induce G1 arrest. During a normal cell cycle the protein 
phosphatase CDC25A promotes G1-S transition by dephosphorylating CDK2. Upon 
DNA damage however ATM is activated and it phosphorylates the CHK2 kinase 
(Shiloh, 2003a). CDK2 then phosphorylates CDC25A resulting in its ubiquitination and 
degradation by the proteasome (Falck et al, 2001). CDK2 is no longer dephosphorylated 
by CDC25A and therefore kept in its inactive form phosphorylated on inhibitory 
threonine 14 and tyrosine 15 (Bartek and Lukas, 2003; Donzelli and Draetta, 2003). 
Upon DNA damage ATM and CHK2 also phosphorylate the tumor suppressor p53 
(Banin et al, 1998; Bartek & Lukas, 2003; Craig et al, 2003; Kastan & Lim, 2000; 
Shiloh, 2003b; Wahl & Carr, 2001). This phosphorylation stabilises p53 by attenuating 
its interaction with the E3 ubiquitin ligase MDM2 that promotes p53 degradation. 
Furthermore p53 phosphorylation promotes its interaction with p300 resulting in p53 
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acetylation and subsequent stabilisation (Dornan et al, 2003; Schon et al, 2002; Tang et 
al, 2008). Active p53 can induce the transcription of its target genes, including 
p21CIP1/WAF1 which acts as a CDK2 inhibitor, preventing it from phosphorylating its 
downstream targets, leading to a cell cycle arrest in G1 phase (Dasika et al, 1999; el-
Deiry et al, 1993; Kastan & Bartek, 2004).  
 
Many of the G1-S checkpoint components are mutated in human tumours. Examples are 
p53, CHK2 and ATM amongst others (Bell et al, 1999; Kastan & Lim, 2000; Shiloh, 
2001a; Vogelstein et al, 2000). Many cancer cells are mutated in p53, resulting in a 
defective G1-S checkpoint. These cells therefore rely on the G2-M checkpoint. In terms 
of new therapies, the development of CHK1 inhibitors might sensitise tumour cells to 
chemotherapeutic agents, more so than wild type cells that have normal p53 expression 
(Kawabe, 2004; Koniaras et al, 2001). 
 
1.6.2 The intra-S checkpoint 
Activation of the intra-S-phase checkpoint leads to transient and reversible cell cycle 
delay by inhibition of new replicon initiation and it is independent of p53 (Lukas et al, 
2004). There are two branches of intra S-phase checkpoint activation (Falck et al, 2002). 
One is similar to the ATM-CHK2-CDC25A-CDK2 pathway as described for the G1–S 
checkpoint (Chapter 1.6.1; (Bartek et al, 2004; Donzelli & Draetta, 2003) except that 
the ATR–CHK1 pathway also becomes activated in response to breaks during S-phase 
(Cliby et al, 1998; Zou & Elledge, 2003). CDC25A degradation-induced CDK2 
inhibition blocks the loading of CDC45, which is required for DNA polymerase α 
(POLα) recruitment into pre-replication complexes. 
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The other pathway includes the phosphorylation of NBS1 (Nijmegen breakage 
syndrome 1) and SMC1 (structural maintenance of chromosome 1) by ATM (Kastan & 
Lim, 2000; Shiloh, 2001b; Yazdi et al, 2002). This phosphorylation is important for the 
inhibition of DNA replication (Bartek et al, 2004).  
 
ATM phosphorylates several checkpoint components upon its activation by IR in S-
phase cells. These ATM targets include CHK2 (Matsuoka et al, 2000; Melchionna et al, 
2000), BRCA1(Cortez et al, 1999) and NBS1 (Gatei et al, 2000; Lim et al, 2000; Zhao 
et al, 2000). When, following IR, cells fail to induce the intra S-phase checkpoint, a 
phenomenon known as radioresistant DNA synthesis (RDS) results. Cells defective in 
ATM (Painter & Young, 1980), NBS1 (Lim et al, 2000) or BRCA1(Xu et al, 2001) all 
exhibit this defect.  
 
1.6.3 The G2–M checkpoint 
The G2–M checkpoint prevents cells from entering mitosis when DNA damage is 
detected in G2-phase. It is also activated when cells progress into G2-phase with 
unrepaired DNA damage from G1- or S-phase. Defects in the G2–M checkpoint might 
allow a damaged cell to progress through the cell cycle, but this can lead to apoptosis.  
Upon IR treatment, ATM becomes activated and phosphorylates CHK2 and p53 (Sancar 
et al, 2004). CHK2 is not essential for the G2–M checkpoint, unlike CHK1 (Liu et al, 
2000; Zhao et al, 2002). CHK2 is however required for cells that are already in G2-
phase to delay mitosis and DT40 cells lacking CHK2 show an increased number of cells 
entering mitosis with damaged DNA (Rainey et al, 2008). ATM also activates ATR, 
which in turn phosphorylates CHK1 (Cuadrado et al, 2006; Jazayeri et al, 2006; Myers 
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& Cortez, 2006). CHK1 phosphorylates and inactivates CDC25A which in turn leads to 
CDK1–Cyclin B1 inactivation and G2–M arrest (Jackson et al, 2000). 
Another target of ATM is MDM2, which negatively regulates p53. Stabilised p53 
upregulates transcription of p21 and 14-3-3σ, which is involved in the initiation of the 
G2–M checkpoint (Niida & Nakanishi, 2006). 14-3-3σ binds to CDK1-cyclin B1 and 
sequesters it into the cytoplasm (Chan et al, 1999). p21 inhibits CDK2–cyclin A and 
CDK 4/6 complexes resulting in inhibition of E2F-dependent transcription via Rb (Cann 
& Hicks, 2007). G2-M regulators targeted by E2F include CDK1, cyclin A, cyclin B1 
and cyclin B2 (DeGregori, 2002). p21 can also directly inhibit the mitotic kinase 
CDK1-cyclin B1, which targets both structural proteins and proteins that regulate 
processes such as transcription and replication (Cann & Hicks, 2007). 
 
1.7 The role of the ATM and ATR protein kinases in the DNA damage 
response 
Ataxia telangiectasia-mutated (ATM), ATM and RAD3-related (ATR) and DNA-
dependent protein kinase (DNA-PK) are members of the phosphatidyl-inositol 3-kinase 
(PI 3-kinase) like family of protein kinases (PIKLs) (Lovejoy & Cortez, 2009). These 
kinases contain a carboxy-terminal kinase domain that is similar to that of PI 3-kinases, 
however none of the PIKL kinases phosphorylate phosphatidylinositol species or other 
phospholipids (Hunter, 1995).  
ATM, ATR and DNA-PK play important roles in various aspects of the DNA damage 
response (Abraham, 2004). DNA-PK seems to play an important role in NHEJ, 
described in section 1.5.2. ATM and ATR act as DNA damage sensors and signal 
transducers and phosphorylate and activate downstream repair factors (Abraham, 2001; 
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Abraham, 2004; Lovejoy & Cortez, 2009; Rouse & Jackson, 2002). ATM is primarily 
involved in the response to DSBs (Andegeko et al, 2001) while ATR responds to a 
broader variety of DNA lesions such as single stranded DNA, UV lesions or blocked 
RFs (Helt et al, 2005; Ward & Chen, 2004) and also indirectly to DSBs through ATM 
and this is restricted to the G2- and S-phases of the cell cycle (Cuadrado et al, 2006; 
Jazayeri et al, 2006; Myers & Cortez, 2006). 
 
ATM was identified by positional cloning of the gene mutated in the human genetic 
disorder ataxia-telangiectasia (AT) (Savitsky et al, 1995a; Savitsky et al, 1995b). AT is 
characterised by neuronal degeneration leading to neuromotor dysfunction and AT cells 
show a high level of genome instability, hypersensitivity to IR and other DSB causing 
agents (Chun & Gatti, 2004; Crawford et al, 2000). ATR was originally identified, 
based on the sequence similarity in the protein kinase domain, as a homologue of fission 
yeast Rad3, whose gene product plays a critical role in sensing DNA structure defects 
and activating damage response pathways (Bentley et al, 1996; Cimprich et al, 1996). 
ATR knockout mice are embryonic lethal and ATR is also essential for survival on the 
cellular level (Brown & Baltimore, 2000; Brown & Baltimore, 2003). Reduced 
expression of ATR in humans, as a result of a splicing mutation, causes Seckel 
syndrome, characterised by growth retardation, microcephaly, mental retardation, and 
impaired DNA-damage response (O'Driscoll et al, 2003). 
 
In undamaged cells ATM can be found as a dimer or multimer, however, in the 
presence of DNA DSBs, these multimers release ATM monomers and ATM undergoes 
auto-phosphorylation at Ser 1981 (Bakkenist & Kastan, 2003) The recruitment of ATM 
to sites of DNA damage requires NBS1 (Falck et al, 2005). NBS1 interacts with 
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MRE11 and RAD50 to form the “MRN” complex. ATR recruitment to sites of DNA 
damage requires the ATR interacting protein ATRIP (Falck et al, 2005). ATRIP can 
bind RPA (replication protein A) which coats ssDNA and this allows ATR-ATRIP to 
localise to DNA damage sites and stressed RFs (Ball et al, 2005; Zou & Elledge, 2003). 
 
Translocation of ATM and ATR to sites of DNA damage is thought to increase their 
kinase activity. ATM and ATR phosphorylate a wide range of substrates on Ser/Thr 
residues that are followed by a Gln, referred to as S/T-Q motifs (Shiloh, 2003a; Traven 
& Heierhorst, 2005). ATM substrates include p53 and the checkpoint kinases CHK1 
and CHK2. ATM and ATR require the help of “mediator” proteins for the 
phosphorylation of downstream targets. One example of these is BRCA1 which forms 
the BRCA1-associated genome surveillance complex (BASC) with ATM and other 
proteins. BRCA1 is required for the ATM and ATR dependent phosphorylation of p53, 
c-Jun, NBS1 and CHK2 after DNA damage (Foray et al, 2003). ATR activity, on the 
other hand, is dependent on the ATRIP-interacting protein TOPBP1 (Mordes & Cortez, 
2008). Other mediator proteins are MDC1, PTIP and 53BP1. A common feature of all 
these proteins is their large size, which allows them to interact with several proteins 
through the presence of multiple BRCT domains (Goldberg et al, 2003; Jowsey et al, 
2004; Mordes & Cortez, 2008; Schultz et al, 2000; Stewart et al, 2003; Yamane et al, 
2002). BRCT domains were first identified in the C-terminus of BRCA1 and they 
facilitate phosphorylation-dependent interactions with other DNA damage responsive 
proteins. In fact most of the BRCT domain-containing proteins participate in DNA-
damage checkpoint and DNA-damage signalling pathways (Stucki et al, 2005; Yu et al, 
2003). ATM and ATR not only control DNA repair by direct phosphorylation of 
downstream factors but are also involved in cell cycle control and progression by 
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phosphorylating the checkpoint kinases CHK1 and CHK2, that become activated by 
ATM/ATR-dependent phosphorylation, and in turn phosphorylate effectors of cell cycle 
progression (Shiloh, 2003). 
 
1.8 DNA replication 
Since the discovery of double stranded DNA, DNA replication has been the focus of 
many studies. During DNA replication the genome of a cell needs to be duplicated once, 
and only once, in a timed and precise manner DNA replication is a central aspect of cell 
proliferation and the basic mechanisms of DNA replication are highly conserved from 
prokaryotic to eukaryotic organisms, however some processes are far more complex in 
eukaryotes. Defects in proteins that are involved in assembly and monitoring of RFs 
lead to genomic instability, and such “chromosome instability syndromes” often lead to 
cancer. 
 
DNA replication starts from origins of replication that are distributed throughout the 
eukaryotic genome. Origins of replications are defined by binding of proteins that 
“license” origins so they are competent to initiate DNA replication (Blow and Tada, 
2000). In order to be activated, origins of replication are bound by proteins that 
“licence” origins so DNA replication can be initiated (Blow and Tada, 2000). In 
contrast to yeast, metazoan origins do not appear to be based on consensus DNA 
sequences (Blow and Tada, 2000). In late M phase and G1 of the cell cycle the ORC 
(origin recognition complex) binds to the origin, leading to recruitment of CDC6 and 
CDT1. This allows the MCM2–7 (minichromosome maintenance 2–7) helicase complex 
to be loaded onto DNA (Gillespie et al, 2001), which “licenses” the ORI to initiate 
DNA replication in S-phase. Before S-phase, CDC45 and the GINS complex are loaded 
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onto the origin and MCM 2–7 is activated by binding to CDC45 and GINS (Moyer et al, 
2006). MCM 2–7 activation also requires the S-phase cyclin-dependent kinase (CDK) 
and CDC7-DBF4 (Early et al, 2004; Sheu & Stillman, 2006). Together with CDC45 and 
GINS, the MCM complex travels along the RF and origins become “unlicensed” after 
origin firing to prevent re-licensing. This is controlled by the degradation of CDT1 at 
the end of G1 and early S-phase and by activation of the CDT1 inhibitor geminin (Blow 
& Dutta, 2005). It has been demonstrated that there is an approximate 20-fold excess of 
the MCM2-7 complex over the number of replication origins used in a normal S-phase. 
This excess is used to “rescue” DNA synthesis when RFs stall, by initiating replication 
from dormant origins between two stalled forks, thereby reducing genome instability 
(Ge et al, 2007).  
 
When DNA replication is initiated an RNA–DNA primer is synthesised on the template 
strands by a complex of DNA primase and polymerase α (POLα) (Langston & 
O'Donnell, 2006b; Maiorano et al, 2006). The replication factor C (RFC) complex binds 
the primer–template DNA and loads the PCNA sliding clamp onto DNA (Majka & 
Burgers, 2004). PCNA acts as a processivity factor for the replicative DNA polymerases 
(Majka and Burgers, 2004); DNA polymerase δ is thought to be the main polymerase 
for the lagging stand and DNA polymerase ε for the leading strand (Nick McElhinny et 
al, 2008; Pursell et al, 2007). On the leading strand replication proceeds continuously 
from 5′ to 3′, in contrast to the lagging strand where synthesis is discontinuous and 
results in “Okazaki” fragments (Langston & O'Donnell, 2006a; Maiorano et al, 2006). 
When the lagging strand polymerase encounters a 5′ end of an Okazaki fragment, this 
end gets displaced and forms a 5′, flap which is cleaved by the endonuclease FEN1 
allowing it to be ligated (Lieber, 1997; Liu et al, 2004). Sometimes flaps escape FEN1-
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mediated cleavage and are processed by the 5′-3′ helicases PIF1 and DNA2, which act 
to elongate the flap (Rossi et al, 2008). 
 
1.8.1 Obstacles that can block replisome progression 
Errors that occur during DNA replication are not the only threat to genome stability 
during S phase. Replication is a challenging task for the cell and the RF machinery must 
overcome various obstacles that could block its progression (Fig 1.4). Such obstacles 
can be due to topological stress, DNA damage in the template DNA, metabolic 
processes (i.e. transcription) or protein “roadblocks”.  
Proteins bound to DNA during replication can provide obstacles for replisome 
progression and this can include the transcription machinery (Fig. 1.4). The RF and the 
RNA polymerase share the same DNA template and this leads to occasional collision of 
these two machineries. Depending on the direction of the collision the lagging or the 
leading strand is affected. If the collision happens head-on, the front edge of the RNA 
polymerase collides with the lagging strand synthesis components of the RF (Mirkin & 
Mirkin, 2007). If the collision occurs co-directionally, the rear end of the RNA 
polymerase collides with the leading strand synthesis machinery of the RF (Mirkin and 
Mirkin, 2007). 
 
Another example of transcriptional related RF stalling are RNA–DNA hybrids such as 
R loops (Santamaria et al, 1998; Viguera et al, 1996). These are structures that are 
formed when cRNA hybridizes with one of the strands in the DNA duplex, displacing 
the other strand and making it form a loop. R loops have been shown to interfere with 
the movement of RFs (Viguera et al., 1996).  
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DNA structure itself can cause replication problems (Fig. 1.4). Repeated sequences, for 
example, in ribosomal DNA are difficult to replicate (see Chapter 1.11.2) and unusual 
DNA structures such as hairpins, triplexes and G- quadruplexes can cause RF stalling. 
Hairpins can arise at sites of tri-nucleotide repeats and replisome pausing at these sites 
can cause RF “slippage” that can result in a loss or increase in the number of individual 
repeats. The expansion of tri-nucleotide repeats has been shown to be responsible for 
several human genetic diseases, including myotonic dystrophy, Huntington’s disease, 
Friedreich’s ataxia and fragile X syndrome (Cummings & Zoghbi, 2000; Mirkin & 
Mirkin, 2007; Warren & Nelson, 1993). 
 
The very compact nature of chromatin can cause replication problems. Stable protein–
DNA complexes and the highly compacted nature of heterochromatin make it very 
difficult to replicate. Proteins such as RIF1 have been implicated in replication through 
heterochromatic regions (Buonomo, 2010). 
 
Replication forks can pause naturally at certain regions of the genome, for example at 
GC rich sites where the DNA polymerase may stall transiently, or sites with an 
abundance of protein–DNA complexes, such as telomeres (Labib & Hodgson, 2007).  
Chromosome fragility with breaks and gaps that occur under conditions of replication 
stress occurs at so called fragile sites. In eukaryotic genomes these regions are very 
prone to chromosomal breakage during replication (Durkin & Glover, 2007). Fragile 
sites are expressed when DNA polymerases are inhibited by agents such as aphidicolin 
indicating that replication inhibition is a cause of chromosomal fragility (Mirkin and 
Mirkin, 2007).  
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There are at least 80 fragile sites in the human genome and these regions are very 
flexible and prone to formation of secondary structures such as multiple hairpins 
(Mirkin and Mirkin, 2007). Fragile sites often occur in regions of the genome that are 
replicated more slowly than normal (Durkin and Glover, 2007). This has led to a model 
in which fragile sites require the slowing of replication, for example at inverted repeats, 
which can then form secondary structures when unwound (Labib and Hodgson, 2007).  
DNA damage such as UV light creates cyclobutane dimers that cause RF stalling (Labib 
and Hodgson, 2007). Interstrand crosslinks (described in Chapter 1.9) also represent RF 
barriers that can be very toxic and lead to cell death. Drugs that arrest RFs are often 
used in the laboratory to induce DNA damage and RF stalling; examples are methyl 
methan sulfonate (MMS) that alkylates DNA and hydroxyurea (HU) that depletes the 
deoxyribonucleotide (dNTP) pool (Bianchi, 1986; Bianchi et al, 1986). 
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crosslink 
e.g. G quadruplex 
e.g. transcription 
e.g. CPT 
e.g. MMS 
Figure 1.4: Common obstacles that block replisome progression. Abbreviations: 
MMS, methyl methansulfonate; CPT, camptothecin  
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1.9 DNA interstrand crosslink repair 
1.9.1 DNA interstrand crosslinks 
ICLs are toxic lesions that covalently link the two strands of a DNA double helix. Such 
lesions are very toxic for proliferating cells and it has been estimated that as few as 
twenty ICLs can lead to apoptosis (Dronkert & Kanaar, 2001; Lawley & Phillips, 1996). 
ICLs are so toxic because the covalent linkage of the two strands of the double helix 
prevents strand separation during DNA replication and thus causes complete blockage 
of the RF. ICLs arise as by-products of normal cellular metabolism and they can also be 
induced by exogenous agents. Well characterised cellular by-products causing ICLs are 
malondialdehyde, acrolein and crotonaldehyde. These are produced during lipid 
peroxidation and their concentration increases in the presence of a high fat diet (Brooks 
& Theruvathu, 2005; Folmer et al, 2003; Kozekov et al, 2003; Marnett, 2000; Minko et 
al, 2008; Niedernhofer et al, 2003; Stone et al, 2008), activated estrogens or in 
alcoholism. Ethanol is metabolised to acetaldehyde, which causes ICLs and is 
carcinogenic (Langevin et al, 2011; Marietta et al, 2009). ICLs can also be induced by 
exogenous crosslinking agents, such as nitrogen mustards, MMC or cisplatin (Noll et al, 
2006). Such bifunctional alkylating agents can induce a variety of mono-adducts and 
ICLs in cells, but it is ICLs that are believed to be responsible for the severe toxicity to 
proliferating cells (Andreassen & Ren, 2009; Deans & West, 2011; McHugh et al, 2001; 
Niedernhofer et al, 2005). Another type of crosslinks are DNA-protein crosslinks, which 
can be for example caused by exposure to formaldehyde (Shaham et al, 1996). 
 
ICL inducing agents are commonly used in cancer therapy (Andreassen & Ren, 2009; 
McHugh et al, 2001; Sanderson & Shield, 1996). Cisplatin for example is used in the 
- 33 - 
 
treatment of testicular cancer with a cure rate of 80-90 % (Nuver et al, 2011). The idea 
to use ICL inducing agents as drugs for chemotherapy is not new: during the Second 
World War sulphur mustard bombs were used as weapons and autopsies of the victims 
revealed that the sulphur mustard had affected the white blood cells leading to a 
decreased number of lymphocytes. In 1946 the first publication about the use of 
nitrogen mustard for the treatment of leukaemia appeared (Goodman et al, 1946). Later, 
the crosslinking agents mitomycin-C (in 1956) and platinum compounds such as 
cisplatin (in 1971) and psoralen (in 1989) began to be used. Only later it was discovered 
that the anti-cancer properties of these drugs were due to the induction of ICLs (Deans 
& West, 2011). Blood, in particular, is very sensitive to the effects of ICLs and many 
insights about the molecular mechanisms of ICL repair have been gained from studying 
the genetic disorder Fanconi anaemia (FA) (Deans & West, 2011). 
 
1.9.2 Fanconi anaemia (FA) 
Fanconi anaemia is a rare, inherited, syndrome characterised by developmental defects, 
skeletal abnormalities, bone marrow failure, cancer predisposition and hypersensitivity 
to crosslinking agents. Individuals with FA also have an elevated risk of haematological 
and squamous cell cancers (Fanconi, 1967). Fanconi anaemia was discovered in 1927 
by the Swiss clinician Guido Fanconi. He described a family in which three children 
had aplastic anaemia, accompanied by a variety of congenital abnormalities (Auerbach, 
2009; Stevens & Meyer, 2002). Soon afterwards, the Swiss clinician Otto Naegeli 
introduced the term “Fanconi’s anaemia” for the disorder (Stevens & Meyer, 2002) after 
more patients presented this combination of symptoms. The diagnostic requirements for 
FA are aplastic anaemia, hyperpigmentation, skeletal malformations, small stature, 
urogenital abnormalities and familial occurrence (Auerbach, 2009). The frequency of 
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FA in the normal population is approximately 1 in 5 million with a carrier frequency of 
0.5% (Joenje & Patel, 2001; Klein & Symington, 2009).  
 
In addition to aplastic anaemia, FA patients often display a wide range of congenital 
abnormalities that include morphological anomalies affecting ear structure, hearing loss, 
growth retardation, endocrine abnormalities, abnormal eye structure, absence or 
hypoplasia of the thumb, vertebral abnormalities, hyperpigmentation, urogenital 
abnormalities, cardio-pulmonary abnormalities, gastrointestinal abnormalities and 
various central nervous system defects including microcephaly and Bell’s palsy 
(Auerbach, 2009). FA is phenotypically heterogeneous; some patients have many 
congenital abnormalities and some have none. The absence of clear congenital 
abnormalities makes diagnosis difficult and a diagnosis of FA is often made late as a 
result (Auerbach, 2009; Giampietro et al, 1993; Klein & Symington, 2009). 
 
However, all FA patients display haematological abnormalities at the median age of 
seven years (Butturini et al, 1994) and the cumulative incidence of bone marrow failure 
by 40 years of age is approximately 90% (Butturini et al, 1994). There is also a massive 
increase in the risk of developing acute-myeloid leukaemia (AML) (Butturini et al, 
1994) with a risk of 52% by the age of 40 years (Deans & West, 2011) as well as 
increased incidence of non-haematological solid tumours (Auerbach, 2009; Rosenberg 
et al, 2003; Taniguchi & D'Andrea, 2006). 
 
Upon treatment with ICL inducing agents such as MMC cells isolated from FA patients 
display a high abundance of chromosomal abnormalities such as radial chromosomes 
(e.g. quadri- or tri-radials) and, in fact, FA is classified as chromosome instability 
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disorder (Schroeder et al, 1964). FA cells are hypersensitive to ICL-inducing agents 
such as MMC or cisplatin, resulting in dramatically increased chromosome breakage 
(Sasaki, 1975). This observation formed the basis of the “chromosome breakage test” 
that is widely used to diagnose FA (Auerbach & Wolman, 1976). This observation 
suggested that FA might be a disorder resulting from defective ICL repair. 
 
FA is genetically heterogeneous. Somatic cell fusion experiments with different FA cell 
lines demonstrated that groups of FA cells could complement the ICL sensitivity of 
others. This observation was validated when different genes were described causing FA. 
At the outset of this thesis 13 FANC genes had been identified. In 2010, mutations in 
Rad51C have been shown to cause a FA like disorder (Vaz et al, 2010) and in 2011 
SLX4/BTBD12 has been added as a new member to the FA proteins. The identification 
of SLX4/BTBD12 as a new FA protein, FANCP, is described in Chapter 4 (Stoepker et 
al, 2011). To date 15 FANC genes have been identified; FANCA, FANCB, FANCC, 
FANCD1, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ, FANCL, FANCM, 
FANCN, FANCO and FANCP (Table 1.2) (de Winter et al, 2000; de Winter et al, 1998; 
Howlett et al, 2002; Levitus et al, 2005; Levran et al, 2005; Litman et al, 2005; Lo Ten 
Foe et al, 1996; Meetei et al, 2003a; Meetei et al, 2004a; Meetei et al, 2005; Meetei et 
al, 2004b; Reid et al, 2007; Smogorzewska et al, 2007; Stoepker et al, 2011a; Strathdee 
et al, 1992; Timmers et al, 2001; Vaz et al, 2010; Xia et al, 2007). Mutations in all these 
genes cause FA or FA-like disorders and FA is autosomal recessive, apart from FANCB 
whose gene is located on the X chromosome. The majority of FA patients have 
mutations in FANCA, FANCG and FANCC.  
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The first direct link between FA and DNA repair was made with the discovery that in 
response to DNA damage in S-phase FANCD2 is mono ubiquitinated at K561 and 
targeted to nuclear foci. The activated FANCD2 co-localises with the DNA repair 
proteins BRCA1 and RAD51 (Garcia-Higuera et al, 2001; Taniguchi et al, 2002). This 
observation suggested that FA might be a result of defects in an S-phase specific DNA 
repair pathway. 
 
FA gene Biochemical activity of gene product 
FANCA Core complex member required for ID ubiquitination 
FANCB Core complex member required for ID ubiquitination 
FANCC Core complex member required for ID ubiquitination 
FANCD1/ BRCA2 HR mediator, downstream of ID ubiquitination 
FANCD2 Ubiquitinated following DNA damage 
FANCE Core complex member required for ID ubiquitination 
FANCF Core complex member required for ID ubiquitination 
FANCG Core complex member required for ID ubiquitination 
FANCI Ubiquitinated following DNA damage 
FANCJ/ BRIP1 Helicase, downstream of ID ubiquitination 
FANCL Core complex member, acts as E3 ligase for ID ubiquitination 
FANCM Helicase that recruits core complex to DNA, required for ID 
ubiquitination 
FANCN/ PALB2 FANCD1 interactor, downstream of ID ubiquitination 
FANCO/ RAD51C HR mediator, downstream of ID ubiquitination 
FANCP/ SLX4 HR mediator, downstream of ID ubiquitination 
 
Table 1.2 The fifteen complementation groups of FA 
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1.9.3 The FA proteins 
The FANC genes were classified in three distinct groups. The first group consists of 
FANC-A, -B, -C, -E, -F, -G, -L and -M. The gene products of this group represent the 
“FA core complex”, a nuclear multi-protein complex that functions as an E3 ubiquitin 
ligase to mono-ubiquitinate the downstream factors FANCI and FANCD2 that form the 
“ID” complex (Moldovan & D'Andrea, 2009; Smogorzewska et al, 2007; Wang, 2007) 
(Fig. 1.7). The mono-ubiquitination of the ID complex occurs via the catalytic RING 
finger domain of FANCL (Alpi et al, 2008; Moldovan & D'Andrea, 2009; Wang, 2007). 
The core complex also contains the FA-associated proteins (FAAP) FAAP100 and 
FAAP24, whose functions are crucial but no patients with mutations in FAAP100 or 
FAAP24 have yet been identified (Ciccia et al, 2007; Ling et al, 2007).  
FANCM and FAAP24 seem to be functionally distinct from the other group members. 
These two proteins appear to be involved in the recognition of stalled RFs and the 
recruitment of the core complex to the ICL, to mono ubiquitinate FANCD2 and FANCI 
(Ciccia et al, 2007; de Winter & Joenje, 2009). FANCM and FAAP24 are members of 
the ERCC4/XPF endonuclease family (see section 1.10.1) but none of these proteins has 
an active nuclease domain. 
 
FANCM has a DEAH helicase domain (Ciccia et al, 2008; Meetei et al, 2005) which 
has DNA translocase activity. It binds DNA structures that resemble recombination 
intermediates, such as HJs and stalled RFs (Gari et al, 2008). FAAP24 can bind ssDNA 
junctions via its nuclease domain (Ciccia et al, 2007). Possibly FANCM-FAAP24 might 
recognise and remodel stalled RFs and recruit the core complex to ubiquitinate 
FANCD2 and FANCI. FANCM associates with the core complex through FANCF 
(Deans & West, 2009). 
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The FANCM-FAAP24 complex is bound to chromatin during the cell cycle but only 
recruits the core complex in S-phase. This is dependent on FANCM phosphorylation, 
which is low in S-phase. After completion of replication, FANCM is 
hyperphosphorylated by the mitotic polo-like kinase 1 (PLK1) and this leads to 
proteasomal degradation of FANCM, thus avoiding the recruitment of the FA core 
complex to chromatin during mitosis (Moldovan & D'Andrea, 2009). 
 
Bloom’s syndrome is FA-like disorder caused by mutations in the RecQ helicase BLM 
(section 1.11) (Karow et al, 1997). The BLM helicase complex plays important roles in 
HR, and it associates with the FA core complex upon treatment with ICL-inducing 
agents (Meetei et al, 2003b). This association is mediated by the interaction of FANCM 
with both FANCF and the BLM helicase complex and disruption of this interaction 
leads to hypersensitivity to ICL-inducing agents (Deans and West, 2009).  
Recent work has also identified two histone-fold containing proteins, MHF1 and MHF2 
to co-elute with FANCM in a large complex (Singh et al, 2010; Yan et al, 2010). The 
MHF heterodimer is required for the stability of FANCM and the localisation of the FA 
core complex to chromatin and consequently for FANCD2 mono-ubiquitination (Singh 
et al., 2010; Yan et al., 2010). The interaction of FANCM with the MHF heterodimer 
also stimulates FANCM-dependent remodelling of the RF (Singh et al., 2010; Yan et 
al., 2010). 
 
The second group of FA genes encodes the FANCD2 and FANCI proteins that form the 
“ID” complex described earlier. FANCD2 and FANCI are paralogues and share only 
weak homology. As described before, the “ID” complex is a substrate for the E3 ligase 
activity of FANCL. Upon RF stalling the “ID” complex becomes mono-ubiquitinated 
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and translocates to chromatin where it appears in sub-nuclear foci (Garcia-Higuera et al, 
2001; Smogorzewska et al, 2007). Mono-ubiquitination of FANCD2 on K561 is 
essential for the repair of ICLs as it serves as a platform for the binding of the recently 
discovered DNA repair nuclease FAN1 (Kratz et al, 2010; MacKay et al, 2010). FANCI 
ubiquitination is not essential for repair; however it might enhance repair efficiency 
(Ishiai et al, 2008). FANCI is phosphorylated by ATR and this is critical for the mono-
ubiquitination of FANCD2 and its translocation to chromatin (Ishiai et al., 2008). ATR 
also phosphorylates other members of the FA machinery, either directly or through its 
downstream effector kinase CHK1. Substrates include FANCA, FANCE, FANCG and 
FANCD2 (Collins et al, 2009; Ho et al, 2006; Kim et al, 2007; Moldovan & D'Andrea, 
2009; Wang et al, 2007). 
 
The E2 conjugating enzyme for FANCD2 and FANCI mono-ubiquitination is UBE2T 
(Alpi et al, 2008). No mutations in UBE2T have yet been found in FA patients. USP1 
has been implicated in FANCD2 de-ubiquitination (Nijman et al, 2005) and cells from 
USP1-deficient mice are ICL-sensitive and show chromosomal instability (Kim et al, 
2009). These cells also exhibit impaired FANCD2 focus formation upon DNA damage 
(Parmar et al, 2010). FA-associated mutations in members of the FA core complex 
result in defects in FANCD2 and FANCI mono-ubiquitination (Moldovan & D'Andrea, 
2009; Wang, 2007). A recent study found that the E3 ubiquitin ligase RAD18 binds 
FANCD2 and is required for efficient mono-ubiquitination and chromatin localisation 
of both FANCD2 and FANCI. Furthermore RAD18-knockout cells show increased 
sensitivity to MMC and a delay in FANCD2 focus formation (Williams et al, 2011). 
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The third group of FA proteins contains FANCD1/BRCA2, FANCN/PALB2 and 
FANCJ/BRIP1 (Moldovan & D'Andrea, 2009) to which FANCO/RAD51C has been 
recently added (Vaz et al, 2010). These proteins are the downstream factors of the FA 
pathway and do not affect the mono-ubiquitination of the ID complex (Fig. 1.7). 
FANCD1/BRCA2 and FANCO/RAD51C promote HR and facilitate the formation of 
RAD51 nucleofilaments. Defects in FANCD1/BRCA2 cause very serious 
manifestations of FA with early-onset leukaemia and solid tumours. FANCD1/BRCA2 
deficiency is embryonic lethal in mice (Suzuki et al, 1997), in contrast to other FA 
mouse models that have only mild defects (Moldovan & D'Andrea, 2009; Nakanishi et 
al, 2005; Sung & Klein, 2006; Wang, 2007). FANCN interacts with FANCD1 and is 
required for the localisation of FANCD1 to chromatin (Xia et al, 2007; Xia et al, 2006). 
FANCJ was identified as a helicase interacting with BRCA1 (Cantor et al, 2004); it has 
a DEAH helicase domain and has 5′–3′ helicase activity (Cantor et al, 2001; Levitus et 
al, 2005; Levran et al, 2005; Litman et al, 2005). FANCJ might be involved in the 
unwinding of D-loops during HR (Gupta et al, 2005). 
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Figure 1.7: The FA proteins and the FA pathway. 1. The FA core complex (in red and 
yellow) and the Fanconi anaemia-associated proteins 24 and 100 recognise the ICL and bind to 
it. FANCI is phosphorylated by an ATM/ATR-dependent mechanism and initiates the FA 
pathway in parallel to the core complex. 2. The E3 ubiquitin ligase subunit FANCL mono-
ubiquitinates FANCD2 on Lys561 and FANCI on Lys523. 3. The downstream factors FANCJ, 
FANCD1, FANCN and FANCO are recruited to the DNA damage site. 
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1.9.4 Mechanisms of ICL repair 
The precise mechanisms of ICL repair are still somewhat unclear. The repair of ICLs 
involves the cooperation of multiple repair pathways including HR, translesion 
synthesis (TLS) and nucleotide excision repair (NER) (McCabe et al, 2009; Moldovan 
& D'Andrea, 2009; Wang, 2007).The complicated nature of ICL repair is probably due 
to ICLs affecting both strands of the DNA duplex, which means they cannot be simply 
excised, at least in S phase. ICL repair can take place outside of S-phase (Akkari et al, 
2000; McHugh & Sarkar, 2006; Sarkar et al, 2006) but the major route of repair 
probably occurs within S-phase (Akkari et al, 2000; Rothfuss & Grompe, 2004; 
Taniguchi et al, 2002). Various models of ICL repair have been proposed and the two 
main models are the two-fork and the single-fork model. In the two-fork model, forks 
approaching from opposite direction converge on the ICL (Raschle et al, 2008). In the 
single-fork model, a single RF encounters the ICL as summarised in Figure 1.8. Here I 
will focus on the single-fork model. 
 
The exact details of ICL repair are not well understood and the precise order of events is 
unclear. However a number of repair pathways and proteins that are essential for ICL 
repair have been identified. Stalled RFs lead to the activation of ATR–ATRIP kinase 
through ATRIP binding to RPA-coated ssDNA (Shigechi et al, 2012). Catalytic 
activation of ATR occurs through association with TOPBP1, leading to events such as 
CHK1 phosphorylation (Kitao & Takata, 2011). FANCI phosphorylation triggers FA 
pathway activation, including FANCD2 mono-ubiquitination. Stalled RFs are also 
detected by FANCM-FAAP24 which then recruits the core complex (Ciccia et al, 2007; 
Niedernhofer, 2007) (Fig 1.7). The recruitment of the core complex to the stalled RF 
results in mono-ubiquitination of FANCD2 and FANCI by the E3 ubiquitin ligase 
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FANCL at K561 and K523 subsequently (Alpi et al, 2008; Garcia-Higuera et al, 2001; 
Smogorzewska et al, 2007). After ubiquitination, FANCI and FANCD2 re-localise to 
chromatin into repair foci where other DNA repair proteins, such as BRCA1, 
FANCD1/BRCA2 and RAD51 are located (Garcia-Higuera et al., 2001; Smogorzewska 
et al., 2007). 
 
An important early step of ICL repair appears to be the “unhooking” of the ICL which 
results in the ICL adduct to one strand. This requires incisions on both sides of the ICL 
by SSEs. One of these incisions appears to be catalysed by MUS81–EME1, 3′ of the 
side of the lesion (Hanada et al, 2007; Hanada et al, 2006). This incision generates a 
one-ended DSB. Then a second endonuclease probably catalyses incision 5′ of the 
lesion, and XPF–ERCC1 has been proposed as a candidate catalysing this event 
(Bergstralh & Sekelsky, 2008; Bhagwat et al, 2009). A recent paper proposed that XPF-
ERCC1 collaborates with the 5′-3′ exonuclease hSNM1A to initiate ICL repair (Wang et 
al, 2011). After incision by XPF-ERCC1 at the 5′ side of the ICL, hSNM1A can digest 
the crosslinked oligonucleotide leaving a gapped intermediate and a single nucleotide 
linked to the complementary strand (Wang et al, 2011). Once the lesion is unhooked, 
TLS can fill the resulting gap (Knipscheer et al, 2009; Niedzwiedz et al, 2004) and the 
unhooked ICL is removed, probably by NER factors (Wang, 2007). The DSB generated 
by unhooking can then be resected to allow the initiation of HR to regenerate an intact 
RF (Fig 1.8). Successful HR-mediated repair of the MUS81-generated DSB depends on 
FANCD1, J and N. 
 
In 2008 Raschle and colleagues developed a system to study ICL repair in vitro. They 
used Xenopus egg extracts containing a 5.6kb plasmid with a single ICL (Deans & 
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West, 2009; Knipscheer et al, 2009; Raschle et al, 2008). During ICL repair in this 
system the ICL always encounters two converging RFs, leading to a two-fork model. 
When both RFs converge on the ICL, one of the nascent leading strands advances to 
within one nucleotide of the ICL. This is followed by incisions near the ICL, translesion 
DNA synthesis and subsequent extension of the nascent strand past the lesion. However, 
it is not yet clear if the two-fork model of repair accurately reflects ICL repair in vivo 
because the plasmid used by Raschle and colleagues is small and in this system the two 
RFs always converge at the crosslink. It is likely that repair can be triggered by only one 
fork stalling at the ICL in cells (Nakanishi et al, 2011). 
 
Knipsheer and colleagues used the same system to study the role of FANCD2 mono-
ubiquitination in ICL repair. They showed that depletion of FANCD2 and FANCI leads 
to defective ICL repair and this can be rescued by reintroduction of recombinant 
FANCD2 and FANCI, but not by a mutated FANCI-FANCD2 complex in which the 
FANCD2 mono-ubiquitination site was altered therefore FANCD2 mono-ubiquitination 
seems to be essential for several steps in ICL repair (Knipscheer et al., 2009).  
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Figure 1.8 Model of Interstrand crosslink repair (an interpretation). 
Various signalling proteins including the Fanconi anaemia (FA) complex are recruited to the 
vicinity of the blocked replisome. This triggers the mono–ubiquitination of FANCD2 and its 
paralogue FANCI at Lys561 and Lys523 respectively, that in turn directs subsequent steps of 
ICL repair by unknown mechanisms. Cleavage of the leading strand template by MUS81, in 
concert with cleavage of the same strand on the opposite side of the ICL by a second nuclease, 
would unhook the ICL. This results in a one–ended DSBs and a gapped duplex with the ICL 
adduct on one strand that is filled in by TLS (trans lesion synthesis). The ICL adduct is excised 
and resection of the DSB generated by unhooking initiates HR, which completes repair. 
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1.10 Structure specific endonucleases 
Structure specific DNA endonucleases (SSEs) are important players in DNA 
replication, repair and recombination. They are enzymes that can cleave phosphodiester 
bonds in nucleic acids and can recognise DNA junctions that contain a dsDNA, or 
ssDNA branch from a dsDNA, such as Holliday junctions, RFs, DNA flaps and loops. 
There are three major classes of SSEs in eukaryotes: the ERCC4 class which includes 
XPF-ERCC1 and MUS81-EME1, the UvrC class which includes SLX1 and the XPG 
class including GEN1 (Ciccia et al, 2008; Klein & Symington, 2009; Mimitou & 
Symington, 2009) (Fig. 1.5). 
 
 
Figure 1.5: Schematic representation of DNA intermediates and SSEs that can cleave 
them.  
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1.10.1 The ERCC4 class of SSEs 
The XPF (or ERCC4) family of nucleases contains the nucleases XPF and MUS81 as 
well as their non-catalytic subunits ERCC1 and EME1 respectively (Fig. 1.6). The 
family also contains archaeal Hef and archaeal XPF (Nishino et al, 2006; Roberts et al, 
2003) (Fig. 1.6). In vertebrates there are two additional family members: FANCM and 
FAAP24 and both have inactive nuclease domains (Ciccia et al, 2008). 
XPF and ERCC1 (xeroderma pigmentosum complementation group F-excision repair 
cross-complementing rodent repair deficiency complementation group 1) exist together 
in a complex. XPF-ERCC1 are highly conserved and represent together with their yeast 
homologues Rad1-Rad10 the most well characterised members of the ERCC4 class of 
SSEs.  
 
 
   
 
 
 
  
Figure 1.6: Schematic diagram of the ERCC4 class nucleases. All proteins contain catalytic  
or catalytic-like and HhH domains. XPF and Hef have additional helicase domains (DEAH 
domains). Archaeal XPF and Hef form homodimers. XPF forms a heterodimer with ERCC1, 
Rad1 with Rad10 and MUS81 with EME1.  
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The interaction of XPF with ERCC1 is crucial for the stability of the heterodimer and 
also for complementation of DNA repair defects (Biggerstaff et al, 1993). ERCC1 was 
first discovered as the human gene that can correct UV sensitivity in one of 11 Chinese 
hamster ovary (CHO) cell complementation groups (Westerveld et al, 1984). XPF-
ERCC1 shows nuclease activity towards a variety of branched DNA structures with 
preferences towards splayed arm, stem loop and bubble structures and it also has 
activity towards 3′ flaps (Ciccia et al, 2008). XPF-ERCC1 incises at the 5’ side of the 
branch point of all these structures (de Laat et al, 1998; Niedernhofer et al, 2001). In 
NER, XPF-ERCC1 makes the incision at the 5′ side of the UV lesion (Chapter 1.2.3) 
(Fig. 1.5). ERCC1 is essential for NER but it cannot complement the UV sensitivity of 
any of the known XP complementation groups in cells from XP patients. Strikingly 
ERCC1
-/- and XPF -/-mice have a much more severe phenotype than other NER mouse 
models indicating a role of XPF–ERCC1 outside NER (Niedernhofer et al, 2001; Tian 
et al, 2004). Furthermore, XPF–ERCC1-deficient cells are hypersensitive to ICL-
causing agents (Busch et al, 1997; De Silva et al, 2000; Gregg et al, 2011; Niedernhofer 
et al, 2004; Westerveld et al, 1984). Also fibroblast cells derived from XP-F patients 
show enhanced sensitivity to MMC and nitrogen mustard but cells from XP-A patients 
do not, although both are NER deficient (Clingen et al, 2007; Niedernhofer et al, 2006; 
Tian et al, 2004). This indicates that XPF–ERCC1 function in ICL repair is separate 
from its function in NER. More evidence for a role of XPF-ERCC1 outside NER was 
gained when a patient with a mutation in XPF was identified that caused the XFE 
progeroid syndrome characterised by profound crosslink sensitivity and progeroid 
symptoms (Niedernhofer et al, 2006).  
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XPF–ERCC1 has been proposed to act at three steps in ICL repair: unhooking of the 
ICL, excision of the unhooked ICL and recombination-mediated DSB repair (Bergstralh 
& Sekelsky, 2008). 
 
Data suggesting a role of XPF-ERCC1 at the unhooking step of ICL has come from in 
vitro experiments using an artificial substrate with a psoralen crosslink. These 
experiments have shown that XPF–ERCC1 can cleave at both sides of the crosslink if a 
single-stranded 3′ flap is adjacent to the ICL (Kuraoka et al, 2000b). It has been 
postulated that XPF-ERCC1 makes the incision at the 5' side of the ICL to promote 
unhooking (De Silva et al, 2000; Kuraoka et al, 2000a). Recent data suggest that XPF-
ERCC1 collaborates with hSNM1A, a 5'-3' exonuclease, at the unhooking step of ICL 
repair (Sengerova et al, 2011; Wang et al, 2011). XPF-ERCC1 however does not seem 
to be required for the activation of the FA pathway, as FANCD2 mono-ubiquitination is 
normal in XPF-ERCC1 deficient cells (Bhagwat et al, 2009).  
 
Repair of ICLs also involves homologous recombination which is induced by a DSB 
that takes place at the stalled RF (Dronkert & Kanaar, 2001). It has been shown that 
crosslinking agents induce the same increase in DSBs in XPF and ERCC1 mutant cells 
as in wild-type cells. This was put forward as additional evidence that XPF–ERCC1 
functions downstream of the DSB. Furthermore DSBs persist much longer in ERCC1-/- 
MEFs and in ERCC1 and XPF mutant human cells, as measured by the presence of 
γH2AX foci and in puls field gel electrophoresis (PFGE) experiments (Clingen et al, 
2005; De Silva et al, 2000; Niedernhofer et al, 2004). Zang and colleagues showed, 
using a plasmid based assay, that the HR step of ICL repair is deficient in the absence of 
- 50 - 
 
XPF and ERCC1 (Zhang et al, 2007b). Also, XPF-ERCC1 deficient fibroblasts are 
hypersensitive to gamma irradiation (Ahmad et al, 2008). 
The Drosophila orthologue MEI-9 (XPF) was identified in a screen for mutants 
showing defects in meiotic recombination (Baker & Carpenter, 1972). MEI-9 and 
ERCC1 also play roles in NER, as expected, but interestingly mei-9 mutants are also 
hypersensitive to ICL-inducing agents (Mason et al, 1981) and show defects in meiotic 
recombination (Baker & Carpenter, 1972). 
 
1.10.1.1 MUS81-EME1 
MUS81 is a member of the XPF nuclease family, and like XPF, it represents the 
catalytic subunit in a heterodimeric SSE together with EME1. MUS81 and EME1 are 
related to each other and they both contain an ERCC4 domain. The ERCC4 domain in 
EME1 however lacks the catalytic residues. It has been shown that the yeast and human 
MUS81 endonucleases preferentially cleave three-way junctions (similar to stalled RF), 
3′ flaps and also HJ precursors (D-loops) (Fig. 1.5) (Chen et al, 2001b; Ciccia et al, 
2003b; Constantinou et al, 2002; Kaliraman et al, 2001; Whitby et al, 2003). MUS81–
EME1 also cleaves intact HJs but the activity is much lower than on nicked HJs. It has 
been shown that MUS81-EME1 cleaves RFs and 3′ flaps 75-fold more efficiently than 
static HJs (Ciccia et al, 2003; Schwartz & Heyer, 2011). MUS81-EME1 cleaves static 
HJs in an asymmetrical manner leaving non ligatable products containing gaps and 
flaps, which require further processing (Boddy et al, 2001) in contrast to “classical” HJ 
resolvases such as archaeal Hjc or E. coli RuvC (see Chapter 1.8.4). 
 
In meiosis I, crossovers (COs) are essential for the exchange of genetic information 
between paternal and maternal chromosomes. It has been shown that MUS81 is 
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important for crossover control in meiosis I (Holloway et al, 2008). In budding yeast 
and mammals COs are controlled by two main pathways, one mediated by the mismatch 
repair proteins MSH4 -MSH5 and MLH1-MLH3 and another one mediated by MUS81 
(Holloway et al, 2008). It has been estimated that in budding yeast 35% of meiotic COs 
are dependent on Mus81 (Schwartz & Heyer, 2011). S. pombe lacking mus81 or eme1 
however produce inviable spores due to defects in meiosis I and these defects can be 
rescued by expression of the bacterial and phage derived HJ resolvase RusA (Boddy et 
al, 2001; Osman et al, 2003b; Svendsen & Harper, 2010b). This implies that Mus81 is 
responsible for almost all meiotic COs in S. pombe. The role of mammalian MUS81-
EME1 in meiosis is controversial, however there is evidence for a meiotic role of 
MUS81 in mammals, since MUS81 -/- mice have a reduced testis size and a lower sperm 
number (Holloway et al., 2008). 
 
1.10.2 UvrC class of SSEs 
The UvrC family of nucleases was originally identified in prokaryotes. The founding 
member UvrC has an N-terminal nuclease domain, the “GIY” domain, which is also 
called URI (UvrC-intron-type) domain. UvrC functions together with UvrAB and 
makes an incision 3′ to the lesion in NER, similar to the function of XFG in mammalian 
NER (Svendsen & Harper, 2010a). Other members of the URI family of nucleases are 
E. coli YhbQ, B. subtilis YazA and yeast Slx1 (Aravind & Koonin, 2001). The yeast 
protein Slx1 is a member of the UvrC family of nucleases and it also contains a C-
terminal cysteine-rich domain similar to a PHD domain (Coulon et al, 2004b; Fricke & 
Brill, 2003). Slx1 acts together with Slx4 and this heterodimer purified from bacteria 
has activity towards 5′ flaps, splayed arm structures, RF structures and weak activity 
towards static HJ structures (Fricke & Brill, 2003) (see Chapter 1.11) (Fig. 1.5). 
- 52 - 
 
Mutations in the conserved GIY domain in Slx1 abolish its nuclease activity in vitro and 
mutations in the C-terminal PHD domain cause functional inactivation in vivo (Coulon 
et al, 2004; Fricke & Brill, 2003).  
 
1.10.3 Holliday junction resolvases 
Holliday junctions (HJs) are four-way DNA structures formed between sister 
chromatids or homologous chromosomes by exchange of complementary strands (see 
1.5.2). HJs arise during DSB repair by HR in mitotic cells and during meiosis. However 
the observed levels of mitotic HJs are tenfold less than in meiotic cells (Bzymek et al, 
2010), indicating that HJs are important intermediates in meiosis. HJs must be removed 
for the completion of meiosis I or DSB repair (Krogh & Symington, 2004). As 
described in section 1.5.3, there a three main pathways of DSB repair by HR: SDSA, 
BIR and the Szostak model. The Szostak model comprises the double HJ (dHJ) as a key 
intermediate.  
 
There are two possibilities for the processing of dHJs. One mechanism is dHJ 
“dissolution”. During dissolution two HJs migrate towards each other to form a 
hemicatenate which is then dissolved by BLM and topoisomerase IIIα. This process 
requires the single-stranded DNA decatenation activity of topoisomerase III and results 
in non-crossover products. The other mechanism for HJ processing is HJ “resolution” 
catalysed by endonucleases, so called resolvases, that cleave the four-way junction 
(Bachrati & Hickson, 2008; Bachrati & Hickson, 2009). Resolvases are key enzymes 
for HJ resolution but the identity of these enzymes has been unclear and therefore has 
become a focus of research for many years. 
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The first enzyme described to have HJ resolvase activity was the bacteriophage T4 
endonuclease VII. This enzyme could cut joined plasmids symmetrically into products 
that could be re-ligated (Mizuuchi et al, 1982). HJ resolvase activity was then also 
shown in extracts from yeast and bacteria (Elborough & West, 1990; Symington & 
Kolodner, 1985; West & Korner, 1985). In E. coli the RuvC enzyme also acts as a dimer 
and can cut HJs symmetrically into re-ligatable products. The first eukaryotic HJ 
activity was found in S. cerevisiae and stem from Ydc2 (Kleff et al, 1992; Whitby & 
Dixon, 1997; White & Lilley, 1997). This enzyme however was of mitochondrial origin 
and therefore did not represent a eukaryotic nuclear HJ resolvase. It has been assumed 
that canonical RuvC-like HJ resolvases must exist in mammalian cells and these have 
been sought intensely. Such enzymes were expected to cleave preferentially HJs over 
other junctions in a symmetrical manner into directly re-ligatable products (Schwartz & 
Heyer, 2011). 
 
The first nuclear HJ processing enzyme to be discovered was the heterodimeric SSE 
Mus81–Eme1 in S. pombe (and human MUS81–EME1) (described in section 1.10.1) 
(Boddy et al, 2001; Chen et al, 2001a; Ciccia et al, 2003a) (see section 1.10.2.1). As 
mentioned earlier it was shown that Mus81 was required in meiosis in S. pombe (section 
1.10.1) (Boddy et al, 2000). S. pombe lacking mus81 or eme1 do not segregate their 
chromosomes in meiosis I accurately and produce inviable spores. This phenotype was 
rescued by expression of RusA, a bacterially-derived HJ resolvase, showing that the 
Mus81 resolvase activity was important for completion of meiosis I (Boddy et al, 2001; 
Boddy et al, 2000; Osman et al, 2003a). In budding yeast (S. cerevisiae) however, 
deletion of MUS81 only leads to a mild decrease in meiotic survival and this could not 
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be rescued by RusA, a phage-derived HJ resolvase, indicating that there are differences 
in Mus81 function between fission yeast and budding yeast (de los Santos et al, 2003).  
 
A role for Mus81–Eme1 in DNA repair has been proposed due to sensitivity of cells 
lacking mus81 to different types of DNA damaging agents, in particular RF stalling 
agents including MMS, hydroxyl urea (HU) and camptothecin (CPT) (Schwartz & 
Heyer, 2011). Mus81 mutants are also synthetic lethal with sgs1, the only yeast RecQ 
helicase which corresponds to human BLM (Mullen et al, 2001). In budding yeast the 
Msh4–Msh5 complex and yen1, both absent in fission yeast, might also play roles in the 
resolution of meiotic DSBs. This might explain why fission yeast are dependent on 
Mus81–Eme1 during meiosis. 
 
In 2008 several further enzymes with activity towards HJs were identified: Yen1 in 
budding yeast and GEN1 in humans (Ip et al, 2008). Yen1 and GEN1 belong to the 
XPG class of SSEs. GEN1 and Yen1 cleave static HJs one nucleotide 3′ to the junction 
in a symmetrical manner and the reaction products are re-ligatable (Ip et al, 2008); this 
is a characteristic of a classical RuvC like HJ resolvase. GEN1 can also cleave RF 
substrates and 5′ flaps but with a lower efficiency compared to HJs. Budding yeast cells 
lacking yen1 however are viable and have no obvious meiotic phenotypes. Only 
yen1∆mms4∆ double mutants fail to resolve meiotic joint molecules indicating a 
functional redundancy between Mus81 and Mms4 in this organism. Fission yeast do not 
have a Yen1 orthologue and this might explain the dependency on Mus81–Eme1 during 
the processing of meiotic crossovers. GEN1-depleted human cells show only mild 
sensitivity towards MMC and CPT (Svendsen et al, 2009) and to date there is no 
evidence for an essential role of GEN1 as a HJ resolvase in higher eukaryotes. 
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1.11 RecQ helicases 
RecQ helicases are involved in the processing of stalled RFs and in the maintenance of 
genomic stability (Bachrati & Hickson, 2008; Bohr, 2008; Cobb et al, 2002). Cells 
lacking RecQ helicases are hypersensitive to inhibitors of DNA replication, show 
defects in S-phase progression, and also accumulate aberrant DNA structures.  
RecQ helicases are DNA structure specific helicases with 3′-5′ directionality. In humans 
there are 5 RecQ helicases and most of them are associated with disease syndromes 
(Bohr, 2008). WRN, when mutated, leads to Werner’s syndrome (Yu et al, 1996); 
mutations in BLM cause Bloom’s syndrome (Ellis et al, 1995; Mohaghegh & Hickson, 
2001); RecQ4 is associated with the Rothmund-Thompson syndrome, RAPADILINO 
(Siitonen et al, 2003) or the Baller-Gerrold syndrome (Van Maldergem et al, 2006). The 
remaining two human RecQ helicases are RecQ1 and RecQ5. Werner’s syndrome and 
Rothmund-Thomson syndrome cause a premature ageing phenotype. A characteristic of 
Bloom’s is chromosomal instability and a high frequency of sister chromatid exchanges 
(SCEs) (Ellis et al., 1995). BLM cells are also hypersensitive to DNA-damaging agents 
and replication inhibitors (Bachrati & Hickson, 2003). The RecQ helicase BLM, with its 
orthologues Rqh1 in S. pombe and Sgs1 in S. cerevisiae, is important in the repair of 
DSBs. BLM interacts with Topoisomerase 3α (TOP3α) in the dissolution of 
recombination products such as HJs. This leads to exclusively non-crossover products. 
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1.12 The Slx4-Slx1 endonuclease 
1.12.1 Identification of the Slx1-Slx4 endonuclease 
Six S. cerevisiae genes were identified in a screen for factors required for viability in 
the absence of the only yeast RecQ helicase Sgs1 (Mullen et al, 2001). These six genes 
identified in the screen for synthetic lethality with Sgs1 encode six proteins that form 
three heterodimeric complexes. One of these complexes is Slx3–Slx2 that corresponds 
to Mus81–Mms4. Another heterodimer is Slx5–Slx8, which is a SUMO targeted E3 
ubiquitin ligase (Burgess et al., 2007). The final heterodimer is Slx1–Slx4 (Burgess et 
al, 2007; Mullen et al, 2001).  
 
First clues to the function of Slx1-Slx4 were found in bioinformatic analyses. Aravind 
and Koonin identified prokaryotic orthologues of the Ku protein, a central player of 
DSB repair through NHEJ (see chapter 1.5.1). They found that in prokaryotes the Ku 
open reading frame almost always lies in the operon that encodes for other DNA repair 
proteins. In Mesorhizobium loti one of these operons includes the ORF of the URI 
endonucleases (UvrC-intron type). In E. coli this is YbhQ and in yeast it corresponds 
to Slx1 (Aravind and Koonin, 2001). The URI type nucleases represent a subgroup of 
the GIY YIG nuclease family (Dunin-Horkawicz et al, 2006). URI-type nucleases are 
often found in bacteria, archaea and viruses and are often stand- alone domains of 
unknown function. Slx1 in S. cerevisiae has an URI-type nuclease domain and a PHD-
type zinc finger domain (Aravind & Koonin, 2000). In contrast to Slx1, Slx4 has no 
nuclease domain or other catalytic motifs. Slx4 is a 748 amino acid protein that 
contains a C-terminal SAP domain and a putative DNA binding domain involved in 
chromosomal organisation (Aravind & Koonin, 2000; Aravind & Koonin, 2001).  
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In vitro the Slx1–Slx4 nuclease shows no activity towards dsDNA, ssDNA or DNA 
overhangs, however the heterodimer cleaves branched DNA structures such as Y-
forks, 3′-flaps, 5′-flaps and RFs (Coulon et al., 2004; Fricke and Brill, 2003). Slx1–
Slx4 can also weakly cleave HJs in vitro (Coulon et al., 2004; Fricke and Brill, 2003) 
but no meiotic defect was observed in Slx1 or Slx4 mutant yeast cells (Mullen et al., 
2001). There is evidence that the nuclease activity of Slx1 is essential for viability of 
S. pombe cells in the absence of the RecQ helicase Rqh1 because mutating the 
catalytic residues in the URI domain of Slx1 causes lethality (Coulon et al., 2004). 
 
1.12.2 Yeast Slx1–Slx4 acts in parallel to Sgs1/Rqh1 to enable 
completion of rDNA replication 
Slx1–Slx4 acts in parallel to Sgs1BLM to enable completion of rDNA replication in late 
S-phase (Coulon et al, 2004a; Petes, 1979). In most eukaryotes the genes encoding 
ribosomal RNA (rDNA) are clustered in tandem repeats which are in a head to tail 
orientation. The copy number of rDNA repeats is controlled by recombination, 
regulating contraction and expansion of the rDNA locus (Kobayashi et al, 1998). S. 
pombe Slx1–Slx4 maintains the rDNA in a process which controls the expansion and 
contraction of rDNA loci by initiating recombination events at stalled RFs (Coulon et 
al, 2004a). Slx1 is tightly bound to chromatin in regions reminiscent of rDNA in the 
nucleolus, similar to Rqh1BLM, which is mostly localised in the nucleoli (Caspari et al, 
2002; Uzawa & Yanagida, 1992). This suggested, together with the observed synthetic 
lethality, that Slx1–Slx4 might function in parallel with Rqh1BLM in the maintenance 
of rDNA. In S. cerevisiae the rDNA locus is situated on chromosome XII and a single 
rDNA unit consists of two transcribed regions coding for 35S and 5S rRNA and two 
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non-transcribed spacer regions (NTS1 and NTS2). Each unit has an origin of 
replication, here named ARS (autonomous replication sequence), and a RF barrier 
(RFB). The RFB is important because it allows the RF to proceed only in the direction 
of transcription, but not the reverse, and this requires the binding of the Fob1 protein 
(Brewer & Fangman, 1988; Linskens & Huberman, 1988; Skryabin et al, 1984; Tsang 
& Carr, 2008). In S-phase, replication starts bi-directionally from the ARS in one of 
every five rDNA units, resulting in a stalled RF in every fifth unit (Brewer & 
Fangman, 1988; Walmsley et al, 1984). Slx1–Slx4 or Rqh1BLM process structures that 
are formed at RFB stalled forks to allow replication of the rDNA to be completed and 
to allow chromosome segregation (Mullen et al, 2001). In the absence of Slx1–Slx4 
and Rqh1BLM, cells arrest in late S-phase/early G2-phase and die. It is believed that 
blocked RFs can regress to form an HJ-like structure (“chicken foot”), which can then 
be processed by Rqh1/Sgs1BLM in a non-recombinogenic manner. Alternatively 
nucleases such as Slx1–Slx4 can cleave these HJ like structures. This would cause RF 
collapse and a one ended DSB that can initiate HR, which restores an intact RF 
(Coulon et al, 2004a).  
 
1.12.3 Slx4 regulates recovery from DNA alkylation damage-induced 
replisome stalling independently of Slx1in budding yeast 
Cells lacking Slx4 are hypersensitive to DNA alkylating agents such as MMS 
(methylmethane sulfonate) but cells lacking Slx1 are not. This indicates a Slx1-
independent role for Slx4 in the repair of alkylation damage. MMS causes N3-
methyladenine formation and blocks replisome progression and cells defective in Slx4 
are defective in recovery from MMS. Slx4∆ cells achieve almost diploid DNA content 
within 3h after removal of MMS but the DNA does not enter a pulse-field gel, 
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indicating that the DNA has not been completely replicated (Flott & Rouse, 2005). 
The checkpoint kinase Rad53 is activated after MMS treatment and in wild type its 
activity decreases after the removal of MMS but in slx4∆ cells Rad53 activity remains 
high (Flott et al, 2007a; Roberts et al, 2006). DNA fibre analysis revealed that DNA 
synthesis in slx4∆ cells could restart after removal of MMS but DNA replication is 
very slow and chromosomes are left with unrepaired gaps. 
 
Slx4 thus seems to play a role in the recovery from MMS and might be involved in the 
regulation of a DNA lesion bypass mechanism. There are two major bypass 
mechanisms: translesion synthesis (TLS) and error-free bypass. In S. cerevisiae these 
pathways both require Rad18 and Rad6. Rad18 is a DNA binding protein that targets 
Rad6 to stalled replisomes, whereas Rad6 is an E2 ubiquitin-conjugating enzyme (E2 
Ubc) (Bailly et al, 1997; Hoege et al, 2002; Jentsch et al, 1987). In TLS, the Rad6–
Rad18 complex mono-ubiquitinates PCNA at Lysine 164. This is important for the 
efficient binding of TLS polymerases to stalled replisomes. However, TLS can be 
mutagenic and is known to be a cause of spontaneous DNA damage-induced 
mutations in cells (Lawrence & Maher, 2001). In the error-free bypass pathway PCNA 
becomes poly-ubiquitinated. This requires, in addition to Rad6-Rad18, the proteins 
Mms2, Ubc13 and Rad5, which form a complex essential for error-free bypass 
(Hofmann & Pickart, 1999; Ulrich & Jentsch, 2000). Deletion of Slx4 increases TLS 
in cells before and after exposure to MMS suggesting that Slx4 is required for error-
free bypass.  
 
Slx4 also interacts with Esc4/Rtt107, which is also required for cellular resistance to 
MMS (Roberts et al, 2006; Zappulla et al, 2006). Esc4/Rtt107 contains BRCT 
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domains (BRCA1-C-terminal domains), which are protein–protein interaction domains 
found in many DNA repair proteins (Callebaut & Mornon, 1997). Cells lacking Esc4 
are hypersensitive not only MMS but to agents that block DNA replication (Chang et 
al, 2002; Hanway et al, 2002; Raschle et al, 2008; Rouse, 2004). Esc4 is required for 
the survival of DNA damage in S-phase but not for the intra-S checkpoint. 
Furthermore Esc4 is phosphorylated by Mec1 (yeast ATR), which is also important for 
recovery from MMS. Slx4 is required for the MMS-induced phosphorylation of Esc4 
by Mec1 (Roberts et al, 2006). 
 
1.12.4 Slx4 promotes 3′ flap cleavage by Rad1-Rad10 during DSB 
repair 
Slx4 also interacts with the structure-specific endonuclease Rad1XPF-Rad10ERCC1 
(Lyndaker et al, 2008). In vitro, Rad1XPF-Rad10ERCC1 preferentially cleaves branched 
DNA structures such as splayed duplexes, 3′-flaps and bubbles (Bardwell et al, 1994; 
Davies et al, 1995; Rodriguez et al, 1996). Rad1XPF-Rad10ERCC1 is known to play a 
role in UV repair (NER) and DSB-repair; in NER, it cleaves at the 5′ side of the UV-
induced DNA lesion (section 1.3.3). As described in chapter 1.5.2 there are three 
major types of DSB repair: HR, SSA, BIR and gene conversion (Figure 1.3). During 
recombinational repair of DSBs it cleaves 3′ flaps that arise during gene conversion 
and SSA. In SSA, after resection of the ends of the DSB, Rad52 and Rad59 promote 
annealing of homologous sequences, resulting in an intermediate with two non-
homologous 3′ tails that are cleaved by Rad1XPF-Rad10ERCC1. During gene conversion 
removal of the non-homologous bases at the 3′-end of the invading strand by Rad1XPF-
Rad10ERCC1 is necessary so that the invading end can act as a primer for new DNA 
synthesis. The requirement of Rad1XPF-Rad10ERCC1 for gene conversion depends on 
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the length of the 3′ tails produced being required for the removal of any tail longer 
than 30 nt. Slx4 is essential for the role of Rad1XPF-Rad10ERCC1 in DSB repair, both in 
SSA and gene conversion, but not for its function in NER (Flott et al, 2007b; 
Lyndaker et al, 2008). 
 
Slx4 and Rad1XPF-Rad10ERCC1 also function in mating type switching in S. cerevisiae 
(Haber, 1998). Budding yeast has two mating types, a and α, and cells can switch their 
mating type; this requires the induction of a DSB in the MAT locus by the HO 
nuclease, triggering HR. During the repair of this HO-induced DSB, a single 3′ non-
homologous tail occurs and this must be cleaved. Rad1XPF-Rad10ERCC1 or Slx4 
deficient cells show G2/M delay and reduced viability during mating type switching 
(Lyndaker et al, 2008). It is not known why Slx4 is required for the cleavage of non-
homologous 3′ flaps by Rad1XPF-Rad10ERCC1 during DSB repair. Binding of Slx4 to 
the catalytic region of Rad1XPF could affect its substrate specificity or its activity 
towards DNA flaps. Slx4 might also help to distort the DNA lesion to make it more 
easily accessible for the Rad1XPF-Rad10ERCC1 endonuclease. This is not required 
during NER due to the open nature of the UV-lesion, which is already unwound by 
DNA repair helicases (Costa et al, 2003; de Laat et al, 1999; Prakash & Prakash, 
2000). 
 
1.12.5 Phosphorylation of Slx4 by Mec1 and Tel1 (ATM and ATR) 
After DNA damage Slx4 is phosphorylated in vivo on at least six residues by the 
yeast ATM and ATR orthologues Mec1ATR and Tel1ATM (Flott et al, 2007b). Cells in 
which three of these phosphorylation sites in Slx4 were mutated were not 
synthetically lethal with Sgs1BLM, however they were not able to rescue the SSA 
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defect in slx4∆ cells (Flott et al., 2007). Furthermore Mec1ATR/Tel1ATM 
phosphorylate Slx4 on Thr 113, and this is required for efficient cleavage of non-
homologous (NH) tails by Rad1XPF-Rad10ERCC1 during SSA and HR (Toh et al, 
2010).  
 
1.13 Why identify and study human Slx4? 
As described in Chapter 1.11, yeast Slx4 is a scaffold and regulator of structure 
specific nucleases and plays essential roles in DNA repair in yeast. Together with 
Slx1 it acts in parallel to Sgs1 in the maintenance of rDNA replication and together 
with Rad1-Rad10 it acts as an important factor in DSB repair. A third function is the 
regulation of recovery from DNA alkylation damage-induced RF stalling. 
Furthermore we know that MUS312, the fly Slx4 orthologue, is involved in the 
resolution of meiotic crossovers and mus312 mutant flies display meiotic defects. 
Therefore Slx4 seems to be a very important repair factor in yeast and flies and it is 
conserved throughout evolution, thus it appears likely that SLX4 plays an important 
role in DNA repair in human cells and as such is worth investigating.  
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Chapter II 
 atera a meth 
 
2.1 Materials 
 
2.1.1 Chemicals  
Protein G Sepharose, activated CH Sepharose, [γ-32P] dATP, HiLoad 26/60 
Superdex 200 preparative grade gel filtration column and enhanced 
chemiluminescence reagent (ECL) were from Amersham Pharmacia Biotech/GE 
Healthcare (Little Chalfont, Buckinghamshire, U.K.). The FLA-2000 
phosphorimager was from Fujifilm (Stamford, USA). Glycerol, methanol, 
isopropanol, acetic acid, acetone, ethanol, tris (hydroxymethyl) methylamine (Tris), 
manganese chloride, magnesium acetate, sucrose, sodium 
ethylenediaminetetraacetate (EDTA), sodium chloride, sodium dodecyl sulphate, 
sodium acetate, and β-mercaptoethanol (biochemical grade) were from BDH 
Chemicals Ltd. (Lutterworth, Leics., UK). Centrifuges and rotors were from 
Beckman Instruments Inc. (Palo Alto, U.S.A.). FACSsafe, FACSclean, FACSrinse, 
FACScalibur, and the BD LSR flow cytometer were from Becton Dickinson (BD 
Biosciences, San Diego, U.S.A.). Unstained molecular weight protein markers for 
SDS-PAGE (broad range), precision plus protein marker (prestained) and gel 
filtration standards (Dextran Blue, thyroglobulin and bovine γ-globulin), mini-cell 
gel tanks, cellophane support, gel-drying apparatus, and GelAir Dryer were from 
BioRad (Hertfordshire, UK). Tissue culture plasticware were from Corning 
Incorporated (NY, U.S.A.), Greiner (Frickenhausen, Germany) or Nunc (Roskilde, 
Denmark). Cell scrapers were from Costar (Cambridge, MA, U.S.A.). Class II 
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microbiological safety cabinet was from Envair (Lancs, U.K.). Biophotometer and 
UVettes were from Eppendorf (Hamburg, Germany). Acrylamide:bis-acrylamide 
(40% (w/v) 29:1) solution was from Flowgen Bioscience (Nottingham, U.K.). 
Nuclease free water was from Fluka (Sigma-Aldrich, Poole, Dorset, U.K.). DMEM, 
RPMI, McCoy’s 5A, Dulbecco’s phosphate buffered saline (PBS), 
penicillin/streptomycin, L-glutamine, trypsin-EDTA, puromycin, the neomycin 
analogue G418, colloidal Coomassie Blue staining kit, pre-cast NuPAGE Novex 4-
12% Bis-Tris polyacrylamide gels, NuPAGE MOPS running buffer (20x), NuPAGE 
LDS Sample Buffer (4x), NuPAGE Transfer Buffer (20x) and X-Cell SureLock 
Mini-Cell electrophoresis system, protein G Sepharose, zeocin and blasticidin were 
from Invitrogen (Paisley, U.K). IgG–free BSA was from Jackson Immunoresearch 
(Suffolk, U.K.). Autoradiography cassettes with intensifying screens and X-ray film 
for detecting ECL signals from western blots were from Kodak (Liverpool, U.K.). 
The Konica SRX-101A automatic film processor was from the Konica Corporation 
(Japan). Cellulose filters (0.22 µm and 0.45 µm), Steriflip columns, and sterile filters 
(0.22 µm) were from Millipore Ltd. (Norwich, UK). Isopropyl thio-β-D-galactoside 
(IPTG) and dithiotheitol (DTT) were from Melford Laboratories (Ipswich, UK). 
LEEC CO2 incubators were from Merck (Dorset, U.K.). Oligonucleotides were 
synthesised by the Oligonucleotide Synthesis Service (University of Dundee), 
Coomassie protein assay reagent (Bradford reagent) and bovine serum albumin 
(BSA) solution for protein standard determination were from Pierce (Cheshire, UK). 
Non-essential amino acids (NEAA) and Na-pyruvate were from Lonza. Skimmed 
milk powder (Marvel) was from Premier Brands (Stafford, UK). Qiagen Plasmid 
Mini kit and Maxi kit, were from Qiagen (Crawley, U.K.). Acetonitrile (HPLC 
grade) and trifluoroacetic acid were from Rathburn Chemicals (Walkerburn, U.K.). 
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Dithiotheitol (DTT), adenosine 5′-triphosphate, and Complete protease inhibitor 
cocktail tablets (containing aprotinin, bestatin, calpain inhibitors, chymostatin, E-64, 
leupeptin, α 2-macroglobulin, pefabloc SC, pepstatin, PMSF, and trypsin inhibitors) 
were from Roche (Lewes, UK). Nitrocellulose membranes were from Schleicher and 
Schuell (Anderman and Co. Ltd., Surrey, UK). Ponceau S solution, ampicillin, foetal 
bovine serum (FBS), dimethyl sulphoxide (DMSO), proteinase K, t-
octylphenoxypolyethoxyethanol (Triton) X-100, polyethylene glycol sorbitan 
monolaurate (Tween-20), Coomassie brilliant blue G-250, bromophenol blue, 
ammonium persulphate, tetramethylethylenediamine (Temed), polyethylenimine 
(PEI), benzonase nuclease, polybrene, puromycin, paraformaldehyde and 
iodoacetamide were from Sigma-Aldrich (Poole, U.K.). Mitomycin-C (MMC) was 
from Calibiochem (Darmstadt, Germany), BL21 Codon Plus (DE3) RIL cells were 
from Stratagene (La Jolla, U.S.A). Neubauer haemacytometer was from VWR 
(Leicestershire, U.K.). 3MM chomatography paper was from Whatman International 
Ltd. (Maidstone, UK).  Dithiobis (succunimidyl propionate) (DSP) was from 
Thermo Scientific (Waltham, USA). Benzonase and thin-layer chomatography plates 
were from Novagen/Merk Biosciences (Darmstadt, Germany). Vectashield 
mounting media was from Vector Laboratories Inc. (California, USA). Bovine 
serum albumin (BSA) IgG free, protease free, was from Jackson Immunoresearch 
laboratories. All other chemicals were of the highest purity grade available from 
Sigma-Aldrich (Poole, Dorset, UK) or from BDH Chemicals Ltd. (Lutterworth, 
UK). 
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2.1.2 In house reagents 
Bacterial culture medium Luria Bertani broth (LB) and LB agar plates were 
provided by the media kitchen service. 
 
2.1.3 Instruments 
 X-Cell SureLock Mini-Cell electrophoresis system and X-Cell II Blot Module 
were from Invitrogen. Automated western processors were from BioRad. X-omat 
autoradiography cassettes with intensifying screens were from Kodak. Automatic 
film processor was from Konica Corporation. Vibrax-VR platform shaker was from 
IKA. Thermomixers were from Eppendorf. pH meters and electrodes were from 
Horiba. Balances were from Ohaus. The 96-well Versamax plate reader was from 
Molecular Devices. Centrifuge - 53 - tubes, rotors and centrifuges were from 
Beckmann. Biofuge pico microcentrifuge was from Haraeus Instruments. Sonicators 
were from Sonics and Materials. Speed-vacs were from CHRIST. Gel 
Electrophoresis System (Horison 11-14) was from Life Technologies. Tissue culture 
2nd class safety cabinets (BioMAT-2 SF) were from Medical Air Technology. 
Tissue culture CO2 incubators were from Binder.  
 
2.1.4 Proteins 
Glutathione S-transferase (GST) and GST-tagged proteins were provided by the 
Protein Production Team (Division of Signal Transduction Therapy (DSTT), 
University of Dundee). The cDNAs were cloned into pGEX plasmids and expressed 
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in BL21 Escherichia coli cells. Ubiquitin and poly-ubiquitin chains were purchased 
from Boston Biochem. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Expressed Protein Plasmid backbone DU Number 
GST-SLX4 270-380 C336A + C339A pGEX6P 33841 
GST-SLX4 400-450 E419A + D420A pGEX6P 33832 
GST-SLX4 270-380 pGEX6P 37045 
GST-SLX4 270-380  C296A + C299A pGEX6P   37049 
GST-SLX4 270-335 pGEX6P 37015 
GST-SLX4 270-335 C296A + C299A pGEX6P 37016 
GST-SLX4 320-380 pGEX6P 37017 
GST-SLX4 320-380 C336A + C339A pGEX6P 37018 
GST-WRNIP1 pGEX6P 33875 
GST-NEMO pGEX6P 19571 
GST- pGEX6P 8667 
Protein Source / Cat. number 
Mono-ubiquitin (human) Boston Biochem / U-100H 
Di-Ub/Ub2 wt Chains (K63-linked) Boston Biochem / UC-300  
Tri-Ub/Ub3 wt Chains (K63-linked) Boston Biochem / UC-315  
Tetra-Ub/Ub4 wt Chains (K63-linked) Boston Biochem / UC-310 
Penta-ubiquitin/Ub5 wt Chains (K63-linked) Boston Biochem/ UC-316 
Hexa-ubiquitin/Ub6 wt Chains (K63-linked) Boston Biochem / UC-317  
Poly-ubiquitin chains (Ub2-7), (K63-linked) Boston Biochem / UC-330 
Poly-Ub wt Chains (1-7) (K48-linked) Boston Biochem / UC-240 
Table 2.1: GST fusion proteins used in this thesis 
Table 2.2: Recombinant ubiquitin and poly-ubiquitin chains used in this thesis 
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2.1.5 Plasmids and oligonucleotides 
All the plasmids used in this thesis, and their sources are described in Table 2.3. 
Plasmids were constructed by Mr Thomas Macartney or Dr Rachel Toth (Cloning 
Team, DSTT, University of Dundee). The correct sequences of all constructs were 
verified by the DNA Sequencing Service (University of Dundee) by full sequencing 
of both strands.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 2.3: Plasmids used in this thesis. 
Name Plasmid Source (DU number) 
GFP-SLX4 213-end pcDNA-FRT/TO 33023 
GFP-SLX4 270-380 c-NLS pcDNA-FRT/TO 33256 
GFP-SLX4 270-380 c-NLS C296A C299A pcDNA-FRT/TO 33257 
GFP-SLX4 270-380 C336A C399A pcDNA-FRT/TO 33862 
GFP-SLX4 pcDNA-FRT/TO 19216 
GFP-SLX4 S1244A pcDNA-FRT/TO 19476 
GFP-SLX4 S1355A pcDNA-FRT/TO 19477 
GFP-SLX4 S1355A S1453A pcDNA-FRT/TO 19489 
GFP-SLX4  S1453A pcDNA-FRT/TO 19478 
GFP-mSLX4 pBABE puro-DU-GFP 33987 
GFP-mouse SLX4 C120A C123A pBABE puro-DU-GFP 37598 
GFP-mouse SLX4 C160A C163A pBABE puro-DU-GFP 37730 
GFP pBABE puro-DU-GFP 32961 
SLX1-FLAG pCMV 5309 
SLX1 E82A FLAG pCMV 19530 
SLX1 R41A FLAG pCMV 19529 
SLX1 R41A E82A FLAG pCMV 19547 
FLAG-XPF pcDNA5 FRT/TO 11950 
FLAG-XPF D704A pcDNA5 FRT/TO 19526 
FLAG-ERCC1 pcDNA5 FRT/TO 11881 
FLAG-MUS81 pcDNA5 FRT/TO 19404 
FLAG-MUS81 D307A pcDNA5 FRT/TO 19542 
SLX4 (mouse)  pBABE puro-DU- 33993 
SLX4 (mouse) C120A C123A pBABE puro-DU- 37597 
SLX4 (mouse)C160A C163A pBABE puro-DU- 37729 
Gag pol pCMV Gag pol (Cell 
Biolabs RV-111) 
35085 
VSV-G pCMv VSV-G (Cell 
Biolabs RV-110) 
35086 
Empty vector pCDNA POG44 13162 
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2.1.6 Small interfering (si) RNA oligos 
siRNA duplexes were purchased from either Dharmacon or Thermo Scientific. The 
sequences are listed in Table 2.3. Sequences of the oligonucleotides used for the 
generation of radiolabelled DNA substrates are shown in Table 2.4. 
Target Oligo Target sequence(sense 
sequence) 
Source 
SLX4 SLX4-PH1 
SLX4-PH2 
AAACGUGAAUGAAGCAGAAUU 
GAACGAAGUCGCACAGAAGUU 
Dharmacon, siGENOME SMART 
pool duplex (PH1 or PH2), D-
014895, BTBD12 
XPF  
XPF-1 
XPF-2 
XPF-3 
XPF-4 
 
XPF 
Pool of: 
UGACAAGGGUACUACAUGA 
GUAGGAUACUUGUGGUUGA 
ACAAGACAAUCCGCCAUUA 
AAGACGAGCUCACGAGUAU 
Or 
AAUGCUAUUGGAAAACCUU 
Thermo Scientific, siGENOME 
SMART pool M-019946-00-0020 
human XPF/ERCC4, NM_005236 
(XPF-1-4) 
 
 
Dharmacon (XPF) 
MUS81 MUS81 Pool of: 
GGGAGCACCUGAAUCCUAA 
CAGGAGCCAUCAAGAAUAA 
GGGUAUACCUGGUGGAAGA 
CAGCCCUGGUGGAUCGAUA 
Dharmacon 
SLX1 SLX1 UGGACAGACCUGCUGGAGAUU Dharmacon 
Luciferase  Control siRNA CGUACGCGGAAUACUUCG Dharmacon 
 
Table 2.4: siRNA oligos used in this thesis 
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Table 2.5: Oligonucleotides for the generation of radiolabelled DNA substrates used in 
this thesis 
 
 
 
  
Oligo Sequence (5’ – 3’) Use 
a GCGTTACAATGGAAACTATTCGTGGCAGTT
GCATCCAACG 
Part of synthetic four way 
junction,   
b CGTTGGATGCAACTGCCACGAATAGTGTCA
GTTCCAGACG 
Part of synthetic four way 
junction, RF analog, Y fork 
structure, duplex (DS), 3’ flap, 5’ 
flap and single strand (SS),  
c CGTCTGGAACTGACACTATTCGTGGCGAAT
GGTCGTAAGC  
Part of synthetic four way 
junction  
d GCTTACGACCATTCGCCACGAATAGTTTCCA
TTGTAACGC 
Part of synthetic  four-way 
junction  
c1 CGTCTGGAACTGACACTATT     Part of synthetic  RF analog 
afix GCGTTACAATGGAAACAGACCGTGGCAGTT
GCATCCAACG 
Part of synthetic  RF analog, 3’ 
flap, Y fork structure (YF), 5’ flap 
d2fix GTCTGTTTCCATTGTAACGC Part of synthetic  RF analog and 
3’ flap  
b-cp CGTCTGGAACTGACACTATTCGTGGCAGTT
GCATCCAACG 
Part of synthetic duplex (DS) 
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2.1.7 Antibodies 
The source and the catalogue numbers of all the antibodies employed in this thesis 
are described in Table 2.5. Antibodies raised against human SLX4 and human SLX1 
and murine SLX4, SLX1, MUS81, ERCC1, EME1 and XPF were generated and 
supplied by the DSTT (Division of Signal Transduction Therapy, University of 
Dundee). The in Table 2.5 indicated amino acids (aa) of the target protein were 
fused to GST and expressed in bacteria. These fusion proteins were used as antigens 
for injection into sheep. The antibody purification protocol is described in section 
2.2.1.8. All secondary antibodies purchased were horseradish peroxidase (HP) 
conjugated.  
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Table 2.6 Antibodies used in this thesis  
 
 
 
Antigen Source Catalogue no. 
HA;  Roche 12CA5 
FLAG (M2) Sigma F1804 
XPF  Thermo MS-1381-p1ABX 
ERCC1  Thermo MS-671-P1ABX 
MUS81  ImmuQuest IQ285 
anti- EME1 ImmuQuest IQ28 
γ-H2AX Bethyl A300-081A 
GFP  Roche 11814460001 
PLK1 SIGMA SAB2101829 
GAPDH  Abcam ab8245 
Ubiquitin Santa Cruz       
Biotechnology 
sc-9133 
SLX4-N (aa 1-300 human) DSTT S712C 
SLX4-C (aa 1564-end human) DSTT S714C 
SLX4-(aa 671-800 human) DSTT S126D 
SLX1 (aa 1-275 human) DSTT S870B 
MUS81 (aa 1-200 mouse) DSTT S163D 
XPF (aa 1-200 mouse) DSTT S164D 
ERCC1 (aa 1-200 mouse) DSTT S161D 
EME1(aa 1-200 mouse) DSTT S166D 
SLX1 (mouse) DSTT S778C 
phospho-H2AX (Ser139) Bethyl A300-081A 
Cyclin B1 Cell Signaling #4138 
Cyclin A (BF683) Cell Signaling #4656 
Cyclin D1 Cell Signaling #2926 
Cyclin E1 Cell Signaling #4129 
Beads for Immunoprecipitation   
GFP-Trap beads _A Chromotek Gta-20 
Anti-FLAG (M2) agarose  Sigma A2220 
Secondary antibodies   
Mouse IgG (H+L) (HRP)  Pierce 31430 
Rabbit IgG (H+L) (HRP)  Pierce 31460 
Sheep IgG (H+L) (HRP) Pierce 31480 
Goat (H+L) (HRP) Pierce 31402 
Mouse IgG (H+L) ( Alexa Fluor® 488 ) Invitrogen A-11001 
Sheep IgG (H+L) ( Alexa Fluor® 488) Invitrogen A-11015 
Rabbit IgG (H+L) (Alexa Fluor®594) Invitrogen A-11012 
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2.1.8 Buffers and solutions 
Blocking buffer for immunofluorescence: 3% (w/v) IgG-free BSA, PBS, 0.2% 
(v/v) Tween-20 
Coomassie blue stain: 50% (v/v) water, 40% (v/v) methanol, 10% (v/v) acetic acid,  
0.2% (w/v) Coomassie Brilliant Blue (G-250) 
Coomassie destain: 50% (v/v) water, 40% (v/v) methanol, 10% (v/v) acetic acid  
2 X HBS: 280 mM NaCl, 1.5 mM Na2HPO4, 50 mM HEPES, pH 7.0. Aliquoted and 
stored at –20°C  
CSK buffer: 10 mM PIPES pH7, 100mM NaCl, 300mM sucrose, 3mM MgCl2 
Gel filtration buffer: 50 mM Tris/HCl pH 7.4, 1 mM EDTA pH 8.0, 150 mM KCl, 
0.1% (v/v) 2-mercaptoethanol, sterile filtered before use 
Kinase assay buffer: 50mM Tris pH 7.5, 0.1 mM EGTA pH8.0, 10 mM magnesium 
chloride, 0.1% (v/v) 2-mercaptoethanol 
Luria Bertani broth (LB): 1% (w/v) tryptone peptone, 0.5% (w/v) yeast extract, 86 
mM NaCl. After autoclaving for 20 min, and cooling down to less than 50°C 
ampicillin (Amp) was added to a final concentration of 50 µg/ml (LB/Amp). 
LB/Amp plates contained additional 2% (w/v) bacto-agar, and were stored at 4°C 
Lysis buffer: 50 mM Tris pH 7.4, 0.5 % (v/v) Triton X-100, 0.27 M Sucrose, 0.15 
M NaCl, , 0.1% β- mercaptoethanol, 1 Complete protease inhibitor tablet per 50 ml 
of lysis buffer  
Nuclease buffer: 20 mM Tris-HCl [pH 7.5], 50 mM NaCl, 10 mM MgCl2, 0.1 
mg/ml BSA 
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Nuclease assay stop buffer: 0.1% (w/v) SDS, 14 mM EDTA and 0.1 mg/ml 
Proteinase K 
Phosphate-buffered saline (PBS) (1x):  137 mM NaCl, 2.7 mM KCl. 4.3 mM 
Na2HPO4, 1.47 mM KH2PO4. Final pH was adjusted to pH 7.4 
SDS Sample Buffer (1x): 1% (w/v) SDS, 1% (v/v) 2-mercaptoethanol, 50 mM 
Tris/HCl pH 6.8 and 6.5% (v/v) glycerol. Buffer was prepared as a 5x stock. 
SDS Electrophoresis Buffer (1x): 25 mM Tris, 192 mM Glycine, 0.1% (w/v )SDS. 
Buffer was prepared as a 10x stock.  
TBS-T: TBS, 0.2% (v/v) Tween 20 
Transfer Buffer (1x): 48 mM Tris, 39 mM Glycine, 20% (v/v) methanol. Buffer 
(without methanol) was prepared as 10x stock. Methanol was added to 1x before 
use. 
Tris buffered saline (TBS): 50 mM Tris/HCl pH 7.6, 150 mM NaCl 
Ubiquitin binding buffer: 25 mM HEPES pH 7.5, 150 mM KCl, 2 mM MgCl2, 
0.5% (v/v) Triton X-100, 1 mM EGTA 
 
2.1.9 Escherichia coli cells 
Transformation-competent Escherichia coli (E. coli) cells (BL21, Top10 or DH5α) 
were provided by Dr Mark Peggie (Cloning Team, DSTT, University of Dundee). 
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2.2 Methods 
2.2.1 General methods 
2.2.1.1 Determination of protein concentration 
Protein concentrations were measured by the Bradford method (Bradford, 1976). A 
standard curve was prepared according to the manufacturer’s protocol, by adding 
increasing amounts of BSA to a final volume of 0.1 ml with water, and then mixing 
with 0.9 ml Bradford reagent. The mixture was allowed to stand at room temperature 
for 5 min. The optical density of the standards was measured at 595 nm (OD595) in 
1.5 ml plastic cuvettes against a reference cuvette containing water (0.1 ml) and 
Bradford reagent (0.9 ml). This was used to construct a standard curve that was 
employed to determine protein concentrations of cell lysates. On average the linear 
range of protein Bradford measurements lies between OD595 0.1 and OD595 0.7. Cell 
lysates were diluted so that the OD595 lay in this range. Bradford measurements were 
performed in triplicate. 
 
2.2.1.2 Determination of DNA concentration 
The absorbance of DNA in aqueous solutions was measured in a disposable 
‘UVette’ at 260 nm with a Biophotometer, using the OD260 of sterile water as zero. 
The integrity of plasmid DNA was assessed by agarose gel electrophoresis. 
 
2.2.1.3 DNA sequencing 
Sequencing of either plasmid DNA or PCR product DNA was performed by The 
Sequencing Service, School of Life Sciences, University of Dundee, using 
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DYEnamic ET terminator chemistry (Amersham Pharmacia Biotech) on Applied 
Biosystems automated DNA sequencers. For DNA sequences containing a high GC 
content (typically > 75%), 10% (v/v) of GC-melt solution (Clontech) was added to 
the sequencing reaction. 
 
2.2.1.4 Separation of proteins by sodium dodecyl sulphate (SDS)-polyacrylamide 
gel electrophoresis (PAGE)  
Protein samples were denatured in lithium dodecyl sulphate (LDS) sample buffer 
(1x) and β-mercaptoethanol (β-ME) (10% (v/v)). Samples were boiled at 95°C for 5-
10 min before loading onto polyacrylamide gels. Two SDS-PAGE systems were 
used in this thesis depending on the experiment. For gels or blots for publication the 
NuPAGE 4-12% Bis-Tris pre-cast gels coupled with the BioRad system for 
electrophoretic transfer was used, Electrophoresis was performed using 
electrophoresis buffer at a constant voltage of 200 V for 60 min. Invitrogen Bis-Tris 
gels were run in Novex NuPAGE 3-[N-morpholino] propane sulphonic acid (MOPS) 
running buffer.  
 
For all other experiments, the ATTO self-pour gel system for gel electrophoresis 
coupled with the BioRad system for electrophoretic transfer. Slab gels for the ATTO 
system were poured between glass plates using separating gel consisting of 0.375 M 
Tris-HCl pH 8.8, 0.1% (w/v) SDS, 10% (w/v) acrylamide/0.4% (w/v) N, N’-
methylene bisacrylamide and 0.075% (w/v) ammonium persulphate.  Polymerisation 
was initiated by the addition of 0.1% (v/v) tetramethylethylenediamine (TEMED). 
Isopropanol was then layered carefully over the acrylamide solution and 
polymerisation allowed to continue for at least 15 min. The isopropanol was 
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removed and stacking gel comprising 0.125 M Tris-HCl (pH 6.8), 0.1% (w/v) SDS. 
3% (w/v) acrylamide/0.08% (w/v) N, N’-methylene bisacrylamide, 0.075% (w/v) 
ammonium persulphate and 0.1% (v/v) TEMED, was poured onto the separating gel 
top and a 14-well comb added prior to polymerisation and left to set for at least 10 
min. Electrophoresis was performed using electrophoresis buffer at a constant 
voltage of 200 V for 60 min. 
 
2.2.1.5 Staining of protein gels 
To visualize proteins after SDS-PAGE, gels were stained in Coomassie stain or 
colloidal Coomassie Blue (for subsequent mass spectrometry analysis) staining 
solution for 60-240 min at room temperature with continual agitation on a rocking 
platform. Gels were destained with destain solution after Coomassie staining, or 
with water after colloidal Coomassie Blue staining, using several changes of solution 
until the background staining was greatly reduced. Protein gels were wrapped 
between two sheets of cellophane support, clamped to BioRad gel-drying apparatus, 
and dried in a GelAir Dryer. 
 
2.2.1.6 Western blotting 
Protein gels were assembled into a gel-membrane sandwich as described in the 
manufacturer’s protocol. Nitrocellulose membrane was placed on a gel, this 
assembly was placed between two pieces of filter paper (3MM), and this structure in 
turn was placed between two sponges. All components were pre-soaked in transfer 
buffer. This assembly was loaded into a BioRad Mini-Cell tank filled with transfer 
buffer, and proteins were transferred to nitrocellulose at 100 V for 1 h. The 
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nitrocellulose membranes were blocked in TBS-T containing skimmed milk (5% 
(w/v) for 1 h at room temperature. Primary antibodies were diluted in TBS-T 
containing skimmed milk (5% (w/v)). Membranes were washed, incubated with 
secondary antibodies conjugated to horseradish peroxidase (all secondary antibodies 
used at 1:5000 dilutions in TBS-T containing 5% (w/v) skimmed milk) for 1 h at 
room temperature. After washing, membranes were developed with enhanced 
chemiluminescence reagent (ECL). To detect secondary antibodies conjugated with 
horseradish peroxidase (HP) ECL reagents 1 and 2 were mixed in equal volumes and 
1 ml of this mix was added to each blot for 1 min. The membrane was then placed in 
a clean piece of polythene roll that was cut to fit into an autorad cassette. The 
membrane was then exposed to Medical X-Ray Film (Konica Minolta) and 
developed in an automatic processor.  
 
2.2.1.7 Autoradiography 
Protein gels or membranes containing radioactively labelled proteins were placed in 
an autoradiography cassette and exposed to X-ray films for different lengths of time. 
Typically, films were exposed for between 2 and 48 h at -80°C. The films were 
developed using a Konica Automatic Film Processor. Alternatively radioactivity was 
visualised using an FLA-2000 phophorimager system and ImageGauge software 
(Fujifilm). 
 
2.2.1.8 Antibody generation 
Antibodies against the protein fragments indicated in Table 2.3 fused to a GST were 
used as antigens for antibody production in sheep. Full length SLX1 fused to GST 
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was also used as an antigen for antibody production in sheep (Table 2.6). The 
antibodies were affinity-purified by the DSTT antibody production team co-
ordinated by H. McLauchlan and J. Hastie (University of Dundee). Antisera were 
raised in sheep at Scottish National Blood Transfusion Service (Penicuik, U.K.).  
For the antibodies the GST-fragments were injected into sheep as GST fusion 
proteins. The antigens were emulsified in Freund’s adjuvant prior to injection. As 
standard protocol, one pre-immune bleed was taken on the same day as the first 
injection of antigen. Thee more injections, one every 28 days, were administered and 
blood was taken seven days after the second, third and fourth injections. To yield a 
fourth bleed of the antibody this was repeated once more. Typically 750 ml of blood 
is taken per bleed, which yields 250-350 ml of serum. Each bleed was allowed to 
clot overnight at 4 oC and, following centrifugation for 60 min at 1500 x g at 4 oC, 
the sheep antiserum was decanted though glass wool and stored at -20 oC. For 
purification the serum was heated for 20 min at 56 oC followed by filtration though a 
0.45 µM filter. The anti-serum was diluted 1:1 in 50 mM Tris/HCl pH 7.5 with 2% 
Triton X-100 and anti-GST antibodies were depleted using a column of GST 
coupled to activated CH Sepharose. Flow-through fractions were affinity purified 
against the relevant antigen. The antibody was eluted with 50 mM glycine pH 2.5 
and neutralized by dialyzing overnight into PBS. 
 
2.2.1.9 Mammalian cell culture 
All media and buffers used for mammalian cell culture were pre-warmed to 37 ºC 
prior to use and all procedures were carried out under aseptic conditions compliant 
with biological safety Category-2 regulations. Unless otherwise indicated, cells were 
- 80 - 
 
cultured and maintained at 37ºC in a 5 % CO2 water-saturated incubator. Cells were 
grown until 80-90 % confluency before splitting for routine maintenance.  
 
2.2.1.9.1 Human embryo kidney 293 (HEK293) cells 
HEK293 cells were purchased from the European Collection of Cell Cultures 
(Salisbury). They were cultured in 150 cm2 flasks (for routine passaging) or on 10 
cm2 plates in DMEM supplemented with 10 % (v/v) foetal bovine serum (FBS) and 
1 % (v/v) penicillin/streptomycin stock solution (10,000 units penicillin and 10 mg 
streptomycin per ml). For passaging of cells, culture medium was aspirated, cells 
were washed once with sterile Dulbecco’s phosphate buffered saline (PBS) and 2 ml 
of sterile trypsin/EDTA was added per flask. Cells were returned to a 37 ºC 
incubator for 5 min. After the cells detached from the surface of the flask, they were 
resuspended to a final volume of 10 ml in complete medium and clumps of cells 
were broken up by passing through a narrow-bore pipette several times. 2 ml of this 
cell suspension was used to seed a 150 cm2 flask to maintain stocks in 25 ml of 
complete medium. For cells destined immediately for experiments, 1 ml of cell 
suspension was used to seed a 10 cm2 plate in 10 ml of complete medium.  
 
2.2.1.9.2 U2OS cells 
U2OS cells were passaged in the same manner as HEK293 cells (Section 2.2.1.9.1). 
U2OS cells were used in most microscopy experiments (as indicated) because of 
their large nuclei. 
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2.2.1.9.3 Human fibroblasts 
Human fibroblasts immortalised with SV40 large T–antigen, taken from an 
individual with unclassified Fanconi anemia (EUFA 1354) and wild type (WT) 
fibroblasts (LN9SV) were cultivated in the same conditions as HEK293 but with 
additional 10% FBS in the medium. The cells were cultured in 150 cm2 flasks (for 
routine passaging) or on 10 cm2 plates for experiments. They were passaged in the 
same manner as HEK 293 cells (Section 2.2.1.9.1).  
 
2.2.1.9.4 Human lymphoblasts 
EBV-transformed lymphoblasts were cultured in RPMI1640 medium containing 
10% FBS.  
 
2.2.1.9.5 Mouse embryonic fibroblasts (MEFs) 
MEFs were cultured in 10 cm2 plates in DMEM supplemented with 10% (V/V) 
foetal bovine serum (FBS) and 1% (V/V) penicillin/streptomycin stock solution 
(10,000 units penicillin and 10 mg streptomycin per ml). Additionally 1 % Na-
Pyruvate (v/v) and 1 % non-essential amino acids (v/v) were added. Complemented 
MEFs were cultured in a medium containing additional puromycin (3ug/ml) to keep 
them under selection. 
 
2.2.1.9.6 Cell freezer stocks 
Cell stocks were stored at -196 °C in liquid nitrogen; when necessary, growing cells 
were frozen down to ensure a constant supply. Cells to be frozen for storage were 
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allowed to grow to 90 % confluence; after washing with PBS, trypsin was added to 
detach cells. Harvested cells were then washed, to remove trypsin, in an excess of 
normal growth media by centrifugation at 800 rpm for 5 min. The supernatant was 
removed and after tapping the tube to loosen up the pellet, cells were resuspended in 
cryogenic storage media (50 % FCS, 10 % DMSO, 40 % DMEM). Cells were 
resuspended so that 1 ml cryogenic storage media contained the same number of 
cells that would have been passaged into a new dish. Aliquots of cell suspension (1 
ml) were stored in 1.5 ml cryogenic screw top vials (Corning) at -80°C in an 
insulated box for 24 h, before transfer to the liquid nitrogen cell freezer. This is 
because, to ensure viability during storage at -196°C, cells must be allowed to cool 
at a rate slow enough to allow the cells time to dehydrate but fast enough to prevent 
excessive dehydration damage. A cooling rate of -1 °C to -3 °C per minute is 
satisfactory for most animal cell cultures. Larger cells or cells having less permeable 
membranes may require a slower freezing rate since their dehydration takes 
somewhat longer.  
 
2.2.1.9.7 Cell counting using a haemocytometer 
Cells were centrifuged at 3000 rpm for 5 min and then re-suspended in DMEN 
media. 50 µl of cell suspension was added to 50 µl of trypan-blue and 50 µl of this 
mixture was placed on a haemocytomter with a glass coverslip placed on top. Cells 
within a 0.1 mm area, delimited by a double line (9 small squares) were counted. 
Cells stained by typan-blue were classed as dead and were not counted. The count 
total is equivalent to the number of cells times 1x104 per 1 ml of cell sample. Cells 
were counted in triplicate.  
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2.2.2 Transfection of HEK293 and U2OS cells with DNA and siRNA 
A modified calcium phosphate precipitation method was used to transiently transfect 
HEK293 cells. DNA-containing solutions were formulated in milliQ-water and 
sterile-filtered through 0.22 µm pore-size syringe filters. siRNAs were dissolved in 
5X siRNA buffer (Dharmacon) and made up with water free from RNase and DNase 
according to manufacturer’s instructions. 
 
For a single transfection experiment in a 10 cm2 plate, confluent HEK293 cells were 
trypsinized as described in Section 2.2.1.9.1 and approximately 4x106 cells were 
seeded onto a 10 cm2 plate. The cells were allowed to adhere to the plates and 
recover from the trypsinisation process for 24 h before transfection. Plasmid DNA 
was purified using the Qiagen Plasmid Maxi kit (Section 2.2.7.2) For each 10 cm2 
plate to be transfected, different amounts of plasmid DNA (typically 10 µg) were 
made up to 50 µl with milliQ-water in a sterile tube. To this, CaCl2-2H20 was added 
to a final concentration of 122 mM, sterile H2O was added to 500 µl and the solution 
was mixed by tapping. The DNA/CaCl2 mixture was added dropwise with constant 
mixing to 500 µl of 2 X HBS Buffer. The resulting solution was left for 15 min at 
room temperature to induce the precipitation of DNA/CaCl2 complexes before 
pipetting the final 1 ml solution drop-wise onto a 10 cm plate. The cells were then 
incubated in a 37°C, incubator for 48 h before cell lysis. For the majority of siRNA 
experiments, the same procedure was used and typically 100 nM siRNA duplex was 
added to each 10 cm2 plate. For transfections in 6 cm2 plates, the exact same 
procedure was used except that thee-fold less volume of every reagent was used.  
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2.2.3 Construction of stable cell lines 
FLP-In T-Rex cells were purchased from Invitrogen. These were used to make cell 
lines stably expressing GFP-SLX4 in a tetracycline inducible manner. These cells 
were passaged as described in Section 2.2.1.9.1 except that media was supplemented 
with 100 µg/ml zeocin (Invitrogen) to select for the maintenance of the FLP 
recombination target (FRT) sites and 15 µg/ml blasticidin (Invitrogen) to select for 
the maintenance of the tetracycline repressor sequence. A schematic diagram 
illustrating the process of creating a stable cell line by this method is shown in 
Figure 2.1. 
 
Cells were split into 10 cm2 dishes containing DMEM and 24 h later they were 
transfected using the modified calcium phosphate method as described in Section 
2.2.1.10 with 1 µg of pcDNA FRT/TO GFP-SLX4 and 9 µg of pOG44 plasmid from 
Invitrogen. pOG44 expresses the FLP recombinase which allows site specific 
recombination of the sequence of interest. 
 
After 48 h, medium was removed from the cells and replaced with DMEM 
supplemented with 15 µg/ml blasticidin and 50 µg/ml hygromycin-B. Hygromycin-
B was used to select for the integration of the sequence of interest present on the 
pcDNA plasmid. This media was refreshed every 48 h until colonies began to appear 
that were visible to eye (approximately 10 days). Drug-resistant colonies were 
trypsinised according to the procedure described in Section 2.2.1.9.1 and “pooled” 
into one 6 cm2 plate. The “pooled” colonies were then expanded in media 
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supplemented with blasticidin and hygromycin-B. Cell lines were tested for 
expression of GFP-SLX4 by the addition of tetracycline at 1 µg/ml 24 h prior to 
lysis and subsequent western blotting. 
 
2.2.4 Making stable MEF cell lines using viruses 
The immortalised mouse embryonic fibroblasts (MEFs) used in this thesis were 
kindly provided by Dennis Castor. They were generated using a previously 
described protocol (Xu, 2005). The immortalized MEFs were stably complemented 
with the cDNA constructs shown in Table 2.3 using the following protocol:  
Firstly, SLX4 expressing viruses were made. To this end, 2.7x106 HEK293T cells 
were plated in a 10 cm2 dish in 10ml DMEM. Cells were ready for transfection after 
18-20hours or when they reached a confluency of 25-30% (50-60% maximum). The 
HEK293T packaging cells were transfected with pBABE puro plasmids expressing 
GFP-mSLX4, GFP-mSLX4 C120A+C123A, GFP-mSLX4 C160A+C163A, and the 
corresponding plasmids expressing untagged proteins (Table 2.3) using the modified 
calcium phosphate method (2.2.1.9.1). To generate viruses containing these plasmids 
a triple-transfection was performed: 4.5µg gag/pol expression vector , 0.5µg VSV-G 
expression vector and 5 µg transfer vector (pBABE) were mixed with 2 x HBS and 
added dropwise to the cells. 12 hours after transfection the medium was replaced 
with 11 ml fresh medium. In the meantime the SLX4 -/- MEFs were split into four 10 
cm2 dishes at a density of 1 x 106 cells/dish.  
 
After 36 hours fresh medium was added to the packaging HEK293T cells. The 
supernatant was filtered through a 0.2 µm filter and mixed with 8 µg/ml polybrene. 
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The supernatant was then added to the SLX4 -/- MEFs. When the MEFs became 
confluent they were split and infected for a second time. Cell that expressed the 
protein of interest were selected for by addition of 3 µg/ml puromycin and the cells 
were kept in selection medium during passaging. 
 
2.2.5 Cell treatment with genotoxins 
Cells were treated with mitomycin-C (MMC) for 24 h at a range of the indicated 
concentrations. Mitomycin-C was dissolved in ethanol to make a 0.5 mg/ml stock 
solution, stored at -20 °C until use. 
 
2.2.6 Cell Lysis and Immunoprecipitation  
2.2.6.1 Cell lysis 
Dishes of cells to be lysed were placed on ice and the media was aspirated. The cells 
were washed gently in ice-cold PBS. Ice-cold lysis buffer (see 2.1.8) was added and 
cells were scraped using a sterile cell scraper. Lysates were placed in a suitable pre-
chilled tube and incubated on ice for 30 min. Cell lysates were centrifuged at 13,000 
rpm for 5 min at 4 °C and supernatants were transferred to clean eppendorfs and 
snap frozen in liquid nitrogen. To make cell extracts for SDS PAGE, 10% β-
mercaptoethanol or 5 mM DTT was added to LDS sample buffer and the desired 
amount of cell lysate was added. The samples were boiled for 10 min. When 
working with SLX4, snap freezing of cell lysates was avoided to prevent SLX4 
degradation and loss of nuclease activity. Instead and immunoprecipitations were 
carried out immediately. 
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2.2.6.2 Immunoprecipitation (IP) 
2.2.6.2.1 Conjugation of antibodies to protein-G Sepharose 
The required volume of protein-G Sepharose was washed 3 times in PBS then 
adjusted to a 50% (v/v) slurry in PBS before addition of antibodies. The 
antibody/Sepharose mixture was mixed on a platform shaker at 4°C. After 60 min, 
the beads were washed 3 times with PBS and as a 50% slurry in PBS at 4°C. 
Generally, 2 µg of antibody was conjugated to 10 µl protein-G Sepharose. For 
FLAG IPs, pre-coupled FLAG-M2 agarose (Sigma) was used. For GFP IPs, pre-
coupled GFP-TRAP (Chromotek) beads were used.  
 
2.2.6.2.2 Immunoprecipitation of proteins: small scale  
Generally 2 µg coupled antibody or 10 µl FLAG-M2 beads or 10 µl GFP-TRAP 
beads was used per 2 mg extract. The antibody-bead conjugate was incubated with 
cell extract for 2 h at 4 °C on a shaking platform or a roller depending on the size of 
the tube used. The supernatant was removed and the beads washed four times with 
500 µl of lysis buffer. Immunoprecipitates were denatured in LDS sample buffer, 
heated at 95 °C for 5 min and then subjected to SDS-PAGE. 
 
2.2.6.2.3 Immunoprecipitation of proteins: large-scale purification of GFP-SLX4 
from HEK293 Cells 
 Cells stably expressing GFP-SLX4 under the control of a tetracycline-inducible 
promoter (see Fig.2.1 ), or parental HEK293 Flp-In cells (Invitrogen), were 
incubated with tetracycline for 24 hr and lysed (see 2.2.2.1). Cell extracts (200 mg 
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total protein each) were incubated with GFP-Trap beads (Chromotek) (100 µl) for 4 
h at 4°C. Beads were washed five times with buffer containing 50 mM Tris/HCl (pH 
7.4), 0.27 M sucrose, 150 mM NaCl, 1% (v/v) Triton X-100, 0.1% (v/v) β-
mercaptoethanol (0.1%), and protease inhibitors (Roche). Bead-bound proteins were 
denatured by boiling in LDS-PAGE sample buffer (Invitrogen) before SDS-PAGE 
on a 4%–12% gradient gel (Invitrogen). The gel was fixed and stained with colloidal 
Coomassie, and the gel lanes containing SLX4-associated proteins were cut into 
slices. Proteins were identified by tryptic digest followed by mass fingerprinting (see 
2.2.3). Generally 100 µl FLAG-M2 beads or 100 µl GFP-TRAP beads was used for 
each 40 mg of protein extract.  
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 Figure 2.1: Schematic diagram of tetracycline inducible cell lines  
A schematic diagram, apapted from Invitrogen, illustrating the main features of the Flp-In T-
rex parental cell line and the pcDNA5 FRT/TO plasmid containing GFP-SLX4 sequences. 
Parental cell lines contain an FRT recombination site and a zeocin resistance gene. pcDNA5 
FTR/TO plasmids contain an FRT site and a hygromycin B resistance gene lacking a 
promoter and ATG initiating codon. FLP recombinase expressed from pOG44 plasmid 
mediates a homologous recombination event between the FRT sites. Insertion of the 
pcDNA5 FRT/TO plasmid into the genome brings the SV40 promoter and initiation codon 
into proximity and frame with the hygromycin-B resistance gene and inactivates the zeocin 
resistance gene. Expression of epitope tagged SLX4 is controlled by a human 
cytomegalovirus promoter in which two tandem copies of the tet operator sequence have 
been inserted. In the absence of tetracycline, the Tet repressor binds to the tet operator 
sequences and represses transcription of SLX4.  
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2.2.7 Mass spectrometric identification of proteins associated with GFP-SLX4 
Large-scale immunoprecipitations were carried out as described in Section 2.2.2.4 
and the immunoprecipitate subjected to SDS-PAGE before trypsin digestion of the 
gel slices. 
 
2.2.7.1 In-gel digestion of proteins for mass spectrometry 
To minimise keratin and other exogenous contaminations, all manipulations of gels 
for mass spectrometry analysis were prepared under a laminar flow hood (Model 
A3VB, Bassaire Limited, Southampton). Protein bands were excised from a 
colloidal Coomassie stained gel using a sterile scalpel. Gel pieces were washed with 
0.5 ml each of 50% acetonitrile/water, 0.1 M NH4HCO3 and 50% acenotrile/50 mM 
NH4HCO3. All washes were performed on a Vibrax shaking platform for 10 min. All 
liquid was removed between washes. Proteins were then reduced with 10 mM DTT 
in 0.1 M NH4HCO3 (45 min, 65 
oC) and alkylated with 50 mM iodoacetamide in 0.1 
M NH4HCO3 (30 min, room temperature). Gel pieces were then repeatedly washed 
with 0.1 M NH4HCO3 and 50% acenotrile/50 mM NH4HCO3. Once colourless, the 
gel pieces were shunk with 0.3 ml acetonitrile for 15 min, the acetonitrile was then 
then removed and a Speed-Vac was used to dry the gel pieces. Gel pieces were then 
swollen in 25 mM Triethylammonium bicarbonate with 5 µg/ml of trypsin and 
incubated over-night at 30oC on a shaker. After 12 h an equivalent volume of 
acetonitrile was added to the digest and incubated for a further 15 min. The 
supernatants were transferred to a clean tube and concentrated to dryness by Speed 
Vac. Meanwhile 100 µl 50% acetonitrile/2.5% formic acid was added to the gel 
- 91 - 
 
pieces. This second extraction was combined with the dried first extract. The 
samples were stored at -20 oC.  
 
2.2.7.2 Mass spectrometry  
Liquid chromatography-mass spectrometry (LC-MS) analysis was performed by Dr. 
David Campbell and Dr. Robert Gourlay. The reconstituted tryptic peptides were 
injected on to a Dionex 3000 nano liquid chomatography system coupled to a 
Thermo-Electron LTQ-orbitrap mass spectrometer. Data files (raw files) were 
converted to MSM files which were then submitted to the in house Mascot server. 
The data was searched against the IPI-Human database with the oxidation of 
methionine as a variable modification.  
 
2.2.8 Measurement of genotoxin hypersensitivity of mammalian cells by 
clonogenic survival assay 
Complemented MEFs (2.2.1.11) were seeded into 10 cm2 dishes. Wild type MEFs 
stably transfected with an empty vector were seeded at a density of 2000 cells per 
dish. SLX4-/- MEFs stably transfected with an empty vector were seeded at a density 
of 5000 cells per dish. All other cell lines were seeded at a density of 3000 cells per 
dish. Cells were allowed to adhere for 8 hours before they were incubated with the 
indicated doses of MMC for 24 h. The medium was removed and the cells were 
washed with PBS. Then fresh drug free medium was added. Cells were then 
incubated for 8-10 days to allow colonies of surviving cells to form. The medium 
was removed and cells were allowed to dry overnight at room temperature. The 
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following day cells were fixed and stained with 2% Giemsa (in methanol) and 
washed with tap water. Colonies with greater than 50 cells were then counted. 
 
2.2.9 Molecular biology 
 
2.2.9.1 Transformation of Escherichia coli cells 
For each transformation, competent E. coli cells (50 µl) from -80°C glycerol stocks 
were thawed on ice. Plasmid DNA (approximately 50 ng) was added to the cells, 
mixed gently, and incubated on ice for 5-20 min. To facilitate the uptake of DNA, 
cells were heat-shocked by incubating the cells at 42 °C for 30 s, and cells were then 
placed back on ice for a further 2 min. Plasmids requiring ampicillin selection were 
streaked directly onto LB/Amp agar plates. For plasmids requiring any other 
selection, LB (1 ml) was added to the cells, and the cells were allowed to recover at 
37 °C for 1 h with shaking before plating onto LB agar plates. Plates were then 
incubated overnight at 37 °C to allow for colony growth. 
 
2.2.9.2 Preparation of plasmid DNA from bacteria 
To prepare small amounts of plasmid DNA in microgram quantities (termed ‘mini-
prep’), DH5α E. coli cells were transformed with plasmid DNA, and a single colony 
was inoculated in LB/Amp or LB/Cml (5 ml). The transformed cells were grown in 
LB media containing appropriate antibiotics to stationary phase by incubation at 37 
°C overnight in a shaking incubator. After centrifugation in an Allegra™6R bench-
top centrifuge (Beckman), plasmid DNA was extracted from the cell pellet by 
sequential lysis, precipitation, binding to Qiagen anion exchange column and elution 
on an automated Qiagen BioRobot 9600 using the QIAsoft 3.0 software program, by 
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the DNA Sequencing Service (University of Dundee). The DNA was eluted in 
sterile water (100 µl) and typically yielded 100-300 µg/ml plasmid DNA.  
To prepare larger quantities of plasmid DNA, ‘maxi-preps’ were performed using 
the Qiagen DNA Maxi Kit. A single bacterial colony, transformed with the relevant 
construct was used to inoculate LB (250 ml) containing the appropriate antibiotic. 
After an overnight incubation at 37 °C, the cells were pelleted by centrifugation at 
3,000 rpm for 10 min in a J-6 Beckman centrifuge. Plasmid DNA was purified 
according to the manufacturer’s instructions. Overnight cultures of 250 ml typically 
yielded 0.5-1 mg plasmid DNA. 
 
2.2.9.3 Gel filtration of whole cell extracts of human fibroblasts 
 All buffers, lysates and markers were sterile filtered before loading onto the column. 
The Superose 6 10/300 column (GE Healthcare) attached and equilibrated overnight 
with thee column volumes of gel filtration buffer (50 mM Tris/HCl 7.4, 1mM 
EDTA, 0.2M sodium chloride, and 0.1% (v/v) 2-mercaptoethanol). For gel filtration 
experiments human fibroblasts were grown in 10 cm2 cell culture dishes and lysed. 
Approximately 3 mg of protein lysate were directly added onto the column (GE 
Healthcare) in buffer containing 50 mM Tris/HCl 7.4 buffer containing 1mM 
EDTA, 0.2M sodium chloride, and 0.1% (v/v) 2-mercaptoethanol. The flow rate was 
0.2 ml/min, and fractions of 400 µl (32) were collected. Molecular weight markers 
(Bio-Rad) were as follows: thyroglobulin (670 kDa) and bovine gamma globulin 
(158 kDa). Every fraction was denatured and subjected to immunoprecipitation and 
western blot analysis.  
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2.2.9.4 Cell cycle arrest 
One day prior to treatment U2OS cells were seeded into 15 cm-diameter-dishes to a 
confluency of 30-40%.On the next day 2.5 mM thymidine was added for 16 h. Cells 
were then washed twice with PBS and placed in normal thymidine free medium for 
12 h. Thymidine (2.5 mM) was added a second time for 16 h. Then cells were 
washed twice with PBS and released into the cell cycle by incubation in normal 
medium. After 12 hours nocodazole (100 ng/ml) was added to the medium for 18 
hours. Nocodazole arrests cells at the G2/M border. Arrested cells round up, 
therefore the medium containing floating mitotic cells was collected carefully and so 
were the next two washes. The medium containing the mitotic cells was transferred 
into a 50 ml centrifuge tube and the cells were pelleted in a Beckman Allegra 
centrifuge for 5 minutes at 1000 rpm. The cell pellet was resuspended and the cells 
were re-plated into 15 cm-diameter-dishes. This point was designated t = 0, at which 
most cells were found to be at the G2/M border by propidium iodide flow cytometry 
analysis.  
 
2.2.9.5 Cell cycle analysis by flow cytometry 
Cells were harvested at indicated time-points using standard trypsinisation as 
described in Section 2.2.1.9.1, washed once in PBS that had been pre-warmed to 37 
°C and then resuspended in ice-cold 70% (v/v) ethanol with gentle vortexing during 
addition. Samples were then stored at -20 °C until required. When required, samples 
were brought to room temperature and washed twice in PBS with 1% (w/v) BSA 
before resuspension in PBS (300 µl) containing propidium iodide (50 µg/ml), 
ribonuclease A (50 µg/ml) and TritonX-100 (0.1% v/v). Samples were then 
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incubated at room temperature for 20 min in the dark before analysis by flow 
cytometry on a Beckman FACS Calibur Flow. Live cells were gated on the flow 
cytometer using forward scatter and side scatter parameters (linear scale), DNA was 
detected in the FL2-H channel (linear). FL2-W and FL2-A were used to distinguish 
single cells. Cell numbers in different cell cycle stages were measured on FlowJo 
using the Dean-Jett-Fox model (Fox, 1980). 
 
2.2.9.6 Immunofluorescence 
MEFs or U2OS cells were grown on 23 mm glass bottom dishes (Wilco). Cells were 
washed twice gently with ice-cold PBS before fixation with 4% paraformaldehyde 
for 10 min at room temperature or in ice cold methanol at -20 °C. Then the cells 
were permeabilised with 0.5% Triton X-100 in phosphate–buffered saline for 10 min 
at room temperature. After several washes in PBS, cells were incubated in blocking 
solution (PBS containing 3% IgG–free BSA (Jackson Immunoresearch) and 0.2% 
Tween 20) for 1 h. Cell were then incubated with primary antibodies (1 µg/ml) in 
blocking solution o/n at 4 °C. After extensive washing in PBS–T (PBS containing 
0.2% Tween20), the cells were incubated with secondary antibodies (2 µg/ml) for 2 
h at room temperature. Coverslips were washed thoroughly in PBS-T and cells were 
incubated with DAPI for 10 min. Imaging was performed using a deltavision DV3 
wide-field deconvolution microscope mounted on a Nikon Diaphot inverted  
microscope and images were deconvolved after acquisition.  
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2.2.9.7 Indirect immunofluorescence with pre-extraction 
MEF or U2OS cells were grown on 23 mm glass-bottomed dishes (Wilco). The 
medium was removed from cells and they were treated for 2 min with 0.5% Triton 
X-100 before fixation in 4% paraformaldehyde for 10 minutes at room temperature 
or ice cold methanol at -20 °C followed by permeabilisation with 0.5% Triton in 
phosphate–buffered saline for 15 min at room temperature. From here the protocol 
proceeds as for indirect immunofluorescence without pre-extraction (see section 
2.2.5.6).  
 
2.2.9.8 Laser micro-irradiation 
For the generation of localised damage in cellular DNA by exposure to an 
ultraviolet-A laser beam, cells were plated on glass-bottomed dishes (Willco-Wells) 
and pre-sensitized with 10µM 5-bromo-2’-deoxyuridine (BrdU). Laser micro-
irradiation was performed by using an Olympus IX70 microscope equipped with a 
37°C heating stage and a 406 nm laser diode (6 mW). The time of cell exposure to 
the laser beam was 200 ms (fast scanning mode). Laser settings were chosen that 
generate a detectable damage response restricted to the laser path in a 
resensitization-dependent manner without noticeable cytotoxicity. Imaging of live 
cells was done on the same microscope. 
 
2.2.9.9 Testing ability of proteins to bind to poly-ubiquitin chains in vitro 
Poly-ubiquitin chains (Boston Biochem) were resuspended in resuspension buffer 
(25 mM HEPES pH 7.5, 150 mM KCl, 2 mM MgCL2, 1 mM EGTA). Next the 
GST-tagged recombinant proteins (10 µg) of interest were incubated with 
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glutathione sepharose beads (15 µl packed volume) for 1 h at 4 °C in 300 µl of 
resuspension buffer supplemented with 1 mg/ml BSA and 0.5 % Triton X-100. The 
beads were washed three times in 500 µl ubiquitin binding buffer (25 mM HEPES 
pH 7.5, 150 mM KCl, 2 mM MgCL2, 1 mM EGTA, 0.5 % Triton X-100). Next 300 
µl of ubiquitin binding buffer were added. The beads were then incubated with 1 µg 
of ubiquitin chains for 1 h at 21 °C on a shaking platform. After incubation the beads 
were washed twice gently with the same buffer and once with resuspension buffer 
before being denatured in LDS sample buffer and subjected to SDS-PAGE followed 
by immunoblotting with an anti-ubiquitin antibody.  
  
2.2.9.10 Measurement of the nuclease activity of the SLX4 complex 
2.2.9.10.1 Preparation of substrates for nuclease assays 
Synthetic DNA structures were made by annealing oligos, one of which was labelled 
with 32P-ATP. For 5′end-labelling, 20 pmol of the indicated oligo was incubated 
with 10 U of T4 polynucleotide kinase (PNK) (New England Biolabs) and 0.5 µl of 
γ-32P –ATP (370 kBq/µl Perkin Elmer) in 1 X PNK buffer (New England Biolabs) at 
37 oC for 30 min – 1 h in a total reaction volume of 10 µl.  For 3′ end-labelling, 20 
pmol of the indicated oligo is incubated with 20 U of terminal transferase (New 
England Biolabs) and 0.5 µl of α-32P -ATP (370 kBq/µl Perkin Elmer) in 1 X 
terminal transferase buffer (New England Biolabs) supplemented with 0.25 mM 
CoCl2 at 37 
oC for 30 min to 1 h in a total reaction volume of 10 µl.  
 
After labelling, enzymes were heat-inactivated and an excess (1.5 molar amount) of 
the relevant oligos for each structure were added. All substrates and standards were 
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annealed by slow cooling 80 oC to room temperature of one 5′ 32P-labeled 
oligonucleotide with the relevant unlabeled ones: for the four-way junction a, b, c, 
and d; for the RF analog, a-fix, b, c1, and d2-fix; for the 3′ flap (3′F), a-fix, b, and 
d2-fix; for the Y fork structure (YF), a-fix and b; for the duplex (DS), b and b-cp; for 
the single strand (SS), b. They were then purified by electrophoresis on a native 8% 
polyacrylamide gel. Gel pieces corresponding to the labelled synthetic structure 
were soaked in 250 µl of 20 mM Tris/HCl pH 7.5 and 50 mM NaCl overnight. DNA 
was then ethanol precipitated from the aqueous solution. The substrates were 
resuspended in 20 mM Tris/HCl pH 7.5 and 50 mM NaCl and their concentrations 
were determined by absorption spectrophotometry. 
 
2.2.9.11 Assaying nuclease activity 
After immunoprecipitation, GFP-Trap beads were washed in lysis buffer and then in 
nuclease buffer (20 mM Tris-HCl [pH 7.5], 50 mM NaCl, 10 mM MgCl2, 0.1 mg/ml 
BSA). Beads were resuspended in 40 µl of nuclease buffer containing the indicated 
DNA substrate to give a final DNA concentration of 5 nM and 0.1 mg/ml calf 
thymus DNA as competitor. Beads were kept in suspension by gentle shaking at 
37°C for 1 hr, and reactions were stopped by the addition of 20 mM EDTA. For the 
ligation experiment, reaction products were split in two before the reaction was 
stopped. EDTA (20 mM) was added to the control samples, whereas 10 mM DTT, 1 
mM ATP, and 400 units of T4 DNA ligase were added to the ligation samples. 
These were incubated for 1 h at room temperature, and the reaction was stopped by 
the addition of 20 mM EDTA. Reaction products were analyzed by native PAGE 
(8% polyacrylamide) or denaturing PAGE (12% polyacrylamide, 8 M urea) in TBE 
buffer. Gels were dried and exposed to PhosphorImager screens. Chemical 
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sequencing ladders derived from oligos a, b, or a-fix were prepared as described 
(Maxam and Gilbert, 1980). 
 
2.2.9.12 Testing GFP-SLX4 immunoprecipitates for phosphorylation by  co-
precipitating kinases 
HEK 293 FlpInTRex cells stably expressing GFP-SLX4 in a tetracycline inducible 
manner were seeded into 15 cm2 dishes and protein expression was induced with 
tetracycline. After 24h cells were lysed and GFP-SLX4 was purified from cell lysate 
(100 mg) using GFP-Trap beads. The parental cell line was used as a control. The 
GFP-immunoprecipitates were split in two and incubated with or without PLK1 
inhibitor (BI 2536, 100 nM) for 30 min. The phosphorylation reaction was started by 
adding a buffer containing 10 mM MgCl2 and 0.1 mM [γ-
32P-ATP]. Assays were 
incubated at 30°C for 30 minutes and stopped by addition of LDS sample buffer. 
Samples were boiled for 5 min at 95°C and subjected to SDS/PAGE electrophoresis. 
Around 90% of the reaction products were subjected to SDS PAGE and the gel was 
stained with colloidal colloidal coomassie.  
 
2.2.10 Bioinformatic identification of orthologs of yeast Slx4 
Position-specific iterative BLAST (PSI-BLAST) database searches of the National 
Center for Biotechnology Information (NCBI) nonredundant protein sequence 
database (nr) (using an E value inclusion threshold of 0.002) revealed significant 
sequence similarity between S. cerevisiae Slx4 and orthologs of an uncharacterised 
protein, BTBD12. Sequence similarity, albeit not significant (E = 0.20), was first 
observed between pufferfish (Tetraodon nigroviridis) BTBD12 (GenInfo 47223907) 
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and yeast Slx4 after five iterations using amino acids 626–748 of the yeast protein as 
query. This observation prompted further PSI-BLAST searches of nr using BTBD12 
sequences from diverse metazoan species. One such PSI-BLAST search employed 
Aedes aegypti BTBD12 amino acids 501–727 (GenInfo 157118966) as query. This 
revealed significant similarity to Cryptococcus protein BSP1 as before, but, in 
addition by iteration 5, revealed significant similarity to proteins, including a 
Candida albicans protein (GenInfo 68471424), which are annotated as orthologs of 
S. cerevisiae Slx4. The similarities that are apparent in an alignment of fungal Slx4 
and metazoan BTBD12 sequences are not easily discernible from many database 
searches owing to a large 100–200 amino acid insert in metazoan, and some fungal, 
homologs that is absent from yeast Slx4. 
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Chapter III 
 
The coordination of structure-specific nucleases by human 
SLX4/BTBD12 is required for DNA repair 
 
3.1 Introduction 
In budding yeast Slx4 is required for flap cleavage by Rad1XPF – Rad10 ERCC1 during 
HR and SSA. Because XPF-ERCC1 mediates flap cleavage during HR and SSA in 
mammalian cells, we reasoned that Slx4 is likely to be conserved in higher 
eukaryotic organisms. In this chapter I describe the identification of higher 
eukaryotic orthologues of Slx4.  
 
3.2 Results: BTBD12/SLX4 is a scaffold and regulator of several 
structure-specific nucleases 
3.2.1 Identification of the human orthologue of yeast Slx4 
At the outset of this work, standard BLAST searches were unable to identify higher 
eukaryotic orthologues of S. cerevisiae Slx4. Although we were able to readily identify 
a range of fungal orthologues of S. cerevisiae Slx4, this was based on and overall low 
protein sequence similarity of Slx4 amongst fungal species. However all yeast 
orthologues have two conserved domains towards their C-terminus; a SAP domain and 
a helix-turn-helix motif (HtH). Studies performed in yeast showed, that mutants lacking 
both of these C-terminal domains cannot rescue the synthetic lethality of sgs1∆ slx4∆ 
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double mutants (Toh et al, 2010). This indicated that the C-terminus of yeast Slx4 is 
important for its function and we reasoned that this region is most likely to be conserved 
across evolution. 
Bioinformatic analyses using the conserved C-terminal region of Slx4 encompassing the 
HtH and the SAP domain revealed the BTBD12 proteins as potentially being higher 
eukaryotic orthologues of yeast Slx4 (Fig. 3.1 A and B). Like their fungal counterparts 
the BTBD12 proteins contain a SAP domain and an HtH motif at their C-terminus. 
Some members, such as the C. elegans protein HIM-18, and all of the mammalian 
proteins also contain a bric-à-brac, tramtrack and broad complex / pox virus zinc finger  
(BTB/POZ domain) and a UBZ4-type ubiquitin binding domain (two in the human 
protein).  
 
3.2.1.1 The domain organisation of human SLX4 
3.2.2.1.1 The UBZ4 domain 
The small protein ubiquitin has been found to play important roles in almost every 
aspect of cell biology. The attachment of ubiquitin to other proteins is referred to as 
ubiquitination and in recent years it has become clear that it plays a very important role 
in the DNA damage response. Many proteins become ubiquitinated at sites of DNA 
damage and this is believed to provide a scaffold for the recruitment of proteins that 
contain ubiquitin-binding domains (UBDs). Originally it was believed that the 
attachment of ubiquitin targets proteins for degradation by the proteasome (Glickman & 
Ciechanover, 2002). However it has recently been found that this is only one effect of 
ubiquitination and is only mediated by poly-ubiquitin chains linked through Lys48 of 
ubiquitin and also by the recently discovered Lys11 linked ubiquitin chains. These 
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however have also been implicated in cell cycle control, possibly functioning rather in 
signalling than proteasomal degradation. Other non-proteasomal signals are mediated 
through the attachment of mono-ubiquitin or ubiquitin chains linked through Lys6 or 
Lys63 (Ikeda & Dikic, 2008). One example is that of the FA proteins FANCI and 
FANCD2, which become mono-ubiquitinated in the response to DNA damage (see 
chapter 1.9). This mono-ubiquitination is essential for the repair of ICLs and acts as a 
recruitment platform for the recently-discovered DNA repair nuclease FAN1 (Kratz et 
al., 2010; MacKay et al., 2010).  
 
FAN1 contains a UBD of the UBZ4 family which is a C2HC Zn-finger found in several 
proteins. UBZ (binding zinc finger) domains have been discovered by bioinformatics 
analysis and yeast two-hybrid screens for the identification of ubiquitin interactors 
(Bienko et al., 2005). Two types of UBZ domains are the UBZ3 and UBZ4 domains, 
both of which are found in many proteins of the DNA repair network and their ubiquitin 
binding has been demonstrated (Bish & Myers, 2007; Crosetto et al., 2008; Notenboom 
et al., 2007b). Strikingly most UBZ4-containing proteins are DNA repair proteins and 
ubiquitin binding has been demonstrated for the Y-family translesion polymerase κ 
(Bienko et al., 2005), Werner-helicase interacting protein WRNIP (Bish and Myers, 
2007; Crosetto et al., 2008), the ubiquitin ligase Rad18 (Notenboom et al., 2007a) and 
recently FAN1 (Kratz et al., 2010; MacKay et al., 2010) and the nuclease SNM1A 
(Yang et al., 2010). The presence of two N-terminal UBZ4 domains in SLX4 suggests 
that it might be recruited to sites of DNA damage by binding to ubiquitinated proteins at 
sites of DNA damage (see Chapter IV). 
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3.2.1.1.2 The SAP domain and the HtH motif 
SAP motifs are putative DNA binding motifs named after the three proteins (SAFA/B, 
ACINUS and PIAS) in which the domain was first discovered (Aravind & Koonin, 
2000). SAP domains can be found in several nuclear proteins. Some DNA repair 
proteins such as RAD18 (Nakajima et al., 2006b), KU70 (Aravind & Koonin, 2000) and 
FAN1 (MacKay et al., 2010) contain a SAP domain which is thought to be a DNA-
binding domain that may be involved in the recognition of aberrant DNA structures at 
sites of DNA damage (Aravind & Koonin, 2000). It has been demonstrated that the SAP 
domain of RAD18 can bind DNA (Notenboom et al, 2007) and it is important for 
RAD18 localisation to sites of DNA damage (Nakajima et al, 2006). SLX4 contains 
SAP domain at its C-terminus and this is conserved in all SLX4 proteins. 
 
Helix turn helix motifs (HTH motifs) are common elements found in about one-third of 
DNA-binding proteins, including DNA repair proteins (Daniels et al, 2004). Originally 
HtH were found to be common in transcription factors but data have emerged showing 
that HtH motifs can be found in proteins of many functions including DNA repair, 
replication and RNA metabolism (Aravind et al, 2005). HtH motifs bind DNA with 
their third helix. SLX4 contains a C-terminal HtH motif and its role in SLX4 function is 
unknown. 
 
3.2.1.1.3 The BTB domain 
BTB (Bric-a-brac, Tramtrack, Broad complex) or POZ (Poxovirus zinc finger) domains 
are widely distributed protein interaction modules, originally identified in D. 
melanogaster, that can amplify or modify protein function (Chen et al, 1995; Perez-
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Torrado et al, 2006; Zollman et al, 1994). BTB domains allow proteins to dimerise or 
oligomerise and many BTB-containing proteins are implicated in human malignancies. 
BTB domains were identified in screens for interaction partners of the Cullin (Cul)3 
Skp1–Cullin–F-box (SCF)-like E3 ubiquitin ligases and it was suggested that BTB 
domains mediate recruitment of the substrate recognition modules to the Cul3 
component of the SCF-like complex (Geyer et al, 2003; Pintard et al, 2004). The 
function of the BTB domain in SLX4 is unknown and is being currently investigated. 
 
We predicted that if BTBD12 really is the human equivalent of yeast Slx4 it should 
interact with the DNA repair nucleases XPF-ERCC1 and human SLX1, even though the 
latter had not yet been identified. To test this hypothesis I purified a GFP tagged version 
of SLX4 from human cells to identify interacting proteins. 
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Figure 3.1: Identification of human SLX4 and its associated structure-specific 
endonucleases 
A: Schematic representation of the domain architecture of BTBD12/SLX4 proteins from five 
different species. UBZ4 (for ubiquitin binding zinc finger) in red, BTB (for BR-C, ttk and 
bab) in green, SAP (after SAF-A/B, Acinus and PIAS) in orange and HtH (for helix turn 
helix) in yellow are shown. H.s., homo sapiens, D.m., drosophila melanogaster, C.e , 
caenorhabditis elegans, S.p. , Saccharomyces pombe, S.c. , Saccharomyces cerevisiae.  
B:  Alignment of SLX4 orthologs in different species. Alignments of the zinc fingers (framed 
in red), BTB domains (framed in green), SAP domains (framed in orange), and HtH motifs 
(framed in yellow). The UniProt identifier number and the relevant species name for each 
protein are indicated. HUMAN, Homo sapiens; MOUSE, Mus musculus; XENLA, Xenopus 
laevis; NEMVE, Nematostella vectensis (sea anemone); 9METZ, Trichoplax adhaerens; 
CAEBR, Caenorhabditis briggsae; CAEEL, Caenorhabditis elegans; AEDAE, Aedes 
aegypti; DROME, Drosophila melanogaster; NEUCR, Neurospora crassa; ASPOR, 
Aspergillus oryzae; EMENI, Emericella nidulans; DEBHA, Debaryomyces hansenii; 
CANAL, Candida albicans; CANGA, Candida glabrata; and YEAST, Saccharomyces 
cerevisiae. ‘‘est Q6INJ4’’ refers to a Xenopus sequence that has been corrected on the basis 
of EST sequence. The red diamond denotes Drosophila melanogaster MUS312. 
A. 
B. 
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3.2.2 Identification of proteins that interact with human SLX4 
To identify SLX4-interacting proteins, I created a HEK293 cell line that stably 
expresses GFP-SLX4 under the control of a tetracycline-inducible promoter (Fig. 3.2 
A). As shown in Figure 3.2 expression of GFP-SLX4 is detected at 7 hours after 
incubation of the cells with tetracycline. The expression of GFP-SLX4 increased in a 
time dependent manner and reached its maximum at about 48-56 hours after induction. 
For all subsequent experiments I induced GFP-SLX4 expression by incubating the cells 
with tetracycline for 24 hours prior to lysis. A stable cell line has the advantage that 
protein levels can be manipulated more easily and reproducibly than with transient 
transfection and expression levels are lower on average. This increases the probability 
of finding physiological interactors of the bait proteins. Inducible protein expression 
also lowers the risk of potentially toxic effects to cell proliferation due to long term 
overexpression. 
 
After inducing GFP-SLX4, extracts of these cells or parental HEK293 cells were 
subjected to immunoprecipitation with GFP-Trap beads. I used GFP-Trap beads 
because of the small size (approximately 13 kDa) of the camelid heavy-chain antibody 
on these beads which minimizes non-specific protein binding to the beads and avoids 
the use of heavy and light antibody chains. Furthermore the single-chain anti-GFP 
antibody has a very high affinity for GFP, which allows very short incubation times 
which further reduces non-specific protein binding (Rothbauer et al, 2008). The GFP-
Trap precipitates were subjected to SDS PAGE and the gel was stained with colloidal 
coomassie. A strong band corresponding to the molecular weight of GFP-SLX4 was 
observed in anti-GFP precipitates from these cells but not from parental HEK293 cells 
(Fig. 3.2 B). Protein bands were excised and after tryptic digest the samples were 
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subjected to liquid chromatography followed by mass spectrometry (LC MS). A range 
of potential SLX4-interacting proteins were found in GFP-SLX4 precipitates and mass 
fingerprinting revealed that some of these proteins are nucleases involved in DNA 
repair (Table 1, Fig. 3.2 B). This included an uncharacterised protein with a high degree 
of similarity to yeast Slx1 which is now referred to as human SLX1 (Fig. 3.2 C and D). 
Sequence searches revealed clear SLX1 orthologues in a range of eukaryotes that show 
three regions of sequence homology: an N-terminal URI-type nuclease domain (Aravind 
et al, 1999), a C-terminal PHD-type RING finger and a central conserved region of 
unknown function (Fig. 3.2 C). 
 
Immunoprecipitates of SLX4 also contained XPF-ERCC1, reminiscent of yeast Rad1-
Rad10, and unexpectedly both subunits of another structure-specific endonuclease, 
MUS81-EME1 (Table 1). MUS81 and EME1, like XPF and ERCC1, are members of 
the MUS81/XPF family of nucleases; ERCC1 and EME1 are catalytically inactive but 
contribute to DNA binding (section 1.10.1). In vitro MUS81-EME1 cleaves branched 
DNA structures such as RFs, nicked Holliday junctions, D-loops and 3′ flaps, and it has 
been implicated in processing of recombination intermediates and stalled replisomes 
(Gaskell et al, 2007; Osman & Whitby, 2007; Roseaulin et al, 2008; Taylor & 
McGowan, 2008). 
 
To confirm these interactions, antibodies raised against the first 300 (“SLX4-N”) or last 
300 (“SLX4-C”) amino acids of SLX4, or antibodies against SLX1 were used to 
precipitate SLX4 and SLX1 from HEK293 cell extracts. Endogenous SLX1, XPF-
ERCC1 and MUS81-EME1 were detected in anti-SLX4 immunoprecipitates (Fig. 3.2 
E) but not in immunoprecipitates with an antibody against an unrelated protein (GST). 
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Similarly, SLX4, XPF-ERCC1 and MUS81-EME1 were detected in anti-SLX1 
immunoprecipitates (Fig. 3.2 E). The interaction of SLX4 with SLX1, XPF-ERCC1 and 
MUS81-EME1 was not affected by ethidium bromide or by treatment with DNaseI or 
benzonase, excluding the possibility that these interactions are mediated through DNA 
(data not shown). On the basis that BTBD12 interacts with the structure-specific 
endonucleases XPF-ERCC1 and SLX1 we concluded that BTBD12 is a human 
orthologue of yeast Slx4. BTBD12 is referred to as SLX4 hereafter. 
 
Furthermore, mass spectrometry analysis revealed other proteins as potential interactors 
of SLX4 (Table 1). These include the protein kinase PLK1, histones and proteins 
involved in telomere maintenance such as TERF2, TERF2IP and RTEL1, which are 
discussed later.  
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Figure 3.2: Identification of proteins that interact with SLX4 
A: Stable tetracycline inducible expression of SLX4 with an N-terminal GFP tag  
Plasmid pcDNA5.1–FRT–TO–GFP–SLX4 (Invitrogen), expressing SLX4 with an N–terminal 
GFP under the control of a tetracycline–inducible promoter, was stably integrated at the FRT 
sites in HEK293 Flp–In cells (Invitrogen) according to the manufacturer’s instructions. GFP–
SLX4 cells were incubated with tetracycline for the times indicated and lysed. Extracts were 
subjected to SDS–PAGE followed by western blotting with indicated antibodies. 
B: Identification of proteins that interact with GFP-SLX4 in HEK293 cells. 
HEK293 Flp–In cells that stably express SLX4 fused to an N–terminal GFP tag under the 
control of a tetracycline–inducible promoter were incubated with tetracycline for 24 hr and 
lysed. Extracts were subjected to immunoprecipitation with GFP–Trap beads and after extensive 
washing precipitates were subjected to SDS–PAGE. The gel was fixed and stained with 
Colloidal Blue (left panel). The gel lane containing SLX4–associated proteins was cut into 
slices, as indicated (right panel), and the proteins in each slice were digested with trypsin and 
subjected to mass spectrometric fingerprinting. A protein marker was used (left lane) and the 
corresponding molecular weights are shown on the left (in kDa). 
C: Schematic representation of the domain architecture SLX1. 
D: Alignment of SLX1 orthologues  from different species. The conserved block of sequence 
framed in blue corresponds to the URI domain, while the block framed in green corresponds to 
the PHD type zinc finger. The block framed in red is unique to SLX1, and the function of this 
region is unknown. The UniProt identifier number and the relevant species name for each 
protein are indicated. HUMAN, Homo sapiens; MOUSE, Mus musculus; XENLA, Xenopus 
laevis; CAEEL, Caenorhabditis elegans; DROME, Drosophila melanogaster; DEBHA, 
Debaryomyces hansenii; CANGA, Candida glabrata; and YEAST, Saccharomyces cerevisiae.  
E: Extracts of HEK293 cells were subjected to immunoprecipitation with antibodies raised 
against SLX1, SLX4 (SLX4-N and SLX4-C), or GST (‘‘IgG’’). SLX4-N is an antibody raised 
against the first 300 amino acids of SLX4, SLX4-C is an antibody raised against the C-terminus 
of SLX4. Precipitates were subjected to SDS PAGE and analysed by western blotting with the 
indicated antibodies. 
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Band 
No. 
Accession Number Protein Name Molecular 
mass 
No. of 
Peptides 
Sequence 
Coverage (%) 
Mascot 
Score 
2 IPI00291796.2 SLX4 / BTBD12 201713 440 71 6519 
3 IPI00218753.1 Topoisomerase2alpha 179398 17 9 142 
4 IPI00219849.1 RTEL1 134968 28 17 157 
5 IPI00449049.5 PARP1 113811 76 46 681 
6 IPI00219179.6 ERCC4 / XPF 105333 181 63 3120 
7 IPI00001639.2 KPNB1Importin subunit beta-1 98420 75 44 1223 
8 IPI00073193.2 EME1 65707 5 7 110 
9 IPI00021248.1 PLK1 68953 88 58 1915 
 IPI00106502.5 KEAP1 Kelch-like ECH-associated protein 1 71160 27 37 327 
 IPI00289454.3 MUS81 61705 28 36 633 
10 IPI00301323.1 DDX18 ATP-dependent RNA helicase 
DDX18 
75702 25 31 298 
11 IPI00303292.1 KPNA1 60952 102 55 1989 
 IPI00024214.1 TERF2 55688 35 46 495 
 IPI00006379.1 NOP5/NOP58 Nucleolar protein 5 60054 21 32 137 
12 IPI00002214.1 KPNA2 58168 87 61 2303 
 IPI00747764.3 KPNA6 61283 48 48 1147 
 IPI00299033.1 KPNA3 58288 46 52 1108 
 IPI00012578.1 KPNA4 58364 46 51 962 
 IPI00303292.1 KPNA1 60952 30 35 500 
 IPI00000001.2 STAU1 63428 19 24 147 
 IPI00179964.5 PTBP1 Isoform 1 of Polypyrimidine tract-
binding protein 1 
57357 15 30 141 
13 IPI00008961.1 TERF2IP 44404 28 43 569 
14 IPI00031812.3 YBX1 Nuclease-sensitive element-binding 
protein 1 
35903 24 49 374 
15 IPI00181728.1 BXDC2 Brix domain-containing protein 2 41660 22 42 240 
16 IPI00014040.1 ERCC1 32884 56 56 871 
 IPI00031535.3 SLX1 31493 16 38 364 
17 IPI00031535.3 SLX1 31493 51 62 1119 
 IPI00031535.3 SLX1 31493 31 53 750 
21 IPI00216457.7 HIST2H2AA4 14087 17 57 511 
 IPI00018534.4 HIST1H2BL Histone H2B type 1-L 13944 11 26 434 
 IPI00171611.7 HIST2H3A 15436 9 30 385 
 IPI00298547.3 PARK7 Protein DJ-1 20050 25 52 329 
22 IPI00216457.7 HIST2H2AA4 14087 18 57 476 
 IPI00003935.6 HIST2H2BE Histone H2B type 2-E 13912 14 26 446 
 IPI00453473.6 HIST1H4H 11360 10 40 109 
23 IPI00216457.7 HIST2H2AA4 14087 62 57 1352 
 IPI00003935.6 HIST2H2BE Histone H2B type 2-E 13912 44 41 1339 
 IPI00171611.7 HIST2H3A 15436 27 54 732 
 IPI00018278.3 H2AFV Histone H2A.V 13501 20 53 364 
 IPI00453473.6 HIST1H4H 11360 12 40 270 
 
Table 3.1: GFP–SLX4–associated proteins identified by mass spectrometry 
Gels slices in Fig. 3.2 B were excised and proteins were identified by mass spectrometric 
fingerprinting. Proteins of obvious interest from a genome stability viewpoint are colour shaded: 
red: bait (GFP-SLX4), blue: SSEs associated with SLX4, green: protein kinase, purple: proteins 
involved in telomere maintenance 
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3.2.3 SLX4 immunoprecipitates have nuclease activity 
The results above showed that SLX4 interacts with the structure-specific endonucleases 
SLX1, XPF-ERCC1 and MUS81-EME1, all of which are known to cleave branched 
DNA structures. I thus predicted that SLX4 immunoprecipitates would have nuclease 
activity towards such branched DNA substrates. To test this, extracts from cells stably 
expressing GFP-SLX4 or GFP alone were subjected to immunoprecipitation with GFP-
trap beads, washed extensively and incubated with synthetic, radiolabelled DNA 
substrates as shown in the schematic diagrams in Figure 3.3 A. These radiolabelled 
substrates were prepared with help from Dr. Anne-Cecile Declais from Prof. David 
Lilley’s laboratory in Dundee. 
 
We used Y-fork, 3′ flap or 5′ flap and a nicked three-way junction as a RF analogue 
(Fig. 3.3 B). Each substrate was labelled on strand a-fix or b, the two longer strands. 
The reaction products were separated by gel electrophoresis under denaturing 
conditions. Even though GFP–only precipitates showed weak activity towards 5′ flap 
DNA, potentially due to a contaminant nuclease, GFP–SLX4 precipitates showed much 
stronger activity (Fig. 3.3 C). Cleavage occurred in the double–stranded (ds) region of 
the same DNA strand as the 5′ tail one nucleotide (nt) before the branchpoint (Fig. 3.3 B 
and C). Immunoprecipitates of GFP–SLX4, but not GFP alone, showed nuclease 
activity towards 3′ flap DNA (Fig. 3.3 C). Again, cleavage occurred in the ds part of the 
same DNA strand as the 3′ tail but this time four nt from the branch (Fig. 3.3 B). GFP–
SLX4 immunoprecipitates showed activity towards the RF substrate, and cleaved either 
strand of the dsDNA region before the branchpoint: four nt before the branch on one 
strand (with the lagging strand at the junction point) or one nt prior to the branch on the 
other strand (with the leading strand at the junction point) (Figs. 3.3 B and C). In 
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contrast GFP–SLX4 immunoprecipitates showed no detectable activity towards Y–fork 
DNA (Fig. 3.3 C). 
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C.  
 
 
Figure 3.3: Structure-specific nuclease activities associated with SLX4 
A: Schematic representation of the three major steps involved in a nucleases assay. First 
synthetic, radiolabelled DNA substrates are generated. These substrates are then incubated with 
immunoprecipitated proteins, in this case GFP-SLX4 and its associated proteins. The reaction 
products are then subjected to DNA electrophoresis and a native or denaturing gel to determine 
the cleavage products and/or cleavage sites. 
B: Schematic diagram of the DNA substrates used. The GFP-SLX4 associated cleavage sites are 
indicated with arrows. The cleavage sites were determined using chemical sequencing ladders 
derived from oligo J5bm–b.  
C: Cells stably expressing GFP-SLX4, or GFP alone, were subjected to immunoprecipitation 
with GFP-Trap beads. After extensive washing, precipitates were incubated with synthetic DNA 
structures: Y fork, 5′ flap, 3′ flap DNA or a RF-like structure, each radiolabelled on the strands 
indicated. Reaction products were subjected to denaturing PAGE (12% polyacrylamide, 8 M 
urea). Chemical sequencing ladders were derived from oligos a-fix or b. 
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I then investigated which of the SLX4 associated nucleases are responsible for the 
cleavage of the various branched DNA species described above. Depletion of MUS81 
from cells expressing GFP–SLX4 using a specific siRNA (Fig. 3.4 A) reduced the 
activity of the GFP–SLX4 immunoprecipitates towards the 3′ flap or RF by 85% and 
66% respectively (Figs. 3.4 B and C). In contrast, siRNA mediated depletion of SLX1 
or XPF increased the activity of GFP–SLX4 towards these substrates (Figs. 3.4 B and 
C). The basis for this increase is not yet clear but may be due to competition between 
nucleases for binding to SLX4. Thus, MUS81 is responsible for most, but not all, of the 
SLX4 associated activity towards DNA flaps and RFs. Immunoprecipitates of GFP–
SLX4, but not GFP alone, also exhibited activity towards a HJ with a core that could 
undergo a number of steps of branch migration thereby presenting all possible di-
nucleotides at the point of strand exchange (Figs. 3.3 B). An SLX1 specific siRNA 
strongly reduced the activity of GFP–SLX4 immunoprecipitates towards the HJ 
substrate. Knockdown of MUS81 reduced the activity of GFP-SLX4 
immunoprecipitates towards the HJ substrate and the RF substrate. However the 
reduction of activity towards the HJ substrate was not as strong as upon depletion of 
SLX1 from the complex. Depletion of XPF with specific siRNA caused no such 
decrease (Figs. 3.4 B and C).  
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Figure 3.4: Effect of siRNA mediated nuclease depletion on nuclease activities of GFP-
SLX4 immunoprecipitates  
A: Cells stably expressing GFP–SLX4 were left untransfected or were transfected with control 
siRNA or siRNA specifically targeting SLX1, MUS81 or XPF. After 48 hr, cells extracts were 
subjected to SDS PAGE and analysis by western blotting with the indicated antibodies.  
B: Cells stably expressing GFP–SLX4 were transfected with control siRNA or siRNA 
specifically targeting SLX1, MUS81 or XPF, or else cells were left untransfected. After 48 hr 
these cells, or cells expressing GFP alone, were lysed and extracts were subjected to 
immunoprecipitation with GFP–Trap beads. After extensive washing, precipitates were 
incubated with a radiolabelled 3′ flap, a radiolabelled synthetic RF–like structure or a 
radiolabelled Holliday junction. Reaction products were subjected to denaturing PAGE (12% 
polyacrylamide, 8 M urea) and gels were dried and subjected to autoradiography. Chemical 
sequencing ladders were derived from oligo J5bm–b.  
C: Quantitation of the data in (B). 
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3.2.4 Effect of SLX4 on the activity of SLX1 and MUS81  
The data above demonstrate that SLX4 precipitates contain three separate structure–
specific nucleases that have activity towards a range of branched DNA structures. This 
raised the question of how SLX4 affects the activity of its associated nucleases. To 
address this, parental HEK293 cells or HEK293 cells stably expressing GFP–SLX4 
were transfected with FLAG–SLX1, FLAG–MUS81 or with FLAG–XPF plus FLAG–
ERCC1 or empty vector. Association of each of the FLAG–tagged nucleases with GFP–
SLX4 was confirmed (Fig. 3.5 A). FLAG immunoprecipitates were incubated with a 
radiolabelled RF analogue or a HJ. Electrophoresis of reaction products on native gels 
(Fig. 3.5 B) or on denaturing gels (Fig. 3.5 C) revealed that FLAG–SLX1 or FLAG–
MUS81 showed little detectable activity towards DNA substrate in the absence of co–
transfected SLX4. However, co–expression of GFP–SLX4 with FLAG–SLX1 or 
FLAG–MUS81 dramatically increased the activity of each nuclease in FLAG 
immunoprecipitates towards the RF substrate (Figs. 3.5 B and C). SLX4 caused a 
striking increase in the activity of FLAG–SLX1 immunoprecipitates towards the HJ 
substrate, processing it fully into a DNA species which co-migrates approximately with 
linear duplex DNA (Fig. 3.5 B and C). In contrast, even in the presence of SLX4, the 
activity of FLAG–MUS81 immunoprecipitates towards HJs was barely detectable (Figs. 
3.5 B and C). FLAG–XPF–ERCC1 immunoprecipitates cleaved the RF substrate and 
HJ at multiple sites away from the branch points to yield DNA that runs slightly faster 
than linear duplex DNA and this was very slightly increased by SLX4 (Fig. 3.5 B and 
C). These data show that SLX4 stimulates the nuclease activity of SLX1, MUS81 and 
XPF in vitro.  
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Figure 3.5: Effect of SLX4 on the activities of the associated SLX1, MUS81 and XPF 
towards different radiolabelled DNA-substrates 
A. Parental HEK293 cells, or HEK293 cells stably expressing GFP–SLX4 were transfected with 
FLAG–SLX1, FLAG– MUS81 or FLAG–XPF plus FLAG–ERCC1. After 48 hr, cells were 
lysed and subjected to immunoprecipitation with anti–FLAG agarose. Precipitates were washed 
and subjected to SDS–PAGE and western blotting with the indicated antibodies. Cell extracts 
were also subjected to western blotting with anti– GFP antibodies to monitor expression of 
SLX4.  
B., C. Same as A, except that anti–FLAG immunoprecipitates were assayed for their ability to 
cleave a radiolabelled RF or HJ. Reaction products were subjected to electrophoresis on native 
PAGE (8% polyacrylamide) (B) or to denaturing PAGE (12% polyacrylamide, 8 M urea) (C) 
and gels were dried and subjected to autoradiography. The migration positions of radioalbelled 
DNA standards (“S”; linear ssDNA, linear dsDNA, 3′ flap and a splayed arm) are indicated in 
B. “R” and “Y” indicate chemical sequencing ladders derived from oligo J5bm– b. 
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3.2.5 Mapping the cleavage of branched DNA structures by SLX4–SLX1 
The cleavage of HJs is of great biological interest, so we characterised further the ability 
of SLX4–SLX1 to cleave these structures. HJ substrates can be cleaved in a 
symmetrical manner giving rise to ligatable DNA products or they can be cleaved in an 
asymmetrical manner leading to gapped and flapped DNA products (Fig. 3.6 A). 
Immunoprecipitates of FLAG–SLX1 co-expressed with GFP–SLX4 (Fig. 3.6 B) were 
incubated with the HJ structure shown in Fig. 3.3 B. The HJ was labelled on each of the 
4 different strands. I assessed the nature of the cleavage products through a ligation 
experiment: the reaction products were split in two whereby only one half was 
incubated with T4 DNA ligase. Both were then analysed side-by-side on a denaturing 
gel. Figure 3.6 C shows that 30% to 40% of the cleavage products disappear after 
ligation to form a species that co-migrates with the substrate. We also observed the 
appearance of higher mobility bands, which probably result from the ligation of 
duplexes containing flaps, or dissociated cleavage products, to other DNA molecules in 
the reaction mixture. Overall, these results suggest that FLAG-SLX1 
immunoprecipitates process four-way DNA junctions in such a way that at least 30% of 
the reaction products are nicked duplexes. These data show that SLX4–SLX1 can 
process HJs to yield a mixture of DNA products.  
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Figure 3.6: Cleavage of Holliday Junctions by SLX4-SLX1 
A: Schematic representation of the possibile outcomes of HJ cleavage. Symmetrical cleavage 
(upper panel), as indicated, leads to ligatable products resulting in long labelled oligos. 
Asymmetrical cleavage (lower panel) results in gapped and flapped cleavage products which 
cannot be ligated by DNA ligase. Such products require further processing. 
B: HEK293 cells expressing GFP alone or GFP-SLX4 were transiently transfected with FLAG-
SLX1, and after 48 hr cells were lysed and extracts subjected to immunoprecipitation with anti-
FLAG antibodies. After extensive washing, precipitates were incubated with synthetic HJs 
radiolabeled on the strands indicated in Fig. 3.6 B. The immunoprecipitates were subjected to 
SDS PAGE and western blotting with the indicated antibodies. 
C: HEK293 cells expressing GFP alone or GFP-SLX4 were transiently transfected with FLAG-
SLX1, and after 48 hr cells were lysed and extracts subjected to immunoprecipitation with anti-
FLAG antibodies. After extensive washing, precipitates were incubated with synthetic HJs 
radiolabeled on the strands indicated. Reaction products were incubated with or without T4 
DNA ligase before denaturing PAGE (12% polyacrylamide, 8 M urea). The fraction of cleavage 
products ligated in the presence of T4 DNA ligase is shown below the panel. 
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To confirm that the nucleolytic activity of the SLX4-SLX1 heterodimer stems from 
SLX1 and not from a contaminating nuclease, we mutated a conserved residue that we 
anticipated would inactivate the SLX1 protein (SLX1 E82A). In this experiment I co-
expressed GFP-SLX4 with FLAG-SLX1, wild type or the catalytic mutant (E82A), and 
incubated anti-FLAG immunoprecipitates with radiolabelled HJ substrates. As shown in 
Figure 3.7 C, mutating the catalytic residue in SLX1 abolishes nuclease activity of the 
SLX4-SLX1 heterodimer towards HJs.  
 
To confirm that the nuclease activity towards RF structures stems from MUS81 I used a 
catalytic mutant of MUS81 as a control (D307A) (Fig. 3.7 B). I co-expressed GFP-
SLX4 with FLAG-MUS81, wild type or the catalytic mutant and incubated the FLAG-
immunoprecipitates with radiolabelled RF substrates. Mutating the catalytic residue in 
MUS81 abolished the nuclease activity of MUS81 towards RF structures. 
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Figure 3.7 Immunoprecipitates of catalytically inactive forms of XPF, MUS81 and SLX1 
do not show nuclease activity. 
A: HEK293 cells expressing GFP alone or GFP-SLX4 were transiently transfected with FLAG-
SLX1, FLAG-XPF + FLAG-ERCC1, FLAG-MUS81 and the catalytically inactive forms of 
these nucleases (for XPF D704A, for MUS81 D307A and for SLX1 E82A). After 48 hr cells 
were lysed and extracts subjected to immunoprecipitation with anti-FLAG antibodies. The 
immunoprecipitates were washed extensively and subjected to SDS PAGE and western blotting 
with the indicated antibodies. 
B: Same as A. After extensive washing, precipitates were incubated with synthetic radiolabelled 
HJs. Reaction products were subjected to denaturing PAGE (12% polyacrylamide, 8 M urea). 
C: Same as B, but a RF analogue was used instead of a HJ substrate. 
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3.3 Discussion 
Yeast Slx4 functions, together with Slx1, in the maintenance of ribosomal DNA 
replication, and it is also important for the function of Rad1 XPF-Rad10ERCC1 in SSA 
(Coulon et al, 2004a; Flott et al, 2007b; Flott & Rouse, 2005). Rad1XPF-Rad10ERCC1 
is found in all eukaryotes, therefore we were interested to know if the same is true 
for Slx4. Slx4 proteins are found in all fungi but have low sequence similarity to one 
another, and bioinformatics analyses, for example BLAST searches, using full-
length yeast Slx4 did not reveal higher eukaryotic orthologues of Slx4. All fungal 
Slx4 proteins have, however, a conserved C-terminal region containing a SAP and 
an HtH domain and more sophisticated bioinformatics searches using these domains 
as an input identified BTBD12 as a putative higher eukaryote orthologue of yeast 
Slx4. All BTBD12 proteins have conserved SAP and HtH domains but the overall 
sequence similarity among this protein family is very low, therefore it was not clear 
at first whether BTBD12 was indeed the human Slx4 orthologue. However, two 
considerations led us to propose that BTBD12 is the human SLX4. Firstly, like yeast 
Slx4 (Flott & Rouse, 2005), BTBD12 is phosphorylated by ATM/ATR in response 
to DNA damage (Matsuoka et al, 2007; Mu et al, 2007), and secondly, BTBD12 
interacts with XPF-ERCC1 and SLX1. There are, however, a number of differences 
between yeast and human SLX4. Human SLX4 interacts with a range of other 
proteins, in addition to XPF-ERCC1 and SLX1, as identified in a large-scale pull-
down of GFP–SLX4 (Table 3.1). SLX4 interacts with the endonuclease MUS81-
EME1 and other proteins linked to DNA repair (MSH2, MSH3), telomere 
maintenance (TRF2, TRF2IP) and the cell cycle (PLK1) (Table 3.1). Human 
MUS81-EME1 interacts with the SAP domain of human SLX4 (Nidhi Nair, personal 
communication), which is conserved in all SLX4 proteins; however the domain in 
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human MUS81 that interacts with SLX4 is not conserved in yeast Mus81, and 
consequently yeast Slx4 does not interact with Mus81. 
Depletion of SLX4 from human cells causes hypersensitivity to ICL-inducing agents 
(Fekairi et al, 2009; Munoz et al, 2009; Svendsen et al, 2009). Also Drosophila 
MUS312SLX4 (Andersen et al, 2009) is hypersensitive to ICLs. Together these data 
suggest that SLX4 is involved in the repair of ICLs. An important and poorly-
understood step of ICL repair is the processing of HR recombination intermediates 
by SSEs. Since SLX4 interacts with a number of SSEs we tested the SLX4 complex 
for its nuclease activity. Attempts to express human SLX4, either alone, or in 
combination with SLX1, in bacteria, yeast or Sf21 cells, were unsuccessful. The 
only method to assay nuclease activity associated with the SLX4 complex was in 
immunoprecipitates of epitope-tagged SLX4 that had been stably-expressed in 
human cells. Such SLX4 immunoprecipitates cleave a variety of branched DNA 
structures in vitro: 3′ flaps, 5′ flaps, RFs and HJs (Fig.3.3 C), but did not appear to 
cleave Y-forks (Fig. 3.3 C). This was unexpected, because Slx1–Slx4 has been–
shown to have a preference towards 5′ flaps and Y-forks (Fricke & Brill, 2003). 
Also, recombinant XPF–ERCC1 can cleave Y forks in vitro.  
SLX4 immunoprecipitates cleave RFs on both strands separately of the arm prior to 
the branch point, and these reactions is probably catalysed by MUS81 and SLX1 
(Fig. 3.5). Simultaneous cleavage on both strands was not observed, indicating that 
these two nucleases are not co-operating in the processing of DNA substrates, at 
least in this assay. The first incision by one nuclease potentially creates an accessible 
substrate for the other. SLX4 might act as a scaffold and regulator to increase the 
efficiency of DNA processing and avoid unwanted processing. 
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SLX4 immunoprecipitates cleave HJs in vitro (Fig. 3.4 and 3.5). This makes it one 
of only three known HJ resolvases in human cells. Previously, two other enzymes 
have been proposed to be physiological HJ resolvases: MUS81-EME1 (Gaskell et 
al., 2007) and GEN1 (Ip et al., 2008). MUS81, however, preferentially cleaves 
nicked HJs. 
The activity of the SLX4 complex towards HJs seems to be largely mediated by 
SLX1, with MUS81 making a minor contribution (Fig.3.4 B and 3.5 C). No cleavage 
of HJs is detected in immunoprecipitates of over-expressed SLX1 alone (with only 
the endogenous levels of SLX4 present), but all the substrate is cleaved when SLX4 
and SLX1 are over-expressed together (Fig. 3.5 C). Moreover, data obtained in other 
laboratories support the proposed HJ resolvase activity of SLX1–SLX4 (Fekairi et 
al, 2009; Svendsen et al, 2009). A recombinant SLX4 fragment containing the HtH 
domain expressed together with SLX1 can cleave HJ substrates efficiently in vitro 
(Svendsen et al., 2009; Fekairi et al., 2009) and this activity is abolished when a 
catalytically inactive form of SLX1 (SLX1 E82A) was used. 
Classical HJ resolvases are expected to cleave HJs in a symmetrical manner 
producing nicked dsDNA duplex structures that can be re-ligated by DNA ligases. 
Symmetrical cleavage by SLX1–SLX4 2nt 3′ to the branchpoint of the junction 
produces nicked duplex structures that can be ligated, however this accounts for only 
about 35% of the generated products (Fig.3.6 C). SLX4 immunoprecipitates also 
cleave HJs in an asymmetrical manner 3–5nt 5′ to the branchpoint and depletion of 
MUS81 from the SLX4 complex reduces this activity, however depletion of SLX1 
reduces both the symmetrical cleavage 3′ to the junction and the asymmetrical 
cleavage 5′ to the junction (Svendsen et al., 2009; Munoz et al., 2009). Interestingly, 
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isolated SLX1–SLX4 (C-terminal fragment) cleaves only in a symmetrical manner, 
whereas SLX1 in the context of the whole SLX4 complex cleaves HJs also at 
asymmetrical positions (Svendsen et al., 2009). To assay the activity of full-length 
SLX4 with SLX1 in a more rigorous way it will be important to express SLX4–
SLX1, and recently our laboratory has been successful in expressing small amounts 
of SLX4–SLX1 in Sf21 insect cells. It will be interesting to test the nuclease activity 
of SLX4-SLX1 towards different branched DNA substrates, in particular HJ 
structures. 
Is SLX4–SLX1 physiologically relevant as an HJ resolvase? HJs arise not only 
during DNA repair but are important intermediates that occur during meiosis I that 
need to be resolved for the completion of meiosis. Budding yeast Slx4–Slx1 is not 
required for meiosis; however SLX4 plays important roles in meiosis in other 
organisms. In flies, MUS312 has been proposed to resolve HJs that arise during 
meiosis (Andersen et al., 2009; Yildiz et al., 2002a) and C. elegans him-18/SLX4 
mutants show major decreases in the frequency of meiotic crossovers (Saito et al., 
2009). Furthermore, human SLX4 is highly expressed in tissues where meiosis 
occurs, such as oocytes and testes (Andersen et al., 2009). Therefore SLX4 clearly 
plays a role in meiosis but which nuclease of the SLX4 complex is important for its 
function in meiosis? Interestingly, mutations in MEI-9 (XPF) in Drosophila cause 
meiotic defects, suggesting a role in HJ processing in meiosis (Yildiz et al., 2002).  
Are the other proposed HJ resolvases physiologically relevant? S. pombe mus81 
mutants show defects in mitotic and meiotic recombination (Osman and Whitby, 
2007), however in other organisms MUS81 does not seem to play a dominant role 
for the processing of HJs (Ciccia et al., 2008). Human GEN1 was shown to cleave 
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HJs in vitro (Ip et al., 2008) but C. elegans mutants lacking GEN1 do not show 
meiotic defects (Bailly et al., 2010), indicating that GEN1 is not the major HJ 
processing factor in meiosis.  
During ICL repair DSBs are generated to allow the re-start of blocked replisomes. 
The induction of these DSBs involves MUS81-EME1. We hypothesised that SLX4–
SLX1 plays a role in the processing of recombination intermediates that arise during 
HR after DSB induction in ICL repair. SLX4 is not required for the induction of the 
DSB as γ-H2AX foci form normally in SLX4- and SLX1-depleted cells treated with 
cisplatin at levels similar to wild-type cells. A proportion of these foci do persist 
however, which indicates a defect in the repair in a subset of these ICL-induced 
DSBs (Munoz et al. 2009). It is possible that SLX4 might be involved in the 
recruitment of XPF-ERCC1 and other nucleases to the ICL, but this is however 
speculative. In yeast, Slx4 is essential for the cleavage of non-homologous tails by 
Rad1 XPF-Rad10 ERCC1during SSA (Flott et al, 2007a; Toh et al, 2010). Maybe SLX4 
has a similar impact on XPF-ERCC1 in mammalian cells. In summary, SLX4 is not 
only a scaffold but also a coordinator of SSE in a way that might be important in the 
processing of DNA structures generated during HR in DSB repair and at stalled 
replisomes (Fig. 3.8). 
The functional impact of SLX4 on the associated nucleases during DNA repair is not 
yet known. Mutations that specifically abolishing the binding of SLX4 to either 
XPF-ERCC1, MUS81-EME1 or SLX1 will help to determine how SLX4 influences 
the function of the associated SSEs. It will also be important to identify the functions 
of the existing identified domains in SLX4 such as the BTB, SAP and HtH domains. 
Data describing the function of the N-terminal UBZ4 domains are shown in Chapter 
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4. Furthermore it will be interesting to study the regulation of SLX4 by 
phosphorylation, since it is known that SLX4 is phosphorylated by ATM/ATR, but 
the functional significance of this is currently not known.  
As mentioned above SLX4 does not only interact with the three SSEs XPF-ERCC1, 
MUS81-EME1 and SLX1. Other proteins identify to interact with SLX4 are TRF2 
and TRF2IP, MSH1 and MSH2 and PLK1. Nothing is known about the role of the 
association of MSH1 and MSH2 with SLX4. The interaction with PLK1 and its 
possible implications in SLX4 function are discussed in Chapter 5. The interaction 
of SLX4 with TRF2 and TRF2IP suggests a role of SLX4 in telomere maintenance. 
That SLX4 associates with telomeres has not only been shown in co-
immunoprecipitation with TRF2 and TRF2IP; SLX4 co-localises with the shelterin 
complex component Rap1 at telomeres in immunofluorescence experiments 
(Svendsen et al., 2009) and proteomics of isolated chromatin (PICh) segments data 
suggest an association of the SLX4 complex with telomeres (Dejardin & Kingston, 
2009). Interestingly D loop and HJ intermediates, structures that can be cleaved by 
the SLX4 complex, are thought to form at telomeres during T loop disassembly 
(Fekairi et al, 2009, Munoz et al, 2009, Svendsen et al, 2009). T loops are structures 
that need to be unwound to allow full replication of the telomere (Griffith et al, 
1999), and this requires the helicase RTEL1. A recent paper suggests that the SLX4 
complex does play a critical role in telomere maintenance in cells that do not have 
RTEL (Vannier et al, 2012).  
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Figure 3.8: A model for the role of the SLX4 complex in ICL repair 
ICLs are very toxic lesions in replicating cells and cause replisomes to stall. One model is that 
the initiation of ICL repair requires two converging RFs. Then the Fanconi anaemia complex is 
recruited to the DNA lesion. In the next step the ICL need to be unhooked and this requires 
incisions at both sites of the ICL. One incision is made on the leading strand template by 
MUS81-EME1 (similar to a 3′ flap structure), the other incision is made on the other side of the 
ICL on the same strand but the required nuclease is unknown but some have been proposed. The 
unhooking of the ICL results in two one-ended DSBs and the unhooked adduct. This is removed 
by excision repair and translesion synthesis can fill the gap. Repair is then completed by HR, the 
step where the SLX1-SLX4 nuclease seems to act. 
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Chapter IV 
SLX4 is mutated in a new Fanconi anaemia subtype and 
SLX4 function requires the first UBZ domain 
 
4.1 Introduction 
Fanconi anaemia (FA) is a rare autosomal recessive and sex linked disorder caused by 
defects in the repair of ICLs. FA is characterised by developmental defects, skeletal 
abnormalities, bone marrow failure and cancer predisposition. At the onset of this study, 
mutations in any of fourteen genes had been shown to cause FA (Patel & Joenje, 2007; 
Wang, 2007). The cellular sensitivity of cells depleted of SLX4 to agents that induce 
ICLs prompted us to investigate SLX4 as a candidate gene for FA. This was achieved in 
collaboration with Dr. Johan de Winter who had previously identified patients with FA 
that was not caused by mutations in the 14 known FA genes. In this chapter I describe 
the identification of SLX4 as the fifteenth FA gene. 
 
4.2 Results 1: SLX4 is mutated in patients with Fanconi anaemia 
4.2.1 Characterisation of SLX4 in patients with unclassified Fanconi anaemia 
Previous work from our laboratory has shown that depletion of SLX4 from human cells 
with siRNA causes defects in ICL repair (Munoz et al, 2009). This raised the possibility 
that human SLX4 mutations might cause FA. At the onset of this study fourteen FA 
genes were known, but Dr. Johan de Winter had identified patients with unclassified 
FA. One of these patients was a Dutch male from a consanguineous family. This patient 
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who had growth retardation, microcephaly, hypo-pigmentation, thumb abnormalities 
and hearing loss, was diagnosed with aplastic anaemia at nine years of age and FA was 
suspected (Table 4.1). The FA diagnosis was confirmed by a chromosomal breakage 
assay on T lymphocyte cultures, which demonstrated a substantially higher number of 
spontaneous and MMC-induced chromosomal aberrations. MMC is a commonly used 
DNA damaging agent that causes ICLs. Lymphoblastoid cells from the affected 
individual were also hypersensitive to MMC in terms of chromosomal breakage and 
growth inhibition (Stoepker et al, 2011a).  
 
 
 
 
  
Table 4.1. Table describing the clinical phenotype of the FA individual EUFA1354. 
The normal values for blood counts correspond to normal values for children corresponding 
to the age of the patient at the age of diagnosis. 
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4.2.2 SLX4 expression and interaction with structure-specific endonucleases in cells 
from Fanconi anaemia patient EUFA1354 
Sequence analysis of genomic DNA and cDNA from the affected individual 
(EUFA1354) in Dr. de Winter’s laboratory, revealed biallelic mutations in the reading 
frame of SLX4 (Fig.4.1 A). A homozygous, 1-bp deletion (c.286del) in the first exon of 
SLX4 was detected which results in a frameshift at codon 96 and a premature stop at 
codon 126. The consanguineous parents and healthy sister of the affected individual 
were heterozygous for this sequence variant. We predicted that the stop codon in the 
SLX4 protein sequence in EUFA1354 cells would result in an alternative SLX4 
transcription start site at codon 213 and this might give rise to an N-terminally truncated 
SLX4 protein in this patient (Fig.4.1 B).  
 
I tested SLX4 expression in cells from the unclassified FA patient (EUFA1354) (Fig. 
4.1 C) using antibodies raised and the N–terminus and C–terminus of SLX4 
respectively. Full-length SLX4 was undetectable by immunoprecipitation with 
antibodies against the N–terminus of SLX4, although very low levels of a truncated 
form of SLX4, running faster than full–length protein, were detected in precipitates 
using antibodies against the SLX4 C–terminus but not against the N–terminus (Fig. 4.1 
C). This suggested that fibroblasts from the affected individual EUFA1354 express very 
low levels of an N–terminally truncated form of SLX4. Consequently, the amounts of 
XPF–ERCC1, SLX1 and MUS81 in SLX4 immunoprecipitates from EUFA1354 
fibroblasts were severely reduced compared with cells expressing wild–type SLX4 (Fig. 
4.1 C).  
 
- 140 - 
 
We suspected that the truncated form of SLX4 in FA-SLX4 cells starts at Met213, since 
this was the next possible start codon in the sequence. Therefore I tested the ability of 
SLX4 (213–end), fused to GFP and expressed in HEK293 cells, to interact with XPF–
ERCC1, SLX1 and MUS81. As shown in Fig. 4.1 D, GFP-SLX4 (213–end) transiently 
transfected into HEK293 cells is expressed at even higher levels than full–length. I 
consistently observed that GFP-SLX4 (213–end) was more highly degraded in cell 
extracts than full length SLX4. However, the levels of endogenous XPF–ERCC1, SLX1 
and MUS81 found in GFP immunoprecipitates from extracts cells expressing (213-end) 
was similar to full–length SLX4. This showed the N–terminally–truncated form of 
SLX4 expressed in cells from patient EUFA1354 can interact with XPF–ERCC1, SLX1 
and MUS81. This suggested that the defect in EUFA1354 cells is not due to an inability 
of the mutant SLX4 to interact with nucleases, but was instead due to the very low 
levels of the SLX4 complex. 
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Figure 4.1: Characterisation of SLX4 in patients with unclassified Fanconi anaemia  
A: Homozygous SLX4 mutation in unclassified Fanconi anaemia patient (EUFA 1354) from a 
consanguinous family. The N-terminal cDNA sequence from the start codon to codon 220 of 
SLX4 is shown. The position of the deletion in codon 96 is highlighted (red). 
B: Schematic representation of SLX4 with the frameshift mutation at codon 96 and the possible 
alternative start at Met 213 are shown. 
C: SLX4 was immunoprecipitated from cell extracts (1mg) of fibroblasts (LN9SV) from normal 
individuals and SLX4 mutant fibroblasts (EUFA1354) from the unclassified Fanconi anaemia 
patient with a frameshift mutation at codon 96 in SLX4. SLX4 immuno-precipitates were 
subjected to SDS PAGE and analysed by western blotting with antibodies against SLX4, SLX1, 
XPF, ERCC1, MUS81 and EME1. 
D: HEK293 cells were transfected with GFP-only, GFP-SLX4 and GFP-SLX4 213-end.  GFP 
immunoprecipitates were subjected to SDS PAGE and analysed by western blotting with the 
indicated antibodies. Untransfected cells and GFP-only transfected cells were used as a control. 
The right panel shows ponceaus S staining of the membrane from the middle panel (GFP IP). 
D. 
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4.2.3 Gel filtration of extracts of cells from FA patient EUFA1354  
The data above indicated that the DNA repair defects in EUFA1354 cells are due to the 
very low levels of SLX4 protein. The truncated form of SLX4 in these cells appeared to 
interact normally with XPF-ERCC1, MUS81-EME1 and SLX1. Therefore I thought it is 
likely that the DNA repair defect in these cells is simply a reflection of the very low 
levels of the intact SLX4 complex. To address this further, I investigated SLX4 
containing complexes in EUFA1354 cells by size exclusion chromatography. The gel 
filtration fractions were collected, subjected to SDS PAGE and analysed by western 
blotting. It was necessary to immunoprecipitate SLX4 from each fraction to achieve 
detectable amounts of SLX4 because the antibody available at the time could not detect 
SLX4 in cell extracts. Consistent with a previous report from this laboratory (Munoz et 
al, 2009) in normal fibroblasts SLX4 exists in a high molecular weight complex of 2 
MDa together with XPF-ERCC1, MUS81-EME1 and SLX1 (Fig. 4.2 A). XPF-ERCC1 
is known to also elute in a lower molecular weight complex without SLX4, MUS81-
EME1 and SLX1 (Munoz et al., 2009). I believe that the lower molecular weight 
fractions containing XPF-ERCC1 represent an SLX4 independent complex required for 
NER.  In EUFA1354 cells SLX4 is undetectable in high molecular weight gel filtration 
fractions (Fig. 4.2 B) and all of the cellular pool of XPF-ERCC1, and SLX1, from 
EUFA1354 cells was in the lower molecular weight complex (Fig. 4.2 B). 
 
Interestingly, MUS81 was still found in a high molecular weight complex, independent 
of SLX4 and EME1. This might also point towards a SLX4 independent role of MUS81 
and is currently being investigated. In summary, this result indicates that due to low 
levels of SLX4 in EUFA1354 cells the SLX4 complex is present only at very low 
levels, which reduces ICL repair capacity.  
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Figure 4.2: XPF/ERCC1 and SLX1 elute only in the low molecular weight fractions from 
Fanconi anaemia patient fibroblast (EUFA 1354) lysates 
A and B: Cell extracts (WCL) were loaded (3 mg of protein per sample) on a Superose 6 10/300 
column (GE Healthcare). The flow rate was 0.2 ml/min, and fractions of 400 µl (32) were 
collected. Molecular weight markers (Bio-Rad) were as follows: dextran blue (2 MDa) 
thyroglobulin (670 kDa) and bovine gamma globulin (158 kDa). Each fraction was denatured and 
subjected to western blot analysis with the indicated antibodies.  
A. Cell extracts of normal fibroblasts (LN9SV) were used as a control.  
B. SLX4 mutant fibroblast from the patient (EUFA 1354). 
A. 
B. 
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4.2.4 SLX4 is mutated in three German siblings with Fanconi anaemia 
We identified a second FA family with mutations in SLX4. The clinical phenotypes of 
the three affected siblings are shown in Table 4.2.  
 
 
 
The three siblings all inherited a 1-bp deletion in SLX4 (c.1093delC, 
p.Gln365SerfsX31) from their father and a splice site mutation (c.1163+3dupT) from 
their mother. The maternal mutation lead to exon 5 skipping, an in-frame deletion that 
disrupts parts of the first and the whole of the second UBZ4 domain (Fig. 4.3 B, middle 
panel). I was interested to know how this mutation affects SLX4 expression and the 
integrity of the SLX4 complex. To test this I immunoprecipitated SLX4 from extracts of 
lymphoblasts from one of the three siblings (VU1600-L) and from normal lymphoblasts 
(HSC93) as control.  I found that the levels of SLX4 protein in VU1600 cells were 
Table 4.2: Clinical phenotype of three German siblings (457-1, 457-2, 457-3) with FA 
resulting from SLX4 mutations 
The table shows the age of FA diagnosis and the presence or absence of typical FA hallmarks such 
as growth retardation abnormal haematology. 
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similar to those immunoprecipitated from wild type control cells (Fig. 4.3 A). The 
SLX4 protein band detected in immunoprecipitates from VU1600 cells however is of 
slightly lower molecular weight compared to the protein detected in HSC93 
immunoprecipitates. This is consistent with a small internal deletion in SLX4 from in 
VU1600 cells (Fig. 4.3 B). SLX4 immunoprecipitated from VU1600-L cells can interact 
with XPF and MUS81 (Fig.4.3 A).  
 
These data suggest that defects in the tandem UBZ domains of SLX4 are responsible for 
the FA phenotype of the three affected siblings. This implies that one or both of the 
UBZ domains of SLX4 is important for ICL repair. Based on the literature, UBZ 
domains target proteins to sites of DNA damage, which in turn suggests that a lack of 
targeting of SLX4 inhibits DNA repair. On this basis I set out to test this hypothesis.  
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Figure 4.3 SLX4 is mutated in three German siblings (457-1, 457-2, 457-3) with FA  
A. SLX4 was immunoprecipitated from cell lysates from lymphoblasts (HSC93) of normal 
individuals and from SLX4 mutant lyphoblasts from a patient with unclassified Fanconi 
anaemia (VU1600-L) with a deletion resulting in skipping of exon 5 in SLX4. SLX4 was also 
immunoprecipitated from SLX4 mutant fibroblasts (EUFA1354) from the unclassified 
Fanconi anaemia patient with a frameshift mutation at codon 96 in SLX4. SLX4 
immunoprecipitates were subjected to SDS PAGE and analysed by western blotting with 
antibodies against SLX4, SLX1, XPF and MUS81. 
B. Schematic representation of the SLX4 protein with its associated nucleases and the two 
mutant forms found in FA patients with mutations in SLX4. Upper panel: SLX4, middle 
panel: SLX4 protein found in one of the three German siblings (VU 1600) with a deletion 
mutation resulting in partial loss of the first and complete loss of the second UBZ4 domain in 
SLX4, lower panel: SLX4 protein found in patient EUFA1354 with. The N-terminus of this 
protein is missing and SLX4 in EUFA1354 fibroblasts is expressed at very low levels. 
B. 
A. 
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4.3 Results 2: Ubiquitin dependent recruitment of SLX4 to sites of DNA 
damage 
 
4.3.1 The ubiquitin binding domains of SLX4 
SLX4 has two different types of ubiquitin binding domains (UBDs): two UBZ4 
domains and a cryptic ubiquitin-interacting-motif (UIM), all of which are located 
towards the N-terminus of SLX4 (Fig. 4.4 A). The two UBZ domains are located 
between residues 293 - 361 in the SLX4 sequence and the cryptic UIM motif can be 
found C-terminal to the UBZ domains, stretching between residues 414 and 436. The 
lower panel of Figure 4.4 A shows the high degree of conservation of the UBZ domain 
of SLX4 and the conserved C2HC motifs, which is characteristic of the UBZ4 family of 
UBDs. The UBZ4 domain is found not only in SLX4 but in a range of other eukaryotic 
proteins (Fig 4.4 B). Strikingly most of the UBZ4 containing proteins play a role in the 
DNA damage response (Hofmann, 2009), including the POL κ translesion synthesis 
polymerase, the RAD18 ubiquitin ligase, and the Werner helicase interacting protein 
WRNIP. All of these proteins are recruited to sites of DNA damage through their UBZ 
domains (Bish & Myers, 2007; Crosetto et al, 2008; Nomura et al, 2012). Recently it 
was shown that the nuclease FAN1 binds to mono-ubiquitinated FANCD2 through its 
UBZ domain (MacKay et al, 2010). These data prompted us to investigate the 
possibility that the tandem UBZ domains in SLX4 bind ubiquitin and recruit SLX4 to 
damaged DNA.  
 
The UIM motif in SLX4 is located C-terminal to the UBZ domains and the overall 
conservation is low, and as such could be considered as a cryptic UIM motif. Figure 4.4 
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C shows an alignment of UIM motifs from different eukaryotic proteins and the UIM 
consensus sequence is shown on the bottom. The main conserved residues are 
highlighted in red. Figure 4.4 D shows an alignment of the SLX4 UIM domain in 
different species. UIM motifs are usually found in proteins that are involved in 
endocytosis and protein trafficking and they can bind both mono- and poly-ubiquitin. 
Since SLX4 appears to have a UIM motif, in addition to the UBZ domains in its N-
terminal region, I included the UIM motif in my investigation of whether SLX4 can 
bind to ubiquitin.  
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A. 
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Figure 4.4: The ubiquitin binding domains of SLX4 
A. Upper panel: Schematic representation of human SLX4 and its domain organisation. The 
two ubiquitin binding zinc fingers (UBZ4) are highlighted in green; these domains range from 
the residues 292 to 361. The first dyad marked as number 1 ranges from residue 293 to 320. 
The second dyad, marked as number 2, starts at residue 333 and ends at 361.  The putative 
ubiquitin interacting motif (UIM) in blue is located C-terminal of the UBZ4 domains and 
ranges from residue 414 to 436. Other domains present in SLX4 are the BTB domain, the SAP 
domain and the HtH motif. Lower panel: Sequence alignment of the UBZ4 domains of SLX4 
in different species with the typical C2HC structure, highlighted in red.  
B. Sequence alignment of UBZ4 domains in different human proteins. The two UBZ4 domains 
of SLX4 are shown on top with the conserved cysteines in red and the conserved histidine in 
blue (C2HC). Identical residues are shaded in black and similar residues are shaded in grey. 
The conserved Cys and His residues that define the two dyads of the UBZ domain are shaded 
in red. Asterisks denote the conserved Cys 296 and Cys 299 residues of the first dyad of the 
first domain and the conserved Cys 336 and Cys 339 residues of the first dyad of the second 
domain. 
C. Sequence alignment of UIM motifs in different proteins 
D.  Sequence alignment of the UIM motif of SLX4 in different species. 
 
D. 
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4.3.2 The UBZ4 domains of SLX4 bind to K63-linked poly-ubiquitin chains 
In order to test binding of the SLX4 UBZ domains to ubiquitin, the UBZ domains were 
expressed in bacteria, alone (UBZ-1 or UBZ-2) or in combination (UBZ-1 + UBZ-2), 
with an N-terminal GST tag in each case. Furthermore mutations in the first two 
conserved cysteine residues of the C2HC zinc finger were made in each UBZ domain. 
These mutations should abolish ubiquitin binding. The UBZ from WRNIP was used as 
a control as it is known to bind to K63-linked poly-ubiquitin chains (Bish & Myers, 
2007). NEMO was also used as control, as it was also reported to bind poly-ubiquitin 
chains (Laplantine et al, 2009).  
 
To test for ubiquitin binding, first GST or GST-SLX4 fragments were immobilised on 
glutathione sepharose beads and then incubated with either K63- or K48- linked poly-
ubiquitin chains. As shown in Figure 4.5 A, an SLX4 fragment containing both UBZ 
domains (UBZ-1+UBZ-2) is capable of interacting with K63-linked poly-ubiquitin 
chains but only weakly with K48-linked poly-ubiquitin. Mutation of the two conserved 
cysteines in the C2HC motif of the first UBZ domain to alanine (C296A and C299A; 
UBZ-1*+UBZ-2) abolish the interaction with poly-ubiquitin whereas mutating the 
second UBZ domain (C336A and C339A; UBZ-1+UBZ-2*) has no apparent effect. 
Strikingly, an SLX4 fragment corresponding to the first UBZ domain alone can interact 
with K63-linked poly-ubiquitin chains (UBZ-1) and this interaction is abolished when 
C296A and C299A are mutated (UBZ-1*). The isolated SLX4 UBZ-2 domain (UBZ-2 
and UBZ-2*) does not interact with K63- or K48-linked poly-ubiquitin chains. These 
data strongly suggest that the first but not the second UBZ domain of SLX4 binds 
preferentially to K63-linked poly-ubiquitin chains in vitro (Fig. 4.5 A). 
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Given that SLX4 binds to poly-ubiquitin I wanted to determine how many ubiquitin 
molecules are required in a ubiquitin polymer for SLX4 binding. I compared the ability 
of the SLX4 (UBZ-1+UBZ-2) fragment to bind to mono-, di-, tri-, tetra-, penta- and 
hexa-ubiquitin. All these polymers had K63 linkages. SLX4 did not bind to mono- and 
di- ubiquitin and bound only very weakly if at all to tetra- and penta-ubiquitin (Fig. 4.5 
B). However, the SLX4 (UBZ-1+UBZ-2) fragment binds to hexa-ubiquitin (Fig. 4.5 B). 
This indicates that six or more ubiquitin molecules in a chain are required for efficient 
SLX4 binding. A lack of a positive control for mono-ubiquitin makes the data obtained 
difficult to interpret. I tried to use GST-tagged FAN1 protein, since it has been 
previously shown to bind to mono-ubiquitinated FANCD2, but this protein has not yet 
been tested for ubiquitin binding in vitro.  
 
In the next experiment I compared the binding of SLX4 (UBZ-1+UBZ-2), WRNIP and 
NEMO to K63-linked poly-ubiquitin chains. WRNIP and NEMO are known to bind 
K63 linked poly-ubiquitin chains. To compare the binding efficiency of the different 
tested proteins I immobilised one microgram of each protein: GST alone, SLX4 GST-
(UBZ-1+UBZ-2), GST-WRNIP or GST-NEMO on glutathione sepharose beads and 
incubated these with different concentrations of K63-linked poly-ubiquitin chains (Fig. 
4.5 C). Bound ubiquitin was detected by western blotting with a pan-ubiquitin antibody. 
In vitro GST-SLX4 (UBZ-1+UBZ-2) binds to K63-linked poly-ubiquitin chains with a 
comparable affinity to GST-NEMO, but weaker affinity than GST-WRNIP. I also tested 
if the SLX4 cryptic UIM binds to ubiquitin. The putative UIM motif in SLX4 is a short 
alpha helix that stretches from D414 to A436 (Fig. 4.5 A). I used a recombinant SLX4 
fragment corresponding to the UIM motif; GST-SLX4 (400-450). GST-SLX4 (400-
450) does not bind to K48 or K63 linked poly-ubiquitin chains (Fig. 4.5 D).  
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Figure 4.5: The UBZ4 domains of SLX4 bind to K63-linked poly-ubiquitin chains 
A. Interaction of the tandem UBZ4 domains in SLX4 with ubiquitin.  K63 or K48 linked poly-
ubiquitin chains were incubated with the following proteins: GST purified GST-control and 
GST-SLX4 270-380 wild type (UBZ wt) or mutant (indicated with *). To determine which of 
the two domains is responsible for ubiquitin binding the conserved cysteine residues in each 
dyad were mutated to alanine; C296 and C299 were mutated in the first (UBZ-1*) and C336 
and C339 in the second UBZ domain (UBZ-2*). To test whether the individual UBZ domains 
are capable of binding ubiquitin, fragments containing either only the first UBZ domain (270-
335) or the second UBZ domain (320-380) were used (wild type and mutant).   GST- WRNIP 
and GST-NEMO were used as controls.  The GST-tagged proteins were purified by binding to 
GST-beads, separated by SDS PAGE and analysed by western blotting with a pan anti-
ubiquitin antibody. The bottom panels show Ponceau S staining of the GST proteins. Input  
lane: 250 ng of ubiquitin chains. 
B. Interaction of the tandem UBZ4 domains in SLX4 with ubiquitin.  Mono ubiquitin, K63 
linked tri-, penta- and hexa-ubiquitin chains were incubated with a GST purified GST-control 
and GST-SLX4 270-380 wt (UBZ wt) or mutant (same as in A). GST-WRNIP was used as 
positive control for ubiquitin chains. The GST-tagged proteins were purified by binding to 
GST-beads, separated by SDS PAGE and analysed by western blotting with a pan anti-
ubiquitin antibody. The bottom panels show Ponceau S staining of the GST proteins. Input 
was 250 ng of ubiquitin. 
C. Interaction of the tandem UBZ in SLX4 with different concentrations of K63 linked poly-
ubiquitin chains. K63 linked poly-ubiquitin chains were incubated with a GST purified GST-
control and GST-SLX4 270-380 wt (GST-SLX4 UBZ). GST-WRNIP was used as positive 
control. Otherwise same as A and C. 
D. Interaction of putative UIM motif of SLX4 with poly-ubiquitin chains. To determine 
whether the putative UIM motif (aa 414-436) is capable of interaction with poly-ubiquitin 
chains a GST-tagged fragment of SLX4 containing the UIM motif was expressed in bacteria 
and purified. The protein was then incubated with K63 and K48 linked poly-ubiquitin chains 
alongside the tandem UBZ4 domains of SLX4 and NEMO (both GST-tagged) as positive 
controls. UIM* indicates a mutant form of the putative UIM motif where the conserved 
residues E419 and D420 were both mutated to alanine to abolish possible ubiquitin interaction. 
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4.3.3 Recruitment of the isolated UBZ domain to sites of DNA damage 
Given that UBZ4-type domains mediate recruitment of WRNIP, POLκ, FAN1 and 
RAD18 to sites of DNA damage I wanted to test whether the UBZ domains of SLX4 
have an analogous function. Normally this would be done by testing the ability of GFP-
SLX4 or endogenous SLX4 to from subnuclear “foci” after DNA damage. However, 
SLX4 forms foci in cells, even before DNA damage in induced (Stoepker et al, 2011b; 
Svendsen et al, 2009). These foci are telomeres and recent data from this laboratory has 
shown that the SLX4 complex is recruited to telomeres by direct interaction of SLX4 
with TRF2 (J. Wilson, unpublished data). Therefore the recruitment of SLX4 to sites of 
DNA damage could not be tested by induction of DNA damage foci. Instead I used a 
406 nm laser for microirradiation to induce tracks of DNA damage and monitor 
recruitment of SLX4.  
 
These experiments were performed in a cell line that stably expresses a fragment of 
SLX4 encompassing both UBZ domains (GFP-SLX4 UBZ-1+UBZ-2) in a tetracycline 
inducible manner. A second cell line was created that expresses the same fragment of 
SLX4 but in this case the two conserved cysteines of the C2HC motif in the first UBZ 
domain were mutated (C296A+C299A) (Fig. 4.6 A). I induced protein expression by 
adding tetracycline to the cells for different times. Cells were lysed and cell extracts 
were subjected to SDS PAGE and analysed by western blotting with an anti-GFP 
antibody (Fig. 4.6 A). Both cell lines express the protein of interest at similar levels and 
were induced with tetracycline for 24 hours for further experiments.  
 
To test whether GFP-SLX4 (UBZ-1+UBZ-2) is recruited to sites of DNA damage, cells 
were seeded into glass bottom dishes and after induction of protein expression with 
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tetracycline; cells were laser micro-irradiated to induce traces of DNA damage. Then 
the cells were fixed and stained with an antibody against γ-H2AX, a marker of DNA 
double strand breaks. GFP-SLX4 (UBZ-1+UBZ-2) is recruited to sites of laser-induced 
DNA damage resulting in a laser stripe which becomes visible after approximately 3-5 
minutes (Fig. 4.6 B). Mutations in the first UBZ domain however result in loss of 
recruitment of this fragment of SLX4 to DNA damage (Fig. 4.6 B).  
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Figure 4.6: Recruitment of the UBZ4 domain to sites of DNA damage 
A. U2OS cells stably expressing GFP-UBZ only (residues 270-380) and GFP-UBZ1 
mutant (C296A+C299A) in a tetracycline–inducible manner.  Plasmid pcDNA5.1–FRT–
TO–GFP– (Invitrogen), expressing the protein of interest with an N–terminal GFP under 
the control of a tetracycline–inducible promoter, was stably integrated at the FRT sites in 
U2OS Flp–In cells according to the manufacturer’s instructions. The cells were incubated 
with tetracycline for the times indicated and lysed. Extracts were subjected to SDS–
PAGE followed by western blotting with the indicated antibodies.  
B. U2OS cells described above were laser micro-irradiated; after 1 h cells were fixed and 
permeabilised. Immunofluorescence was performed with antibodies against γ-H2AX 
(middle panels) and secondary antibodies conjugated to AlexaFluor 594. 
A. 
B. 
kDa 
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I next wanted to test the recruitment of full length SLX4 fused to GFP and the effect of 
mutating the first UBZ domain of SLX4 on recruitment to sites of laser induced DNA 
damage. This was not possible because I found that SLX4 oligomerises through the 
BTB-domains (unpublished data). Therefore UBZ-mutated SLX4 would bind to the 
endogenous protein. I created a cell line expressing a siRNA protected form of SLX4 to 
enable knock-down of the endogenous protein to monitor the recruitment of GFP-SLX4, 
but the remaining endogenous protein was still sufficient to recruit the mutant GFP-
tagged protein (data not shown).  
 
4.3.4 UBZ4 dependent recruitment of SLX4 to sites of DNA damage  
As it was difficult to investigate the recruitment of SLX4 to sites of laser induced DNA 
damage in human cells I decided to take advantage of SLX4-/- MEFs that were kindly 
provided by Dennis Castor, a post-doctoral researcher in our laboratory. These cells are 
a powerful tool that allowed me to investigate the recruitment of SLX4 to sites of DNA 
damage and to assess whether this is UBZ4 dependent.  
 
As shown in Figure 4.7 A the SLX4 -/- MEFs do not express SLX4 or SLX1; the 
stability of the latter depends on SLX4. The protein levels of the other SLX4-associated 
nucleases XPF and MUS81 however are normal in SLX4 -/- cells (Fig. 4.7 C). For these 
experiments retroviral vectors were used to stably express mouse SLX4 in SLX4 -/- 
MEFs. I selected clones that express GFP-mSLX4 or untagged mSLX4 at close to 
endogenous levels. I also made cells that stably express SLX4 with mutations in the first 
(mSLX4 UBZ-1*) or the second (mSLX4 UBZ-2*) UBZ domain of the protein. For 
control purposes, cells were also complemented with GFP-alone or with an empty 
plasmid (Fig. 4.7 B and C). 
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First I tested the protein levels of XPF-ERCC1, MUS81 and SLX1 in cell extracts from 
these cell lines. The protein levels of XPF-ERCC1, MUS81 and SLX1 in SLX4 -/- MEF 
extracts from cells complemented with the above mentioned constructs were 
comparable (Fig. 4.7 B). Next, I tested whether mutations in the UBZ domains of 
mSLX4 affected the interaction of mSLX4 with the associated nucleases XPF, MUS81 
and SLX1. As shown in Fig. 4.7 C the protein levels of XPF-ERCC1, MUS81-EME1 
and SLX1 in mSLX4 immunoprecipitates of SLX4-/- MEF complemented with GFP-
mSLX4-UBZ-1*, GFP-mSLX4-UBZ-2*, mSLX4-UBZ1* and mSLX4-UBZ2* are 
similar to those complemented with GFP-mSLX4 and mSLX4.  Knowing that the 
assembly of the SLX4 complex is not affected I decided to test GFP-SLX4 and the two 
mutant cell lines for recruitment of SLX4 to sites of laser induced DNA damage.  
 
For this experiment, cells were seeded into glass bottom dishes and treated with BrdU 
for 24 hr to sensitise for DNA damage, on the next day the cells were laser micro 
irradiated and a timelapse experiment was performed (Fig. 4.7 D).  GFP-mSLX4 is 
recruited to sites of DNA damage and as shown in Figure 4.7 D it is recruited to the 
damaged region after approximately 5 minutes and reaches the highest intensity at 20-
30 minutes after laser micro-irradiation. This is similar to the data obtained for GFP-
SLX4 UBZ-2*, where the two conserved cysteines of the C2HC motif are mutated in 
the second UBZ4 domain in SLX4. Similar to wild type, GFP-mSLX4 UBZ-2* is 
recruited to the sites of DNA damage and a laser stripe can be detected at 5 minutes 
after laser micro-irradiation (Fig. 4.7 D lower panel). Strikingly no recruitment can be 
observed for GFP-mSLX4 UBZ-1* (Fig. 4.7 D middle panel). The laser stripes detected 
in the timelapse experiment were very weak. Therefore I decided to fix the cells after 
laser microirradiationand and stain them with an antibody for the DNA damage marker 
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γ-H2AX and an antibody against GFP (Fig. 4.7 E). As shown in Figure 4.7 E, GFP-
mSLX4 is recruited to sites of DNA damage after laser microirradiation and the same 
can be observed for GFP-mSLX4-UBZ2*. GFP-mSLX4-UBZ1* however is not 
recruited, even though DNA damage was induced, as seen by the strong signal detected 
for γ-H2AX (Fig. 4.7 E). These observations correlate well with the previously obtained 
in vitro data, where mutations in the first UBZ domain of SLX4 lead to loss of 
interaction with ubiquitin.  
 
To show that the endogenous SLX4 is indeed recruited to sites of laser induced damage 
I seeded U2OS cells into glass bottom dishes and labelled the cells with BrDU 24 h 
prior to the experiment. BrDU labelling is known to increase the signal of γ H2AX after 
laser microirradiation. The next day I used a 406 nm laser for microirradiation to induce 
DNA damage. One hour after DNA damage was induced I fixed the cells and stained 
with antibodies against SLX4 and γ-H2AX (Fig. 4.7 F). Endogenous SLX4 is recruited 
to sites of laser DNA damage. 
 
Taken together these data show that the first of the two UBZ domains of SLX4 is 
required for recruitment of SLX4 to sites of DNA damage and mutating this domain 
completely abolishes the recruitment of SLX4 to DNA damage. 
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Figure 4.7: UBZ4 dependent recruitment of SLX4 to sites of DNA damage 
A. Adapted from Dennis Castor. Western blot showing protein levels of SLX4 in wt (+/+), 
SLX4 heterozygous(+/-) and SLX4 null (-/-) mouse embryonic fibroblasts (MEFs). GAPDH 
was used as loading control. 
B. SLX4 -/- MEFs were complemented with empty plasmid, GFP, mSLX4, GFP-mSLX4 (left 
panel) and the UBZ mutants mSLX4 UBZ-1*(conserved cysteines in the first UBZ4 domain are 
mutated to alanine), mSLX4 UBZ-2*(conserved cysteines in the second UBZ domain are 
mutated to alanine), GFP-mSLX4 UBZ-1* and GFP-mSLX4 UBZ-2* (right panel, all western 
blots stem from the same experiment and  each  lane shows a western blot from the same 
membrane). Cell extracts of the complemented SLX4 -/- MEFs were subjected to SDS PAGE 
and analysed by western blotting. 
C. Same as B but this time Immunoprecipitates of the complemented SLX4 -/- MEFs from B of 
mSLX4 were subjected to SDS PAGE and analysed by western blotting with the indicated 
antibodies 
D. SLX4 -/- MEFs complemented with GFP-mSLX4, GFP-mSLX4 UBZ-1* (conserved 
Cysteines in the first UBZ domain are mutated to Alanine) or GFP-mSLX4 UBZ-2* (conserved 
Cysteines in the second UBZ domain are mutated to Alanine) were laser micro-irradiated and 
monitored over a time of one hour. Pictures were taken every ten minutes. The white arrows 
indicated the appearing laser stripes.  
E. SLX4 -/- MEFs complemented with GFP-mSLX4, GFP-mSLX4 UBZ-1* or GFP-mSLX4 
UBZ4-2* were laser microirradiated; after 1 h cells were fixed and permeabilised. 
Immunofluorescence was performed with antibodies against γ-H2AX (middle panels) and 
secondary antibodies conjugated to AlexaFluor 594 
F. U2OS cells were laser micro-irradiated; after 1 h cells were fixed and permeabilised. 
Immunofluorescence was performed with antibodies against SLX4 (left panels) and γ-H2AX 
(middle panels) and secondary antibodies conjugated to AlexaFluor 488 or AlexaFluor 594. 
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4.3.5 Mutations in the first of the tandem UBZ4 domains of SLX4 cause ICL 
sensitivity 
The data above show that the first, but not the second UBZ domain in SLX4 is required 
for SLX4 recruitment to sites of DNA damage. Furthermore, in cells from the three 
German siblings with Fanconi anaemia described in chapter 4.2.4, all of the second and 
half of the first UBZ domain of SLX4 are deleted. This suggested that at least one of the 
UBZ domains in SLX4 is essential for SLX4 function. To test if one or both UBZ 
domains are required I used the SLX4 -/- MEFs that I complemented with wild type 
mSLX4 or mSLX4 bearing mutations in the conserved cysteine residues in the first or 
the second UBZ domain (Fig. 4.7 B and C). I carried out clonogenic survival assays to 
test these cells for DNA damage sensitivity. As negative control I used SLX4 -/- MEFs 
complemented with an empty vector. SLX4 wild type MEFs complemented with an 
empty vector were used as a positive control.  
 
First the cells were seeded into dishes and after about 8 hours they were treated with the 
in Figure 4.8 indicated concentrations of the crosslinking agent MMC. After 24 hr the 
cells were washed and incubated in fresh medium for up to 10 days (until colonies of 
>/= 50 cells have formed). The cell colonies were dried and stained with Giemsa stain, 
then the colonies were counted. 
 
As shown in Figure 4.8. SLX4 -/- MEFs complemented with an empty vector showed 
pronounced hypersensitivity to MMC compared to wild type MEFs harbouring an 
empty vector and only about 1% of cells survived the highest dose of MMC (40 ng/ml). 
Stable expression of wild type mSLX4 rescued the MMC sensitivity of the SLX4 -/- 
cells and around 70% of the cells survived the highest concentration of MMC used in 
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this experiment. However, mSLX4 bearing mutations in the conserved cysteines in the 
first UBZ domain (mSLX4 UBZ4-1*) could not rescue the DNA damage sensitivity of 
SLX4 -/- cells. SLX4 bearing mutations in the second UBZ domain almost fully rescued 
this phenotype, but residual weak DNA damage sensitivity was observed (Fig. 4.8). 
Taken together these data show, that the first UBZ domain of SLX4 is essential for 
SLX4 function and the cellular resistance to MMC. 
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Figure 4.8: Mutations in the first of the tandem UBZ4 domains of SLX4 cause ICL 
sensitivity 
SLX4 -/- MEFs complemented with mSLX4, mSLX4 UBZ-1* (conserved cysteines in the first 
UBZ4 domain are mutated to alanine) or mSLX4 UBZ-2* (conserved cysteines in the second 
UBZ4 domain are mutated to alanine) were seeded into 10cm dishes at a very low density 
(2000-3000 cells / dish). After 10 hours the cells were treated with the indicated concentrations 
of MMC for 24 hours. Then the cells were washed and fresh medium was added followed by 
incubation for 10 days. The resulting colonies were stained with Giemsa and the surviving 
colonies were counted. Wild type and SLX4 -/-MEFs complemented with an empty plasmid 
were used as positive and negative controls. The result represents three independent 
experiments. 
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4.4 Discussion 
As discussed in the previous chapter, depletion of SLX4 from cells causes 
hypersensitivity to ICL-inducing agents (Fekairi et al., 2009; Munoz et al., 2009). 
This observation prompted us to test samples from patients with unclassified 
Fanconi anaemia (FA) for mutations in SLX4, as hypersensitivity to ICLs is a 
hallmark of FA at the cellular level. We identified a patient (EUFA1354) with a 
point mutation in SLX4 that causes the expression of low levels of an N-terminal 
truncated SLX4 protein (Fig. 4.1 C). The point mutation results in the creation of a 
premature stop at codon 126. The low protein levels of SLX4 expressed in 
EUFA1354 cells are therefore probably due to the transcription machinery having to 
find an alternative ORF, which in this case lies 213 codons further downstream of 
the original start. The N-terminally truncated protein expressed in EUFA1354 cells 
however is still capable of interacting with SLX1, MUS81–EME1 and XPF–ERCC1 
indicating that all binding motifs essential for the interaction with these nucleases 
are still present in the truncated form of SLX4 (Fig. 4.1 C). This was confirmed by 
an experiment in which GFP-SLX4 213-end, corresponding to the protein expressed 
in EUFA1354 cells, bound to the associated nucleases with a similar affinity to that 
of the full-length protein (Fig. 4.1 D).  
 
As shown in Figure 4.2 A, SLX4 elutes in high molecular weight gel filtration 
fractions together with XPF-ERCC1, MUS81-EME1 and SLX1. However, in 
EUFA1354 fibroblasts SLX4 and SLX1 are no longer detectable in a high molecular 
weight complex, and XPF-ERCC1 is only present in the smaller, SLX4-independent, 
pool. This fraction is probably the SLX4-independent XPF–ERCC1 pool required 
for NER. We propose that EUFA1354 cells express such a low level of SLX4 that it 
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cannot fulfil its role as a scaffold and coordinator of SSEs in ICL repair. The low 
levels of SLX4 protein also cause low levels of SLX1, the catalytic subunit of the 
SLX4–SLX1 nuclease and, as shown in Figure 3.4 B, depletion of SLX1 from the 
SLX4 complex reduces the ability to cleave HJ structures. Therefore the phenotype 
of EUFA1354 cells is likely due to both the lack of SLX4 function as scaffold and 
coordinator of SSEs and to the lack of SLX1 nuclease activity. It will be interesting 
to test whether XPF–ERCC1 in SLX4-/- MEFs also only elutes as the NER pool in a 
gel filtration experiment. The third SLX4-associated endonuclease, MUS81, is still 
present in a high molecular weight complex in EUFA1354 cells, suggesting a SLX4-
independent role, which is currently being studied in the laboratory.  
 
The identification of SLX4 mutations in three German siblings with FA suggested 
that the UBZ domains of SLX4 might be functionally important. Cells from these 
FA patients express a truncated form of SLX4 that lacks parts of the first, and the 
whole second, UBZ domain of SLX4 (Fig. 4.3 B). It was not clear which of the two 
UBZ domains is most important for SLX4 function. As shown in Fig. 4.3 A, the 
SLX4 protein from these cells interacts with the three associated SSEs and the 
expression levels are only slightly lower than in wild-type cells. Therefore, in 
contrast to EUFA1354 cells, the FA phenotype is not due to low levels of SLX4 
protein. Is the lack of function of the UBZ domains causing the Fanconi anaemia 
phenotype? It has been shown that other DNA repair proteins are recruited to sites of 
DNA damage through their UBZ domains by binding to ubiquitinated proteins. 
Therefore I tested the SLX4 UBZ domains for ubiquitin binding in vitro. The first 
UBZ domain in SLX4 binds preferentially to K63 linked poly-ubiquitin chains in 
vitro (Fig. 4.5 A) and mutations in this domain abolish the interaction with ubiquitin. 
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Mutations in the second domain however do not abolish ubiquitin binding and the 
isolated second UBZ domain does not bind to ubiquitin. The role of the second UBZ 
domain in SLX4 is unclear and remains to be investigated. It might, however, play a 
structural role as a potential gatekeeper, allowing the first UBZ domain to bind 
ubiquitin more efficiently. Maybe the second UBZ domain plays a role in 
determining the substrate specificity of the SLX4 complex. 
 
I then tested if SLX4 is recruited to sites of DNA damage and whether this is 
dependent on the UBZ domains. As mentioned above, other proteins involved in 
DNA repair are recruited to DNA damage via their UBZ domains. Examples are the 
recently-discovered FAN1 protein, which binds to mono-ubiquitinated FANCD2 via 
its UBZ4 domain (MacKay et. al., 2010), WRNIP, Polκ and Rad18. Polκ forms 
nuclear DNA damage foci after UV treatment and this requires its UBZ domain 
(Guo et. al., 2007). Unfortunately it was not possible to investigate the recruitment 
of SLX4 to DNA damage foci because the SLX4 protein forms spontaneous sub-
nuclear foci, independent of DNA damage. These foci are telomeres and the role of 
SLX4 in telomere maintenance is currently being investigated in the laboratory. I 
decided to test whether SLX4 is recruited to laser tracks after laser micro-irradiation. 
I found that SLX4 is recruited to sites of DNA damage through its UBZ domain and 
this recruitment is dependent on the first UBZ domain (Fig. 4.7 D and F). 
Interestingly, mutations in the second UBZ domain do not abolish the recruitment of 
SLX4 to sites of DNA damage. This is in agreement with the in vitro data that show 
that the second UBZ domain does not bind to ubiquitin.  
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A potential criticism of these experiments is that the DNA damage induced by the 
406 nm laser is not physiological therefore it will also be interesting to investigate if 
SLX4 is recruited to UV-induced psoralen crosslinks (Thazhathveetil et al, 2007). 
This method allows us to look specifically at recruitment to ICLs, in contrast to the 
induction of DNA damage with a 406 nm laser which causes a variety of DNA 
lesions. 
 
One hallmark of FA is the cellular sensitivity to ICL inducing agents such as MMC. 
SLX4-/- MEFs are hypersensitive to such ICL inducing agents including MMC and 
this sensitivity is rescued by complementation with wild type mouse SLX4. SLX4 
with mutations in the second UBZ domain can partially rescue the ICL 
hypersensitivity of SLX4-/- MEFs. However SLX4-/- MEFs complemented with 
SLX4 UBZ-1* are just as hypersensitive to the crosslinking agent MMC as non-
complemented SLX4-/- MEFs (Fig. 4.8). These data strengthen our hypothesis that 
SLX4 is recruited to sites of DNA damage through the first UBZ domain. It will be 
also important to test whether SLX4 in cells from the three German siblings with FA 
is recruited to DNA damage, since the SLX4 protein expressed in these cells lacks 
parts of the first and the whole second UBZ domain; I have obtained preliminary 
data that indicate that recruitment of SLX4 to laser-induced DNA damage in these 
cells is absent. These cells however are difficult to manipulate for microscopy and 
the available antibodies against SLX4 do not work well for microscopy in skin 
fibroblasts.  
 
An interesting observation has been made in the De Winter laboratory, showing that 
SLX4 is also important for the sub-nuclear localisation of its complex partners. In 
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normal cells the XPF–ERCC1 nuclease forms nuclear foci that co-localise with 
SLX4 (Stoepker et al., 2011). In EUFA1354 fibroblasts, however, these foci cannot 
be detected even though the XPF–ERCC1 protein levels are normal. ERCC1 foci re-
appear in GFP-SLX4 transfected EUFA1354 cells. This confirms that SLX4 is 
essential for the localisation of the XPF–ERCC1 nuclease to sub-nuclear foci. This 
is currently under investigation. 
 
Where does SLX4 act in the ICL repair pathway? It is difficult to place SLX4 into 
the FA pathway since all the common markers, such as FANCD2 mono-
ubiquitination or the recruitment of downstream targets appear to be normal in the 
FANC-P cells. The available data suggests that SLX4 acts downstream of FANCD2 
in the FA pathway and after the generation of the one-ended DSB by MUS81. 
However, if SLX4 interacts with FANCD2 it might be recruited earlier, since 
FANCD2 is proposed to recruit proteins for unhooking TLS and HR. It is possible 
that SLX4 acts in different steps of the ICL repair pathway. For example, SLX4 may 
recruit XPF–ERCC1 to the ICL to enable the excision and/or unhooking step of the 
ICL repair pathway, and later in the pathway its association with SLX1 might be 
crucial for the resolution of crossovers that arise during HR. 
 
A recent paper suggests that SLX4 might bind to mono-ubiquitylated FANCD2 at 
ICLs (Yamamoto et al., 2011). Data obtained in our laboratory do not confirm this 
interaction, however nor could it disprove it. Data shown in this chapter shows 
however, that the first UBZ domain of SLX4 has a preference for poly-ubiquitin 
chains. Whether or not FANCD2 plays a role in SLX4 recruitment to sites of DNA 
damage can be investigated using FANCD2-deficient cells (PD20 cells) and a cell 
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line expressing a mutant form of FANCD2 (K561R) that cannot be mono-
ubiquitylated. If FANCD2 is required for SLX4 recruitment via the UBZ domain 
then it will be important to discover the poly-ubiquitinated ligand at the sites of 
DNA damage that is required for SLX4 recruitment via binding of the UBZ domain 
of SLX4. 
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Chapter V 
Preliminary data: Putative mechanisms of SLX4 regulation 
 
5.1 Introduction 
Budding yeast Slx4 is phosphorylated by Mec1/Tel1 (yeast ATR/ATM) and this is 
important for efficient DNA repair. It is likely that mammalian SLX4 is also regulated 
by phosphorylation. In this light, global phosphoproteomic screens identified SLX4 as 
one of thousands of proteins phosphorylated on ATR/ATM consensus sites in genotoxin 
treated cells (Matsuoka et al, 2007; Mu et al, 2007). In this chapter I describe the 
identification of the PLK1 kinase in SLX4 immunoprecipitates and present preliminary 
data giving evidence for a regulation of SLX4 during the cell cycle.  
 
5.2 Results 
5.2.1 Processing of SLX4 by a novel mechanism during S phase of the cell cycle 
Previous work identified several sites on SLX4 that conform to the consensus sequence 
for cyclin–dependent kinases (CDKs) that control cell cycle progression. This prompted 
me to test if the SLX4 complex is regulated during the cell cycle. I started by checking 
SLX4 protein levels, and the association of SLX4 with nucleases, in cells proceeding 
synchronously through the cell cycle. U2OS cells were arrested in S–phase by double 
thymidine block, released from S–phase and blocked in mitosis with nocodazole. Flow 
cytometry analysis showed that this resulted in a cell population highly enriched in cells 
arrested in mitosis (Fig. 5.1 B). These cells were released from mitosis by washing the 
cells free of nocodazole, so that cells proceeded synchronously through the cell cycle 
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judged by flow cytometry analysis (Fig. 5.1 A) and western blotting with cell–cycle 
regulated proteins (Fig. 5.1 A). For example, PLK1 and cyclin B were enriched were 
predominantly expressed in mitotic cells whereas cyclin A was expressed, as expected, 
in late S–phase cells.  
 
Extracts were subjected to immunoprecipitation with antibodies against the N–terminus 
of SLX4. Western blotting of precipitates with the same antibodies revealed that as cells 
entered S–phase, full length SLX4 disappeared and simultaneously SLX4 appeared to 
be proteolysed into two N–terminally truncated fragments (Fig. 5.1 C). The levels of 
XPF in SLX4 precipitates was constant throughout the cell cycle but at the times when 
SLX4 was fragmented, the level of MUS81 in SLX4 N–terminal precipitates dropped 
dramatically (Fig. 5.1 C, upper panel). SLX1 interacts with the C–terminal 150 amino 
acids of SLX4. SLX1 was immunoprecipitated from these extracts and the precipitates 
were subjected to western blotting with antibodies that recognise the N– or C–terminus 
of SLX4. This revealed that the amount of SLX4 with an intact N–terminus associated 
with SLX1 decreased dramatically in S–phase at the times when SLX4 fragmentation 
occurs (Fig. 5.1 C, lower panel). Blotting of the SLX1 precipitates with antibodies that 
recognise the C–terminus of SLX4 revealed a small fragment of approximately 100 
kDa. These data suggest that SLX4 is proteolysed into three fragments as cells enter S–
phase: an N-terminal fragment that bound to XPF–ERCC1, a middle fragment that was 
degraded and a C–terminal fragment that was bound to SLX1. MUS81–EME1 normally 
binds to the middle of SLX4 that is degraded in S–phase; thus MUS81–EME1 is no 
longer bound to SLX4 in S–phase. These data strongly suggest that the SLX4 scaffold is 
proteolysed during S–phase resulting in at least two nuclease sub–complexes. This 
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mode of regulation is highly unusual and there do not appear to be similar examples in 
the literature. 
 
I wished to purify SLX4 from S–phase cells to sequence the fragments but I found 
cleavage of SLX4 highly variable. I have tried a vast range of conditions to solve this 
problem. I recently found that simply arresting U2OS cells in early S–phase by double–
thymidine block followed by release for 4 h, when cells are in mid–late S–phase causes 
complete and reproducible SLX4 cleavage. These conditions might make it possible to 
determine the points of SLX4 cleavage in S–phase.  
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Figure 5.1: SLX4 is processed by an unknown mechanism during the G1/S transition of 
the cell cycle 
A: U2OS cells were arrested in G1 phase with a double thymidine block followed by an M-
phase arrest with nocodazole for 20 hours. The cells were released from the nocodazole block 
and samples were collected every 2 hours for 21 hours. The Cells were lysed and samples were 
subjected to SDS PAGE. Proteins of interest were detected by western blotting.  
B: Same as A. except U2OS cells were fixed with 70% EtOH and the DNA content was 
measured by flow cytometry after DNA staining with propidium iodide. 
C: SLX4 becomes cleaved during the G1/S transition of the cell cycle. Upper panel: SLX4 was 
immunoprecipitated with an antibody that recognises the N-terminus of SLX4 from cell lysates 
(1 mg) from synchronised U2OS cells.  The SLX4 immunoprecipitates were subjected to SDS 
PAGE and analysed by western blotting. Co-immunoprecipitated XPF and MUS81 were also 
analysed. Lower panel: SLX1 binds to full length SLX4 and to C-terminal cleavage products of 
SLX4. SLX1 was immunoprecipitated from cell lysates (1 mg) from synchronised U2OS cells.  
SLX1 immunoprecipitates were subjected to SDS PAGE and analysed by western blotting of 
SLX1 and its binding partners SLX4, XPF and MUS81. SLX1 interacts with the C-terminus of 
SLX4 and C-terminal fragments of SLX4 in late G1 and S phase. XPF binds to the N-terminus 
of SLX4 and therefore its interaction with SLX1 is weaker in S phase. The interaction of SLX1 
with MUS81 is almost abolished in late G1 and S phase. 
D:Schematic model for the cell cycle dependent cleavage of SLX4. 
The possible sizes of two N-terminal (176 kDa and 128 kDa) and one C-terminal ( 100 kDa) 
cleavage products were calculated taken the size of the bands detected by western blotting. 
XPF-ERCC1 interacts with the N-terminus and SLX1 with the C-terminus of SLX4. The 
interaction with MUS81 seems to be abolished during late G1 and S phase. 
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5.2.2 SLX4 interacts with PLK1 and is phosphorylated by PLK1 in vitro 
In Chapter 3, I described the identification of SLX4 interacting proteins by mass 
spectrometry. This screen revealed the protein kinase PLK1 (Table 3.1). The interaction 
of SLX4 and PLK1 was confirmed by endogenous co-immunoprecipitation experiments 
using extracts of HEK293 cells (Fig. 5.2 A). The association of PLK1 with SLX4 was 
resistant to washing the precipiates with up to 1M NaCl (data not shown). PLK1 has a 
polo-box domain (PBD) towards the C–terminus that binds to a subset of 
phosphorylated Ser/Thr–Pro motifs (Cheng et al, 2003; Elia et al, 2003). The consensus 
polo box binding motif (PBM) for PLK1 is S–(pS/pT)–P. In this light SLX4 has four 
polo-box binding motifs, centred on the Ser residues S960, S1244, S1355 and S1453 
(Fig. 5.2 B). Phosphorylation site mapping carried out in this laboratory previously 
showed that one of these residues in SLX4 – S1453 – in phosphorylated in vivo (data 
not shown). The serine residue in each of the four SLX4 PBM motifs was mutated to 
alanine and the effect of each mutation on the binding of SLX4 to PLK1 was assessed. 
Only mutation of S1453 abolished the binding of SLX4 to PLK1 (Fig. 5.2 C). In future, 
it will be important to test if S1453 is phosphorylated by CDKs in vivo and if 
phosphorylated S1453is required for binding of SLX4 to PLK1. 
 
 
- 184 - 
 
 
 
 
A. 
B. 
- 185 - 
 
 
  
Figure 5.2: A mutation of SLX4 Ser1453 abolishes its interaction with polo-like 
kinase 1 (PLK1)  
A: Confirmation that endogenous SLX4 interacts with PLK1. Extracts from HEK293 
cells were subjected to immunoprecipitation with antibodies raised against SLX4, PLK1 
or GST (“IgG”). Precipitates were subjected to SDS PAGE and analysed by western 
blotting with the indicated antibodies. 
B: Sequence alignment of the region of SLX4 containing the four polo-box binding 
motifs (PBD) found in SLX4 which centre on S960A, S1244A, S1355A and S1453A. 
The optimal recognition sequence motif for PLK1 is Ser-[pSer/pThr]-[Pro/X]. The 
residues surrounding the central phosphorylated residue are highlighted in red, the central 
phosphorylated residue (pSer/pThr) of the PBD is highlighted in green. Human SLX4 
protein (H. sapiens) was aligned with horse (E. caballus), mouse (M. musculus) and 
chicken (G. gallus) orthologues. 
C: HEK293 cells were transfected with wild type SLX4 or with SLX4 being mutated at  
S960A, S1244A, S1355A and S1453A. GFP-SLX4 was immunoprecipitated with GFP 
Trap beads. Extracts (upper panel) and immunoprecipitates (lower panel) were subjected 
to SDS PAGE and western blotting with the indicated antibodies. GAPDH was used as a 
loading control in cell lysates. 
 
 
 
 
 
 
  
C. 
GFP 
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I next tested if SLX4 is phosphorylated by co-precipitated kinases such as PLK1. GFP-
SLX4, or GFP only, was immunoprecipitated from HEK293 cells and precipitates were 
washed and incubated in kinase buffer containing magnesium and [γ-32P]–ATP. SDS–
PAGE and autoradiography revealed a radiolabelled band at the expected molecular 
weight of GFP–SLX4 in precipitates from extracts of cells expressing GFP–SLX4 but 
not GFP only (Fig. 5.2 A and B). Pre–incubation of precipitates with the PLK1 
inhibitors BI 2536 (Lenart et al, 2007; Steegmaier et al, 2007) or BI D1870 (Sapkota et 
al, 2007) dramatically reduced the activity of the SLX4–asscociated kinase. These data 
demonstrate that SLX4 associates with PLK1 and that PLK1 can phosphorylate SLX4 
in vitro. 
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Figure 5.1.2: Phosphorylation of SLX4 by co-precipitating kinases 
A: Cells stably expressing tetracycline inducible GFP-SLX4 were incubated with tetracycline 
for 24 h to induce GFP-SLX4 expression. Cells were lysed and GFP-SLX4 was 
immunoprecipitated with GFP-Trap beads. A GFP-only expressing cell line was used as a 
control. The GFP-SLX4 immunoprecipitates were washed with a lysis buffer containing 750 
mM salt and incubated with the PLK1 inhibitor BI 2536 (5 nM and 15 nM) and BI D1870 (20 
nM and 100 nM) for 15 min. The phosphorylation reactions were started by adding [γ-32P-
ATP] and stopped after 1 hour with LDS sample buffer. The reaction product as well as a GFP-
only control and an untreated sample were subjected to SDS PAGE and the gel was stained with 
colloidal coomassie (upper panel).  
B: Autoradiograph of an overnight exposure of the gel from A.  
C: Schematic model for a possible mechanism of SLX4 phosphorylation by PLK1.  
1. A cyclin dependent kinase phosphorylates one of the four polo-box binding domains (PBD). 
2. PLK1 binds to the PBD with its polo-box domain. 3. PLK1 needs to bind to a phosphorylated 
residue in a polo-box binding domain in order to be able to phosphorylate SLX4, probably on 
Ser287. 
 
  
C. 
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5.3 Discussion 
Human SLX4 has many similarities to yeast Slx4. However, although yeast Slx4 is 
regulated by phosphorylation in a way that controls its function, almost nothing is 
known about the regulation of human SLX4. One can imagine that a protein complex 
with nuclease activity might be very tightly regulated to prevent inappropriate cleavage 
of the genome. SLX4 could be regulated in a variety of ways, by phosphorylation for 
example.  
 
In this Chapter, I described preliminary data showing a possible regulation of SLX4 
through phosphorylation. Apart from being interested in DNA damage inducible 
phosphorylation sites I was interested in studying cell cycle dependent phosphorylation 
of SLX4 by PLK1 and CDKs. In the initial screen for interactors of SLX4 I identified 
PLK1 (Table 3.1). PLK1 plays a role during the cell cycle in particular during G2/M 
transition and metaphase–anaphase transition and the exit from mitosis. PLK1 can 
phosphorylate proteins to positively or negatively modulate their function (Strebhardt & 
Ullrich, 2006). I found that PLK1 binds with a high affinity to SLX4 and this binding is 
resistant to washing with buffers containing up to 1M NaCl and as described PLK1 
phosphorylates SLX4 in vitro (Fig. 5.2). In the context of SLX4 we currently assume 
that SLX4 first needs to be phosphorylated by a CDK on an [pS/pT]-P motif that lies in 
a polo-box binding motif, such as S1453 which is essential for PLK1 binding (Fig. 5.2 
C). In the next step PLK1 is able to bind through its polo-box domain to the 
phosphorylated residue and this enables PLK1 to phosphorylate SLX4. Previous work 
in our laboratory identified S287, a potential PLK1 site, to be phosphorylated on SLX4 
and we raised a phosphorylation specific antibody against this residue. We also raised 
an antibody against phosphorylated S1453, in the PLK1 binding motif on SLX4. These 
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two antibodies should be used to test whether the PLK1 binding is dependent on 
phosphorylation of SLX4 by a CDK. Phosphorylation of S1453 and S287 should be 
tested at different stages of the cell cycle in the presence/absence of CDK inhibitors 
(e.g. olomoucine, roscovitine, RO 3306) (Vermeulen et al, 2003) and the presence of 
PLK1 in SLX4 immunoprecipitates will be investigated. The effects of SLX4 mutated 
in Ser1453 or Ser287 on cell cycle progression will also be interesting to investigate. It 
will be also interesting to see if SLX4 is involved in the repair of DNA damage in 
mitosis.  
 
My data suggested that CDKs and PLK1 might also play a role in the processing of 
SLX4 during the S-phase of the cell cycle. SLX4 is being processed into smaller C- and 
N-terminal fragments during the S-phase of an unperturbed cell cycle. The two N-
terminal ~176kDa and ~128 kDa fragments can still interact with XPF-ERCC1 and the 
C-terminal ~100 kDa fragment can still bind to SLX1. The interaction with MUS81-
EME1 seems to be abolished in S-phase. These observations indicate that the 
interactions of SLX4 with XPF and SLX1 seem to be required in all cell cycle stages, 
whereas the binding of MUS81 to SLX4 is not required in late G1 and S phase. As 
indicated by the gel filtration data from SLX4 mutant FA fibroblasts (EUFA1354) 
MUS81 elutes in fractions of high molecular weight independent of SLX4. Maybe 
MUS81 has SLX4 independent functions during S-phase. The next steps to investigate 
the mechanisms of SLX4 processing during S-phase are to perform a cell cycle 
experiment similar to Fig.5.1 in the presence of DNA damage. Is SLX4 processed 
during S-phase in the presence of DNA damage? Maybe SLX4 is cleaved during an 
unperturbed cell cycle to avoid the potential danger of unneeded DNA cleavage arising 
from a complex with such a high nuclease activity. SLX4 will probably not be cleaved 
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in the presence of DNA damage. Currently the mechanism of this processing of SLX4 
during the cell cycle is unknown and it will be interesting to know which effect the 
processing of SLX4 has on its function in the S phase of the cell cycle. One important 
point to mention is that the smaller SLX4 fragments that we see in SLX4 
immunoprecipitates from S-phase cells might not be products of proteolytic cleavage. 
Maybe they are splicing variants of SLX4. It will be important to use Cyclohexamide, 
an inhibitor of protein synthesis, and also investigate this on the mRNA level. However, 
currently we assume that proteolytic cleavage of SLX4 in S-phase leads to smaller 
fragments of SLX4. It is also important to identify the cleavage sites on SLX4 and to 
find the protease responsible for this event. For this one should make use of mass 
spectrometry tools and protease inhibitors. Once the S-phase dependent cleavage sites 
on SLX4 are known SLX4 fragments can be generated and tested for nuclease activity 
on different substrates. This will help to answer the question if the processed forms of 
SLX4 and the associated nucleases still have nuclease activity and if the substrate 
specificity is affected. These experiments should yield important insights into SLX4 
regulation. 
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7. Conclusions and final discussion 
In this thesis I presented the identification of human SLX4 (BTBD12) as an 
orthologue of yeast Slx4. Human SLX4 acts as a scaffold and coordinator of the 
DNA repair nucleases XPF-ERCC1, MUS81-EME1 and SLX1. I obtained data that 
shows that the SLX4 complex has nuclease activity towards branched DNA 
structures. Furthermore I found evidence that SLX4 is an important factor in the HR 
step of ICL repair, where it acts in the processing of recombination intermediates. 
The SLX1-SLX4 nuclease shows activity towards HJs in vitro and might be 
important for the processing of meiotic crossovers. 
A crucial evidence for the physiologically important role of SLX4 stem from the 
identification of patients with Fanconi anaemia who have mutations in SLX4. 
Therefore SLX4 represents a new member of the FA/BRCA pathway and has been 
named FANC-P. The SLX4 protein in some patient cells is lacking parts of the 
tandem UBZ4 domains and I showed that SLX4 recruitment is dependent on the first 
of the tandem UBZ4 domains and mutations in this domain cause MMC sensitivity. 
In the last chapter I described a possible mechanism of SLX4 regulation by 
phosphorylation and the cell cycle. 
In yeast, Slx4 functions together with Slx1 in the completion of ribosomal DNA 
replication and furthermore, Slx4 acts together with Rad1-Rad10 in SSA. Rad1XPF-
Rad10ERCC1 are conserved in all eukaryotes and therefore it was interesting to 
investigate whether orthologues of Slx4 and Slx1 can be found in higher eukaryotes 
as well. Bioinformatic analyses revealed putative higher eukaryotic orthologues of 
yeast Slx4, the BTBD12 proteins. Like yeast Slx4 BTBD12 is phosphorylated by 
ATM/ATR and furthermore it interacts with the two DNA repair nucleases XPF-
- 193 - 
 
ERCC1 and SLX1. These points strengthened the hypothesis that BTBD12 is indeed 
a human Slx4 orthologue and therefore we referred to it as SLX4 thereafter. 
Surprisingly mass fingerprint analysis revealed that SLX4 interacts with a third 
nuclease, MUS81-EME1.  Gel filtration analyses showed that SLX4 co-elutes with 
XPF-ERCC1, MUS81-EME1 and SLX1 in a high molecular weight complex of 
around 2 MDa (Munoz et al., 2009). 
Depletion of SLX4 or SLX1 from cells causes ICL sensitivity and this indicated a 
role of SLX4 and SLX1 in the repair of ICLs. One important step of ICL repair is 
the processing of recombination intermediates by nucleases during HR. In chapter 3 
I showed that SLX4 immunoprecipitates have nuclease activity towards  3’ flaps, 5’ 
flaps, RFs and HJs and the nuclease activity of the SLX4 associated SSEs towards 
these structures is dependent on SLX4. Therefore I proposed that SLX4 acts as a 
scaffold and regulator of DNA repair nucleases. The activity towards RFs and 3’ 
flaps stems mainly from MUS81-EME1 and is enhanced in the presence of SLX4. 
SLX1 provides the cleavage of HJs with minor contribution of MUS81 and this is 
dependent on SLX4. The activity of the SLX4 complex towards HJs was of 
particular interest and to date only 3 enzymes have been identified in higher 
eukaryotes that can cleave such structures: GEN1, MUS81-EME1 and SLX4-SLX1.  
MUS81-EME1 however preferentially cleaves nicked HJs.  
Interestingly I observed that SLX4 immunoprecipitates cleave HJs in an 
asymmetrical manner. Classical HJ resolvases however are supposed to cleave HJs 
in a symmetrical manner leading to nicked duplexes that can be easily ligated (see 
1.10.3). SLX4 however assembles a toolkit of three SSEs and it is possible that the 
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asymmetrical products generated by SLX1 and MUS81 can be further processed, for 
example by XPF-ERCC1.  
HJs are intermediates of DNA repair and meiosis I and their resolution is crucial. 
Drosophila Mus312SLX4 and C. elegans HIM-18SLX4 mutants show defects in meiotic 
crossover resolution (Andersen et al, 2009; Saito et al, 2009). This indicates a 
physiologically important role of SLX4 and the SLX4 complex. It seems that in flies 
MEI-9, the Drosophila XPF orthologue, plays an important role in meiosis and S. 
pombe Mus81 mutants do not produce viable spores. A recent paper shows that C. 
elegans slx1 mutants have an altered crossover distribution, but not crossover 
frequency, in meiosis. Furthermore the authors suggest that SLX1 acts as a non-
crossover promoting factor in DSB repair (Saito et al, 2012). 
The main clue about the physiological importance of SLX4 came from the 
observation that cells depleted of SLX4 using siRNA are sensitive towards 
crosslinking agents, suggesting an involvement of SLX4 in the repair of ICLs. 
Cellular ICL sensitivity is a hallmark of the genetic disease FA. Therefore we 
hypothesised that SLX4 is important for ICL repair and it might be mutated in FA. 
This hypothesis was confirmed with the identification of one patient with FA 
(EUFA1354) who has a mutation in SLX4 that leads to the expression of very low 
levels of a truncated SLX4 protein (Stoepker et al, 2011). This protein interacts with 
the three SSEs of the SLX4 complex, gel filtration analysis however revealed that 
SLX4 and SLX1 are no longer detectable in a high molecular weight complex in 
contrast to extracts from normal cells. MUS81 however can be still found in a high 
molecular weight complex, indicating a SLX4 independent function (Stoepker et al, 
2011). We proposed that the FA phenotype of these cells is due to the very low 
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levels of the SLX4 complex. SLX4 cannot fulfil its role as a scaffold. Furthermore, 
low levels of SLX4 protein in cells lead to low expression of SLX1 and this causes 
the lack of SLX1 nuclease activity. Interestingly low levels of SLX4 protein also 
affect the correct cellular localisation of XPF-ERCC1. In normal cells XPF-ERCC1 
forms spontaneous sub-nuclear foci. These foci are undetectable in EUFA1354 
fibroblasts. They are however rescued by expression of exogenous SLX4 in these 
cells (Stoepker at al., 2011). SLX4 is therefore essential for the localisation of XPF 
to chromatin and probably for its function. 
We identified a second family with three siblings suffering from FA. The SLX4 
protein expressed in cells from these patients (VU 1600) lacks parts of the first and 
the whole second UBZ4 domain of SLX4. The expression levels of SLX4 in these 
cells are normal and the mutant protein can still interact with XPF-ERCC1, MUS81-
EME1 and SLX1 (Stoepker et al, 2011). This suggested that the FA phenotype 
might be caused by the lack of a functional UBZ domain. I showed that the first of 
the two UBZ domains in SLX4 binds K63 linked poly-ubiquitin chains. Furthermore 
I demonstrated in SLX4 complemented SLX4 -/- MEFs that the recruitment of SLX4 
is dependent on the first UBZ domain. Interestingly, mutations in the first of the two 
UBZ domains cause MMC sensitivity. Taken together this shows that mutations in 
the first UBZ domain cause FA. It will be important to make SLX4 mutant cell lines 
that correspond to the mutations found in the VU1600 cells. These cells should be 
then tested for MMC sensitivity and recruitment of SLX4. 
In summary SLX4 is recruited to sites of DNA damage via the first of the two UBZ 
domains in its N-terminus by binding to a yet unidentified poly-ubiquitinated 
substrate. Once recruited, SLX4 can fulfil its function in ICL repair as a scaffold and 
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regulator of DNA repair nucleases. In FANCP cells FANCD2 is mono-ubiquitinated 
and gamma-H2AX foci form, they however persist. This indicates that SLX4 acts in 
ICL repair downstream of FANCD2 mono-ubiquitination after the DSB generation 
by MUS81. It might be involved in the HR step of ICL repair and the associated 
nucleases can cleave the recombination intermediates that arise during HR. 
Interestingly SLX4 is not only a scaffold for DNA repair nucleases. It also interacts 
with other proteins, such as TRF2, a member of the shelterin complex, and the 
protein kinase PLK1 (Munoz et al, 2009). A recent paper describes that knockdown 
of SLX4 results in lower cellular levels of TRF2 and a reduced number of 
hSNM1B/Apollo foci, however the authors attribute the reduction of 
hSNM1B/Apollo foci to the reduced levels of TRF2 and not directly to the SLX4 
knockdown. Furthermore hSNM1B/Apollo has been shown to be a new interactor of 
SLX4 and both act epistatically in the FA/BRCA pathway downstream of FANCD2 
mono-ubiquitination in HR (Salewsky et al, 2012).  
In the initial mass fingerprint analysis for potential interactors of SLX4 I identified 
the protein kinase PLK1. Previous studies in the lab identified the phosphorylation 
site S287 on SLX4 as potential PLK1 phosphorylating site. Furthermore I found that 
SLX4 is phosphorylated on S1453. This is a CDK consensus site. I proposed that 
SLX4 is phosphorylated by a CDK which allows PLK1 to bind with its polo box and 
then it can in turn phosphorylate SLX4 on S287. Interestingly I observed that SLX4 
is processed into fragments of lower molecular weight in the G1/S transition of the 
cell cycle. It is important to ask whether the phosphorylation of SLX4 by CDKs and 
PLK1 participates in this processing event. During this process, SLX4 is cleaved 
into N- and C-terminal fragments. The N-terminal fragment still associates with 
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XPF-ERCC1 and the C-terminal fragment associates with SLX1. MUS81-EME1 
does not seem to associate with SLX4 in S phase of the cell cycle. It will be very 
interesting to investigate the role of this processing for SLX4 function. Why is 
MUS81 not bound to SLX4 in S-phase? It will be also important to investigate 
whether the cleaved fragments have nuclease activity. It is also not clear whether 
this processing can be observed when cells have been treated with DNA damage.  
In this thesis I have answered some questions about SLX4, however there are still 
plenty remaining, many of which will be hopefully answered soon. 
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